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Abstract 
GLUT4 is the insulin-regulated glucose transporter found in muscle and adipose 
tissue.  On insulin stimulation, GLUT4 translocates from a slowly recycling 
storage compartment (GLUT4 storage vesicles or GSVs) to the plasma membrane.  
This allows glucose to enter cells by diffusion down its concentration gradient, 
clearing glucose from the plasma.  This response is defective in the disease 
states of insulin resistance and type 2 diabetes.  The aim of this study is to 
understand how GLUT4 enters GSVs, which will hopefully extend our knowledge 
of insulin responsive tissues. 
Previous studies from our lab, expressing GLUT4 in yeast, have shown that 
GLUT4 is subject to the same nitrogen- and ubiquitin-dependent trafficking as 
the yeast amino acid permease Gap1p.  In my thesis I have extended these 
studies into 3T3-L1 adipocytes, and shown that GLUT4 is ubiquitinated in this 
insulin responsive cell line.  A ubiquitin resistant version of GLUT4 (HA-GLUT4 
7K/R) has an impaired ability to enter GSVs and does not translocate in response 
to insulin.  However GLUT4 mutants with single ubiquitination sites outwith the 
large intracellular loop are ubiquitinated and traffic in an identical manner to 
wild type GLUT4, addressing concerns that mutation of the large intracellular 
loop of GLUT4 in HA-GLUT4 7K/R affects its trafficking. 
The GGA family of clathrin adaptor proteins have previously been implicated in 
sorting of newly synthesised GLUT4 into GSVs.  Our lab has shown previously that 
the two yeast Ggas are required for ubiquitin dependent trafficking of GLUT4 in 
yeast, as is the case for Gap1p.  I have gone on to show that the ubiquitin 
binding function of the GGA3 GAT domain is, at least partially, required for an in 
vitro interaction between GLUT4 and the VHS-GAT domains of GGA3.  When 
expressed in adipocytes, a ubiquitin binding deficient mutant of myc-GGA3 
reduces the proportion of GLUT4 loaded into a subcellular fraction enriched in 
GSVs, suggesting that GLUT4 ubiquitination is one of the signals for GGA 
dependent sorting into GSVs. 
As ubiquitination is usually thought of as a signal to direct lysosomal 
degradation, and only 0.1 % of total GLUT4 is ubiquitinated at any one time, 
there may be a role for a deubiquitination step in ubiquitin dependent GLUT4 
traffic.  Work by our collaborator (Nai-Wen Chi, UCSD) has demonstrated that 
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the GSV cargo IRAP and its binding partner tankyrase-1 are required for normal 
insulin responsive GLUT4 traffic.  An interaction between tankyrase and the 
deubiquitinase (DUB) USP25 has been demonstrated by yeast two hybrid analysis, 
and this DUB contains a putative tankyrase binding motif.  USP25 may therefore 
be recruited to GSVs by IRAP, with tankyrase acting as a scaffold.  I 
demonstrated that GST-USP25 binds tankyrase-1 from an adipocyte lysate, and 
that a version of the enzyme with a mutation in the putative tankyrase binding 
motif (GST-USP25 R1049A) does not.  I also used siRNA to deplete USP25 from 
3T3-L1 adipocytes, and found that this results in a reduction of GLUT4 levels in 
these cells.  A concomitant reduction in the fold change of insulin-stimulated 
glucose transport into these cells suggests that GLUT4 is not sequestered in 
GSVs, but is rather directed to the lysosome.   
In summary, my data show that ubiquitination of GLUT4 is required for the 
transporter to be loaded into its insulin responsive compartment (GSVs).  I also 
began to characterise the role of the ubiquitin binding GAT domain of GGA3 and 
the deubiquitinase USP25 in GLUT4 traffic, opening up two further avenues for 
research into the insulin regulated trafficking of GLUT4. 
 
4 
Table of contents 
 
Abstract ..................................................................................... 2 
List of tables................................................................................ 7 
List of figures............................................................................... 8 
Acknowledgements.......................................................................10 
Declaration ................................................................................11 
Abbreviations..............................................................................12 
Chapter 1 – Introduction ................................................................16 
1.1 Compartmentalisation of eukaryotic cells .................................. 17 
1.1.1 Vesicle traffic.............................................................. 18 
1.1.2 SNARE proteins ............................................................ 19 
1.1.3 Intrinsic protein signals................................................... 20 
1.1.4 Sorting via post-translational modification............................ 20 
1.1.5 Ubiquitin as a post translational modification. ....................... 21 
1.1.6 Other ubiquitin modifications. .......................................... 22 
1.2 Ubiquitination regulates protein traffic..................................... 23 
1.2.1 ESCRTs and multivesicular body sorting. .............................. 24 
1.2.2 GGA proteins sort ubiquitinated substrates ........................... 26 
1.3 Deubiquitinating enzymes (DUBs) ............................................ 28 
1.3.1 Role of DUBs in endocytic and endosomal traffic. ................... 29 
1.4 GLUT4 and Type 2 diabetes. .................................................. 31 
1.4.1 Glucose homeostasis and Type 2 Diabetes ............................ 31 
1.4.2 GLUT4....................................................................... 33 
1.4.3 GLUT4 traffic in insulin responsive cells............................... 34 
1.4.4 GLUT4 Storage vesicles................................................... 36 
1.5 A role for ubiquitin in the trafficking of GLUT4?........................... 38 
1.5.1 Ubiquitin-like proteins regulate GLUT4 traffic. ...................... 38 
1.5.2 Evidence from yeast. ..................................................... 40 
1.5.3 Evidence from 3T3-L1 adipocytes....................................... 40 
1.5.4 GGA proteins regulate GLUT4 entry into GSVs........................ 41 
1.6 Is GLUT4 deubiquitination required for its insulin responsive traffic? .. 42 
1.6.1 IRAP and Tankyrase ....................................................... 43 
1.6.2 USP25: a candidate GLUT4 DUB......................................... 44 
1.6.3 3T3-L1 adipocyte data versus knockout mice: a confusing picture.47 
1.7 A model for ubiquitin dependent loading of GLUT4 into GSVs........... 48 
1.8 Aims of the project............................................................. 48 
Chapter 2 - Materials & Methods ......................................................49 
2.1 Materials. ........................................................................ 50 
2.1.1 Reagents, enzymes and media components........................... 50 
2.1.2 Bacterial and yeast strains............................................... 50 
2.2 Yeast cell culture............................................................... 50 
2.2.1 Preparation of yeast competent cells .................................. 51 
2.2.2 Yeast transformation ..................................................... 51 
2.2.3 Preparation of yeast cell lysates for SDS-PAGE and immunoblot... 51 
2.2.4 Plasmid rescue from yeast ............................................... 52 
2.2.5 APNE assay. ................................................................ 52 
2.3 Mammalian cell culture techniques.......................................... 53 
2.3.1 Cell culture of 3T3-L1 murine fibroblasts and adipocytes .......... 53 
2.3.2 RNA oligonucleotide synthesis........................................... 53 
2.3.3 Transfection of 3T3-L1 adipocytes with siRNA oligonucleotides. .. 53 
2.3.4 Retroviral infection of 3T3-L1 fibroblasts ............................. 54 
5 
2.3.5 Cell culture of Plat-E cells ............................................... 54 
2.3.6 Preparation of retrovirus using Plat-E cells. .......................... 54 
2.4 DNA manipulation .............................................................. 54 
2.4.1 Plasmid DNA purification................................................. 55 
2.4.2 DNA oligonucleotide synthesis........................................... 55 
2.4.3 Polymerase Chain Reaction .............................................. 55 
2.4.4 Site Directed Mutagenesis................................................ 57 
2.4.5 Plasmid construction...................................................... 58 
2.5 Protein methods ................................................................ 59 
2.5.1 Elecrophoretic separation of proteins.................................. 59 
2.5.2 Transfer of proteins to nitrocellulose membranes ................... 60 
2.5.3 Immunoblot analysis ...................................................... 60 
2.5.4 Antibodies .................................................................. 60 
2.5.5 Quantification of immunoblots.......................................... 61 
2.5.6 GST fusion protein preparation ......................................... 61 
2.5.7 GST fusion protein concentration estimation ......................... 62 
2.6 GST fusion protein pull-down with yeast lysate............................ 62 
2.7 GST fusion protein pull-down with 3T3-L1 adipocyte lysate. ............ 63 
2.8 Indirect immunofluorescence with 3T3-L1 adipocytes. ................... 64 
2.9 [3H]2-Deoxyglucose uptake assays ........................................... 64 
2.10 Isolation of low density microsomes from 3T3-L1 adipocytes............ 65 
2.11 Iodixanol gradient analysis of LDMs from 3T3-L1 adipocytes............. 66 
2.12 Enrichment of GSVs using subcellular fractionation....................... 66 
Chapter 3 - Ubiquitination and insulin responsive trafficking of GLUT4 ......73 
3.1 Introduction ..................................................................... 74 
3.2 Aims of the chapter. ........................................................... 77 
3.3 Expression of HA-GLUT4 and HA-GLUT4 7K/R .............................. 78 
3.4 A single ubiquitination site is sufficient to permit insulin-stimulated 
translocation of GLUT4. ............................................................... 81 
3.4.1 HA-GLUT4 6K/R K109 and K495 are ubiquitinated in 3T3-L1 
adipocytes............................................................................. 81 
3.4.2 HA-GLUT4 7K/R cannot translocate in response to insulin.......... 85 
3.4.3 HA-GLUT4 6K/R K109 and K495 translocate readily in response to 
insulin stimulation. .................................................................. 87 
3.5 Does the 7K/R mutation affect loading of GLUT4 into the insulin 
responsive compartment? ............................................................. 88 
3.6 Chapter discussion.............................................................. 93 
Chapter 4 - The ubiquitin binding GAT domain of GGA3 in ubiquitin mediated 
GLUT4 traffic. .............................................................................96 
4.1 Introduction ..................................................................... 97 
4.2 Aims of the chapter. ........................................................... 99 
4.3 Ubiquitin and GLUT4 interaction with the GGA3 GAT domain. .......... 99 
4.3.1 Mutagenesis of the GAT domain ablates ubiquitin binding in vitro.99 
4.3.2 Expression of HA-GLUT4 and HA-GLUT4 7K/R in yeast. ............102 
4.3.3 Construction of the yeast strain BHNY1...............................104 
4.3.4 An in vitro interaction between GLUT4 and GST-GGA3-VHS-GAT is 
partly ubiquitin dependent. .......................................................107 
4.4 Expression of a ubiquitin-binding mutant of myc-GGA3 in 3T3-L1 
adipocytes. .............................................................................109 
4.4.1 Does expression of myc-GGA3 and myc-GGA3mut alter GLUT4 loading 
into the insulin responsive compartment?.......................................113 
4.4.2 Does expression of myc-GGA3 and myc-GGA3mut alter insulin 
responsive [3H]2-deoxyglucose uptake?..........................................115 
6 
4.5 Chapter Discussion.............................................................117 
Chapter 5 - Deubiquitination and GLUT4 traffic. ................................ 122 
5.1 Introduction ....................................................................123 
5.2 Aims of the chapter ...........................................................125 
5.3 In vitro interaction of USP25 with tankyrase 1............................125 
5.3.1 Expression and purification of recombinant GST-USP25............126 
5.3.2 Pull-down assay on adipocyte lysates using GST and GST-USP25 .127 
5.3.3 Does mutation of the putative tankyrase binding motif of USP25 
disrupt the in vitro interaction with tankyrase?................................129 
5.4 siRNA mediated depletion of USP25 in 3T3-L1 adipocytes reduces GLUT4 
stability .................................................................................131 
5.4.1 Is GLUT4 redirected to the lysosome as a consequence of USP25 
depletion? ............................................................................132 
5.4.2 Is glucose uptake affected by depletion of USP25? .................134 
5.5 Generation and characterisation of USP25 antisera. .....................135 
5.6 Chapter Discussion.............................................................139 
Chapter 6 – Final Discussion .......................................................... 145 
6.1 Ubiquitination of GLUT4......................................................146 
6.2 The GGA3 GAT domain and GLUT4 traffic. ................................149 
6.3 The deubiquitinase USP25 and GLUT4 traffic. ............................152 
6.4 Future directions ..............................................................154 
Chapter 7 – Appendices ............................................................... 156 
7.1 Appendix I – Glucose transport assay data for Figure 4.11 ..............157 
7.2 Appendix II – Glucose transport assay data for Figure 5.9 ...............158 
7.3 Appendix III – publications arising from this work ........................159 
Bibliography ............................................................................. 160 
 
7 
List of tables 
Table 2.1 Primary antibodies used in this study. ..................................... 67 
Table 2.2 Secondary antibodies used in this study. .................................. 68 
Table 2.3 Plasmids used in this study .................................................. 70 
Table 2.4 siRNA target sequences used in this study................................. 70 
Table 2.5 DNA oligonucleotides used in this study ................................... 71 
Table 2.6 E. coli strains used in this study. ........................................... 72 
Table 2.7 S. cerevisiae strains used in this study..................................... 72 
Table 3.1 Percentage translocation of HA-GLUT4 and mutants thereof in 
response to 200 nM insulin. .............................................................. 87 
Table 7.1 [3H] 2-deoxyglucose uptake data for Figure 4.11........................157 
Table 7.2 Glucose transport assay data for Figure 5.9..............................158 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
List of figures 
Figure 1.1 Organelles within a mammalian cell....................................... 17 
Figure 1.2 Ubiquitin conjugation to target proteins. ................................ 22 
Figure 1.3 Gap1p traffic in S. Cerevisiae .............................................. 24 
Figure 1.4 Membrane protein trafficking to multivesicular bodies................. 25 
Figure 1.5 Domain structure of a typical GGA protein............................... 27 
Figure 1.6 Regulation of glucose homeostasis by insulin. ........................... 32 
Figure 1.7 Insulin stimulates translocation of GLUT4 from intracellular stores to 
the cell surface. ........................................................................... 33 
Figure 1.8 A model of GLUT4 traffic in insulin responsive cells. ................... 36 
Figure 1.9 A ubiquitin-resistant version of GLUT4 cannot exit the syntaxin 16 
positive subdomain of the TGN in 3T3-L1 adipocytes. ............................... 40 
Figure 1.10 Schematic of tankyrase-1 and 2. ......................................... 44 
Figure 1.11 Schematic of USP25a. ...................................................... 45 
Figure 1.12 Model for USP25 regulation by SUMOlation and ubiquitination. ..... 46 
Figure 1.13 A model for ubiquitin dependent GLUT4 loading into GSVs. ......... 48 
Figure 3.1 hGLUT4 expressed in yeast requires ubiquitin acceptor sites to enter 
the proteolytically active endosomal system. ........................................ 76 
Figure 3.2 Schematic of GLUT4 in the plasma membrane with cytosolic lysines 
(putative ubiquitination sites) indicated............................................... 77 
Figure 3.3 DNA sequence alignment of HA-GLUT4 from pHA-GLUT4 and the 
hGLUT4 sequence. ........................................................................ 79 
Figure 3.4 Construction of pRM55....................................................... 80 
Figure 3.5 Expression of HA-GLUT4 and mutants in 3T3-L1 adipocytes. .......... 81 
Figure 3.6 GLUT4 is ubiquitinated in 3T3-L1 adipocytes. ........................... 83 
Figure 3.7 Ubiquitination of HA-GLUT4 variants in 3T3-L1 adipocytes. ........... 84 
Figure 3.8 HA-GLUT4 7K/R cannot translocate in response to insulin. ............ 86 
Figure 3.9 Three example iodixanol gradient fractionation profiles of HA-GLUT4 
in 3T3-L1 adipocytes. ..................................................................... 90 
Figure 3.10 HA-GLUT4 7K-R cannot enter the insulin responsive compartment. 92 
Figure 4.1 Purification of GGA3 VHS-GATmut. ........................................100 
Figure 4.2 Mutation of the GAT domain ablates ubiquitin binding in vitro. .....101 
Figure 4.3 Generation of pCAL4. .......................................................103 
Figure 4.4 Expression of HA-GLUT4 in yeast..........................................104 
Figure 4.5 HA-GLUT4 expressed in yeast interacts with GST-VHS-GAT...........105 
Figure 4.6 GLUT4 expressed in yeast interacts with GST-VHS-GAT in a ubiquitin 
dependent manner. ......................................................................107 
Figure 4.7 GST-VHS-GAT pull-down assay on 3T3-L1 adipocyte lysates. .........109 
Figure 4.8 Expression of myc-GGA3 and myc-GGA3mut in 3T3-L1 adipocytes. ...111 
Figure 4.9 Localisation of myc-GGA3 and myc-GGA3mut expressed in 3T3-L1 
adipocytes. ................................................................................112 
Figure 4.10 GLUT4 loading into the 16,000 xg supernatant is reduced by 
expression of myc-GGA3mut. ............................................................114 
Figure 4.11 Insulin stimulated glucose uptake rate is not affected by expression 
of myc-GGA3 or myc-GGA3mut. .........................................................116 
Figure 4.12 Recombinant GGA3 proteins used in this chapter.....................117 
Figure 4.13 A model for GGA function in GSV cargo recruitment. ................120 
Figure 5.1 Protein sequence alignment of vertebrate USP25. .....................126 
Figure 5.2 Coomassie stained SDS-PAGE gel of GST-USP25 purification..........127 
Figure 5.3 Comparison of GST-USP25 and GST protein expression levels. .......128 
9 
Figure 5.4 Pull-down assay on adipocyte lysates using immobilised recombinant 
GST and GST-USP25. .....................................................................129 
Figure 5.5 Quantification of purified GST-USP25 and GST-USP25 R1049A. ......130 
Figure 5.6 Mutation of the conserved arginine residue in the USP25 tankyrase 
binding motif prevents interaction with tankyrase 1. ..............................131 
Figure 5.7 siRNA mediated depletion of USP25 results in a reduction in GLUT4 
protein levels. ............................................................................132 
Figure 5.8 Treatment of siRNA transfected 3T3-L1 adipocytes with 15 mM NH4Cl.
..............................................................................................134 
Figure 5.9 Fold change in [3H] 2-deoxyglucose uptake is reduced on insulin 
stimulation of USP25 depleted 3T3-L1 adipocytes. .................................135 
Figure 5.10 Thrombin cleavage of GST-USP25. ......................................136 
Figure 5.11 Sera from rabbits 2198 and 2199 tested against recombinant GST and 
GST-USP25. ................................................................................137 
Figure 5.12 Testing sera 2198 and 2199 against 3T3-L1 adipocyte lysates. .....138 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
Acknowledgements 
First of all I’d like to thank my supervisor Dr. Nia Bryant for all the constructive 
criticism, advice and support over the last few years, especially running those 
gels when I was getting a bit overwhelmed and letting me stop doing iodixanol 
gradients…!  THANK YOU. 
 
A big thank you to Dr Rebecca McCann (aka Wee Becky, Beckster etc) for getting 
the ball rolling on the GLUT4-ubiquitin project, and answering my repeated 
questions in the early days.  Most importantly, thank you for the box of index 
cards with solution and media recipes – the importance of which cannot be 
underestimated.   
 
Thank you to Dr Scott Shanks (aka Dr Scotch Eggs) for being a generally awesome 
benchmate (and neighbour), and providing a sounding board and source of all 
yeast and PCR knowledge.  Also thanks to Dr Chris Macdonald (aka The Curly 
One/Zebra) for the regular cloning advice, pub sessions and the template for a 
low-stress write-up.  This is probably the time to apologise for all the buffers I 
stole, sorry about that… 
 
Thanks to the rest of the current Bryant group, especially Iain for being a 
competent (ahem) “minion”, and those who have gone on to better things – 
Tom, Lindsay (COG), and Maz.  You’ve all helped in big or small ways.  Also to 
the rest of lab 241, especially the 3T3-L1/GLUT4 crew (holla!), thanks for the 
help, advice and general banter (especially during long sessions in the virus room 
of cell culture eh Andy?) over the last few years.  Also thank you to Professor 
Frances Brosky’s group at UCSF for making my visit there enjoyable. 
 
Thanks to all my other friends up in Glasgow for the good times over the last few 
years, especially those going through a PhD at the same time.  It’s good to know 
I wasn’t alone.  Also to the Sunday night Cooper’s pub quiz team and all the 
people I met through GUSWPC for keeping me active, healthy and occasionally 
inebriated during my time at Glasgow. 
 
Finally a massive thank you to Mum and Dad (Linda and John) for the constant 
encouragement, advice, love and support. 
11 
Declaration 
 
I declare that the work presented in this thesis has been carried out by myself 
unless otherwise stated.  It is entirely of my own composition and has not been 
submitted, in whole or in part, for any other degree.  Permission has been 
granted by the publisher for any reproduced figures. 
 
 
Christopher Anthony Lamb 
 
November 2010 
 
12 
Abbreviations 
~  approximately 
ADP  adenosine diphosphate 
ALP  alkaline phosphatise 
A  amps 
AP  adaptor protein/assembly polypeptide complex 
APNE  N-acetyl-DL-phenylalanine β-naphthyl ester 
AS160  Akt substrate of 160 kilodaltons 
ARF  ADP ribosylation factor 
ATP  adenosine triphosphate 
b  DNA base pair   
BSA  bovine serum albumin 
°C  degrees Celsius 
cDNA  complementary DNA 
CEN  centromeric 
cfu  colony forming unit 
Ci  curie 
CPS  carboxypeptidase S 
CPY  carboxypeptidase Y 
C-terminal carboxy terminal 
CuSO4  copper sulphate 
ddH2O  double distilled water 
DMEM  Dulbecco’s modified Eagle’s medium 
DMF  dimethyl formamide 
DMSO  dimethyl sulphoxide 
DNA  deoxyribonucleic acid 
DNTP  deoxynucleotide triphosphate 
DUB  deubiquitinating enzyme 
E1  ubiquitin activating enzyme 
E2  ubiquitin conjugating enzyme 
E3  ubiquitin ligase 
E. coli  Escherichia coli 
ECL  enhanced chemiluminescence 
EDTA  ethylenediamine tetraacetic acid 
ER  endoplasmic reticulum 
13 
FCS  foetal calf serum 
FM4-64 N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenyl-
hexatrienyl)pyridiumdibromide 
5-FOA  5-fluoroorotic acid 
g  gram 
xg  multiple of gravitational force 
GAE  γ adaptin ear 
GAT  GGA and TOM1 
GFP  Aequorea victoria green fluorescent protein 
GGA  Golgi localised, γ adaptin ear containing, ARF binding protein 
GLUT  glucose transporter 
GST  glutathione-S-transferase 
GSV  GLUT4 storage vesicle 
GUV  giant unilamellar vesicle 
H2O2  hydrogen peroxide 
HA  influenza haemagglutinin epitope tag 
HCl  hydrochloric acid 
HDM  high density microsome 
HEPES  2[4(2-Hydroxyethyl)-1-piperazine]ethanesulphonic acid 
HES  HEPES, sucrose, EDTA 
HRP  horseradish peroxidise 
Ig  immunoglobulin isotype 
IPTG  isopropyl-β-D-thiogalactopyranoside 
IRAP  insulin responsive aminopeptidase 
IRS  insulin receptor substrate 
IRV  insulin responsive vesicle 
JAMM  JAB1, MPN/MOV34 metalloenzymes 
k  kilo (prefix) 
KCl  potassium chloride 
kd  dissociation constant 
K2HPO4 dipotassium hydrogen orthophosphate 
KH2PO4 potassium dihydrogen orthophosphate 
KOAc  potassium acetate 
KOH  potassium hydroxide 
l  litre 
LDM  low density microsome 
LiOAC  lithium acetate 
14 
LSB  Laemmli’s sample buffer 
µ  micro (prefix) 
m  milli (prefix) 
M  molar 
MgSO4  magnesium sulphate 
MHCII  major histocompatability complex class II molecule 
min  minute 
MVB  multivesicular body 
n  nano (prefix) 
N-terminal Amino-terminal 
NaCl  sodium chloride 
Na2HPO4 disodium hydrogen orthophosphate 
NaH2PO4 sodiun dihydrogen orthophosphate 
NaOH  sodium hydroxide 
NCS  newborn calf serum 
NEM  N-ethyl maleimide 
NH4Cl  ammonium chloride 
NSF  N-ethyl maleimide sensitive factor 
OD600  optical density at 600 nm 
ORF  open reading frame 
OTU  otubain 
p  pico (prefix)  
PAGE  polyacrylamide gel elecrophoresis 
PBS  phosphate buffered saline 
PBS-T  0.1 % Tween-20 in phosphate buffered saline 
PCR  polymerase chain reaction 
PI  phosphatidylinositol 
PIPES  1,4-piperazinediethanesulphonic acid 
PKB  protein kinase B/Akt 
PKC  protein kinase C 
RNA  ribonucleic acid 
RS  retention sequence 
S. cerevisiae Saccharomyces cerevisiae; Baker’s yeast 
SD  yeast synthetic dextrose media 
SDM  site directed mutagenesis 
SDS  sodium dodecyl sulphate 
SH2  Src-homology 2 
15 
SIM  SUMO interacting motif 
siRNA  short interfering RNA 
SNARE  soluble NSF attachment protein receptor 
SUMO  small ubiquitin like modifier 
TAE  tris-acetic acid-EDTA 
TE  tris-EDTA 
TEMED N,N,N’,N’,-tetramethyl ethylene diamine 
TfR  transferrin receptor 
TGN  trans-Golgi network 
Tris  2-amino-2(hydroxymethyl)-1,3-propanediol 
Ub  ubiquitin 
UBA  ubiquitin associated domain 
Ubc  ubiquitin conjugating enzyme 
UBL  ubiquitin like 
UBX  ubiquitin regulatory X 
UCH  Ubiquitin C-terminal hydrolase 
UIM  ubiquitin interacting motif 
USP  ubiquitin specific protease 
UTR  untranslated region 
VAMP  vesicle associated membrane protein 
VHS  Vps27, Hrs, STAM 
VPS  vacuolar protein sorting 
v/v  units per unit volume 
w/v  units weight per unit volume 
Wnt  Wingless/Int protein 
YPD  yeast extract, peptone, dextrose 
YT  yeast extract, tryptone, NaCl 
  
 
 
 
 
Chapter 1 – Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1  17 
1.1 Compartmentalisation of eukaryotic cells 
One of the defining features of eukaryotic cells is the presence of internal 
membrane bound organelles, such as the nucleus, mitochondria and an 
endomembrane system (Figure 1.1) (Vellai and Vida, 1999;Dacks and Field, 
2007).  These characteristics allow the compartmentalisation of reactions in 
specialised organelles.  For example, lysosomes are the site of hydrolysis of 
proteins and phagocytosed particles, peroxisomes are the location of peroxide 
breakdown, secretory protein synthesis occurs at the endoplasmic reticulum, 
and so on. 
Lysosome
Mitochondrion
Endoplasmic 
Reticulum
Nucleus
Golgi apparatus
EndosomeTransport vesicles
 
Figure 1.1 Organelles within a mammalian cell. 
Reproduced with permission from http://www.abcam.com/index.html?pageconfig=resource&rid=16 
 
A problem with this system is that molecules may need to move from one 
compartment to another to carry out their function.  As an example, secreted 
proteins are synthesised in the endoplasmic reticulum, modified in the Golgi 
membranes and must then reach the plasma membrane.  Additionally, many 
cells need to move molecules from one compartment to another in response to 
external stimuli.  Examples of this include mast cell degranulation in response to 
stimulation with specific antigen (Lawson et al., 1978), secretion of hormones, 
such as insulin secretion in response to raised plasma glucose (Eliasson et al., 
2008), and synaptic vesicle exocytosis (Martin, 1997). 
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Therefore, mechanisms must be in place to permit the movement of proteins 
from one compartment to another, allowing molecules to move to the correct 
site to carry out their function while still maintaining organellar identity. 
 
1.1.1 Vesicle traffic 
One of the main routes by which proteins can move from one compartment to 
another is through the formation of coated vesicles (Kirchhausen, 2000).  The 
formation of coated vesicles is required to collect molecules destined for 
another compartment together, helping to maintain organelle identity 
throughout the life of a cell.  There are three main coat protein families found 
in mammalian and yeast cells.  COPI (coatomer protein I) consists of a complex 
with seven subunits which appears to be involved in retrograde traffic from the 
Golgi to the endoplasmic reticulum and through the Golgi cisternae 
(Kirchhausen, 2000). GTP-bound ArfI is responsible for recruiting COPI complexes 
to membranes (Serafini et al., 1991).  The γ subunit of the COPI complex is 
responsible for cargo recognition, recognising cytosolic motifs such as the 
dilysine (KKXX) (Harter et al., 1996). 
COPII coated vesicles are required for anterograde traffic from the endoplasmic 
reticulum to the Golgi (Kirchhausen, 2000).  The GTPase Sec12p recruits Sar1p to 
the membrane (Barlowe et al., 1993;Barlowe and Schekman, 1993) and this 
forms the basis for a complex forming which includes the cargo recognition 
module of Sec23/24p and the Sec13/Sec31p coat (Barlowe et al., 1994). 
Clathrin coats are the third main family of vesicle coat complexes and are 
distributed throughout various intracellular transport processes. Clathrin coats 
consist of heavy and light chains, with three heavy chains forming a three legged 
structure (“triskelion”) and these recruit the light chain (Brodsky et al., 2001).  
However clathrin coats do not interact with vesicle cargos directly – they rely on 
adaptor molecules to facilitate interaction (Knuehl et al., 2006). 
The role of clathrin adaptors is to link the cytosolic domains of vesicle cargos 
and sorting receptors (via specific sorting motifs as described in section 1.1.3) 
with clathrin coats (Robinson, 2004).  Several protein families fulfil this role – 
these include Dab2 (Mishra et al., 2002), the GGAs (Golgi localised, γ-adaptin 
ear containing, ARF-binding proteins) (Pelham, 2004;Robinson, 2004) and the AP 
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(adaptor protein/assembly polypeptide) complexes 1-4 (Robinson, 2004).  AP1 
and 2 were the first adaptors characterised (Keen, 1987;Robinson, 2004).  GGAs 
are discussed more extensively in section 1.2.2.  
 
1.1.2 SNARE proteins 
To allow transport vesicles to reach their target compartment, a mechanism for 
selective targeting of said compartments is required.  This selectivity is 
conferred in part by a family of proteins called SNAREs (soluble, N-ethyl 
maleimide sensitive factor attachment receptor proteins) (McNew et al., 2000).  
SNAREs are often termed the “minimal machinery for membrane fusion” as 
purified SNARE proteins reconstituted in liposomes can induce liposome fusion in 
vitro (Weber et al., 1998). 
In general, SNAREs have a single transmembrane domain, a highly conserved 60-
70 amino acid SNARE motif and an N terminal peptide of variable length and 
structure (Jahn and Scheller, 2006).  Fusion occurs when four SNARE motifs align 
in parallel and interact to form an energetically favourable core complex (Sutton 
et al., 1998).  The four SNARE motifs are generally contributed by two or three 
Q SNAREs (with a central glutamine residue) and one R SNARE (with a central 
arginine residue) (Fasshauer et al., 1998).  The four SNARE motifs zipper 
together, pulling vesicle and target membranes together and contributing to 
fusion of the membranes.  All participating SNAREs subsequently exist as a 
complex on the target membrane (the cis-complex).  The cis-complex is 
disassembled in an ATP-dependent manner (Sollner et al., 1993), which allows 
the SNAREs to be recycled for further rounds of fusion (Jahn and Scheller, 2006). 
SNARE proteins associate with specific membranes within the cell where they 
catalyse particular fusion reactions.  For example, syntaxin-4 is a plasma 
membrane SNARE, whereas VAMP2 is associated with secretory vesicles, such as 
those involved in neurotransmitter release (Hong, 2005).  This means that 
specific SNARE complexes can form between these membranes to facilitate 
membrane fusion (McNew et al., 2000). 
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1.1.3 Intrinsic protein signals 
Proteins themselves may contain intrinsic signals that direct their trafficking 
from one compartment to another, due to recognition by coat protein 
components or their adaptors (as discussed in 1.1.1). Two well characterised 
intrinsic sorting motifs are acidic dileucine motifs, usually conforming to the 
sequence DXXLL, and tyrosine based motifs (YXXΦ, where Φ is a bulky 
hydrophobic residue).  The acidic dileucine motif is found in proteins which are 
sorted from the trans-Golgi network (TGN) into the endosomal system, including 
the two mannose-6-phosphate receptors (Chen et al., 1997;Tortorella et al., 
2007;Braulke and Bonifacino, 2009) and sortilin (Shiba et al., 2002).  The motif is 
bound by the VHS domain of GGA proteins (Nielsen et al., 2001;Shiba et al., 
2002).  YXXΦ motifs are also found in proteins which traffic along the lysosomal 
pathway, including LAMP-1 (Honing et al., 1996;Braulke and Bonifacino, 2009), 
with the modification being bound by the AP-1 and 2 adaptor complexes (Honing 
et al., 1996).  YXXΦ motifs are required for Golgi exit and entry into the 
endosomal system. 
 
1.1.4 Sorting via post-translational modification 
Post translational protein modifications are those which occur once a 
polypeptide chain has been produced, and can include protein conjugation to 
carbohydrates, lipids, functional groups such as phosphates, and other proteins.  
One well characterized modification required for protein sorting is the mannose-
6-phosphate modification found on soluble proteins directed to the endosomal 
system and eventually the lysosome, such as cathepsin D (Hida et al., 2007).   
This modification allows binding of the lysosomal hydrolases to one of the two 
mannose-6-phosphate receptors (MPR); the cation-dependent MPR and the 
cation independent MPR (Ghosh et al., 2003;Braulke and Bonifacino, 2009).   
These two receptors then direct sorting of the hydrolases in a manner dependent 
on the receptor cytosolic targeting motifs, as described in 1.1.3. 
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1.1.5 Ubiquitin as a post translational modification. 
Ubiquitin is a 76 amino acid polypeptide, highly conserved throughout 
eukaryotes (Goldstein et al., 1975;Ciechanover, 2005).  Proteins can be modified 
at free amino groups (usually lysine residues, but occasionally the N-terminal 
residue of a protein (Coulombe et al., 2004), serine, cysteine or threonine 
(Ishikura et al., 2010)) by the addition of ubiquitin moieties which, depending on 
the type of modification, can result in degradation at the proteasome for soluble 
proteins, or for membrane proteins trafficking through the endosomal system, 
leading ultimately to lysosomal degradation (Hicke and Dunn, 2003;Piper and 
Luzio, 2007).   
Ubiquitin’s proteolysis-stimulating activity was initially identified as APF-1 (ATP-
dependent proteolysis factor 1), an 8.5 kD protein component of reticulocyte 
lysate required for proteolysis, which could be conjugated reversibly to protein 
substrates (Ciechanover, 2005).  Later studies confirmed that APF-1 was 
ubiquitin (Wilkinson et al., 1980).  Ubiquitin is conjugated to proteins through 
the action of three different enzymes.  E1 (ubiquitin activating) enzymes 
activate and form a high energy thioester bond with ubiquitin.  E2 (ubiquitin 
conjugating) enzymes receive ubiquitin from E1 via a transthiolation reaction.  
Then the E2 and E3 (ubiquitin ligase) enzymes work together to transfer 
ubiquitin to a lysine side chain (Ciechanover, 2005).  The E3 enzymes are the 
most numerous of the three groups and give each reaction its substrate 
specificity, often providing a platform for E2 and substrate to bind (Pickart, 
2001). 
 The proteolysis-activating activity of ubiquitin was initially associated with the 
proteasome, a large 26 S multienzyme complex consisting of a 19 S regulatory 
particle and 20 S core particle which degrades substrates modified with a 
polyubiquitin chain linked through lysine 48 of ubiquitin (K48 linked 
polyubiquitin) (Ciechanover, 2005).  However, as discussed in the next section, 
more recent work has identified that other ubiquitin modifications exist and 
these have various roles.   
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1.1.6 Other ubiquitin modifications. 
Addition of a single ubiquitin moiety (monoubiquitination), often at multiple 
lysine residues, has been shown to be involved in endocytosis and protein 
trafficking (Haglund et al., 2003;Urbe, 2005). Ubiquitin itself contains seven 
lysine residues (at positions 6, 11, 27, 29, 33, 48 and 63) (Pickart and Fushman, 
2004), and polymeric chains at all of these residues have been reported in vivo 
(Peng et al., 2003).  K63 linked polyubiquitin has been implicated in vesicle 
trafficking (discussed further in the next section) and regulation of signalling 
cascades, by forming a scaffold on which signalling intermediates may assemble 
(Kanayama et al., 2004).  The BRCA1/BARD1 ubiquitin ligase complex assembles 
K6 polyubiquitin chains in vitro (Wu-Baer et al., 2003) and the BRCA1 subunit 
can be autoubiquitinated with these chains (Wu-Baer et al., 2003).  For the 
purposes of this study, the role of monoubiquitination and K63 linked 
polyubiquitin in protein traffic will be considered further in the next section. 
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Figure 1.2 Ubiquitin conjugation to target proteins.   
A. Free ubiquitin is activated by formation of a high energy thioester bond with an E1 enzyme.  B. A 
transthiolation reaction passes ubiquitin to the E2 enzyme.  C. The E2 and E3 enzymes work 
together, via a thiol-ester intermediate on the E3 ligase to D. Transfer ubiquitin to protein 
substrates. 
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1.2 Ubiquitination regulates protein traffic 
It is now becoming widely accepted that many plasma membrane receptors and 
channels are internalised on the basis of monoubiquitin or K63 linked 
polyubiquitin modifications (Urbe, 2005).  Examples in mammalian cells include 
MHCII β chain in dendritic cells (Shin et al., 2006), aquaporin 2 in Madin-Darby 
canine kidney cells (Kamsteeg et al., 2006) and the neurotrophin receptor TrkA 
(Geetha et al., 2005;Wooten and Geetha, 2006).  The protein is ubiquitinated, 
internalised and either trafficked to the lysosome for degradation, or in the case 
of some proteins they may be recycled back to the cell surface (Shenoy, 
2007;Berthouze et al., 2009;Mukai et al., 2010) (discussed further in section 
1.3). 
In Saccharomyces cerevisiae (yeast) and mammalian cells the role of ubiquitin in 
membrane protein traffic has been extensively studied, and it appears that the 
modification plays a role in more than internalisation of membrane proteins.  A 
particularly well studied example is the general amino acid permease Gap1p.  
This twelve-transmembrane domain channel protein is regulated in response to 
nitrogen availability (Roberg et al., 1997;Magasanik and Kaiser, 2002).  On 
preferential nitrogen sources such as glutamate Gap1p is trafficked directly to 
the proteolytically active endosomal system (Roberg et al., 1997).  However on 
poor nitrogen sources Gap1p is directed to the plasma membrane to increase 
amino acid uptake into the cell (Roberg et al., 1997) (Figure 1.3). 
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Figure 1.3 Gap1p traffic in S. Cerevisiae 
On rich nitrogen sources, for example glutamate, Gap1p is sorted to the endosomes to be 
degraded at the vacuole.  On poor nitrogen sources such as proline, where amino acid uptake is 
required, Gap1p is directed to the plasma membrane.  Adapted with permission from Macmillan 
Publishers Ltd from Bryant et al., copyright (2002)  
 
Work over the last decade has elucidated the role ubiquitin plays in this process, 
and one study (Risinger and Kaiser, 2008) has identified that different ubiquitin 
modifications on Gap1p give rise to different trafficking events.  
Monoubiquitination, which is dependent on a ubiquitin ligase complex containing 
the E3 ligase Rsp5p and the adaptor proteins Bul1p/2p, causes internalisation of 
Gap1p from the plasma membrane (Helliwell et al., 2001;Soetens et al., 
2001;Risinger and Kaiser, 2008).  However, polyubiquitination is required for the 
direct sorting of Gap1p from the TGN to the vacuole in favourable nitrogen 
conditions (Risinger and Kaiser, 2008).  In summary, the studies on yeast Gap1p 
showed that i) an external stimulus can alter the trafficking of a membrane 
protein in yeast and ii) the ubiquitination status of a membrane protein at the 
TGN can target its trafficking into the endosomal system. 
 
1.2.1 ESCRTs and multivesicular body sorting. 
The ultimate fate of ubiquitinated membrane proteins is entry into the 
intralumenal vesicles (ILVs) of multivesicular bodies (MVBs), which subsequently 
fuse with lysosomes (Piper and Luzio, 2007).  The contents of the MVB are 
degraded by lysosomal hydrolases on fusion of the MVB with the limiting 
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membrane of the lysosome (Hicke and Dunn, 2003;Woodman and Futter, 2008) 
(Figure 1.4).  
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Figure 1.4 Membrane protein trafficking to multivesicular bodies.  
Ubiquitinated plasma membrane receptors and channels, and biosynthetic cargoes destined for the 
lysosome, are trafficked via the endosomal system to the limiting membrane of multivesicular 
bodies (MVBs) where they may be internalised into intralumenal vesicles.  Rescue and recycling of 
ubiquitinated proteins can occur at the recycling endosome. 
 
In yeast, multivesicular bodies were originally identified as a “pre-vacuolar 
compartment” which becomes enlarged when a subset of yeast VPS (vacuolar 
protein sorting) genes are mutated – the so called “class E” mutants (Raymond 
et al., 1992;Piper et al., 1995;Woodman and Futter, 2008).  The yeast class E 
Vps proteins represent the ESCRT proteins (Endosomal Sorting Complex Required 
for Transport), which have orthologues in mammalian cells.  In the following 
discussion the yeast orthologues are only named when the nomenclature differs 
from the mammalian orthologue.  
There are currently thought to be four ESCRT complexes.  ESCRT-0 is a complex 
of Hrs (hepatocyte growth factor regulated tyrosine kinase) and STAM (signal 
transducing adaptor molecule) (Vps27 and Hse1 in yeast, respectively) (Urbe, 
2005;Williams and Urbe, 2007).  Both ESCRT-0 components can bind ubiquitin, 
through the UIM (ubiquitin interacting motif) found on STAM and the unusual 
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ubiquitin binding VHS (Vps27, Hrs, STAM) domain of Hrs (Ren and Hurley, 2010).  
This results in clustering of ubiquitinated cargoes into microdomains (Bilodeau et 
al., 2002;Williams and Urbe, 2007), aided by ESCRT-0 binding to clathrin 
(Raiborg et al., 2006). 
ESCRT-I in mammals is a trimeric complex consisting of VPS23/TSG101, VPS28 
and one of four VPS37 isoforms, with the addition of Mvb12 in yeast (Raiborg and 
Stenmark, 2009).  ESCRTII is a tetramer with two subunits of VPS25 and single 
subunits of VPS36 and VPS22 (Williams and Urbe, 2007;Wollert et al., 2009).  
Both complexes have a relatively low affinity for ubiquitin and are thought to 
function only when cargo has been pre-clustered by the ESCRT-0 complex 
(Raiborg and Stenmark, 2009). 
After passing from ESCRT-0 to II, ubiquitinated cargos are received by ESCRT-III.  
ESCRT-III is composed of a number of highly charged subunits referred to as 
CHMPs (charged multivesicular body proteins) in mammals (Vps2,4,20,24 and 32 
in yeast), several of which are capable of forming polymeric structures (Williams 
and Urbe, 2007;Raiborg and Stenmark, 2009).  This complex seems to be 
required for membrane deformation and the final budding of ILVs.   
A recent study using recombinant ESCRT components to reconstitute 
intralumenal vesicle budding into giant unilamellar vesicles (GUVs) has identified 
the roles of the four ESCRT complexes in ILV budding (Wollert and Hurley, 2010).  
ESCRT-0 clusters the model cargoes of GFP/CFP fused to the C-terminus of 
ubiquitin in microdomains.  ESCRT-I and II are involved in formation of 
membrane buds, localising to bud necks and confining cargoes to the buds.  
ESCRT-I and II finally recruit ESCRT-III components and cause scission of the bud 
necks, resulting in ILV formation (Wollert and Hurley, 2010).  This study provides 
compelling evidence of the mechanism underlying ILV formation. 
  
1.2.2 GGA proteins sort ubiquitinated substrates 
The GGA (Golgi localised, gamma adaptin ear containing, Arf binding) family of 
clathrin adaptor proteins was discovered simultaneously by three groups in 2000 
(Dell'Angelica et al., 2000;Hirst et al., 2000;Boman et al., 2000).  There are two 
family members in yeast (Gga1/2p) and three in humans (GGA1-3) (Dell'Angelica 
et al., 2000;Hirst et al., 2000;Boman et al., 2000).  GGAs contain four domains: 
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the VHS domain which binds acidic dileucine sorting motifs, the GAT (GGA and 
TOM1) domain which interacts with both Arf and ubiquitin, a clathrin binding 
hinge region and a gamma adaptin ear like domain which interacts with 
accessory proteins (Mattera et al., 2004;Pelham, 2004). 
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Figure 1.5 Domain structure of a typical GGA protein. 
Interacting partners for each domain are indicated. 
 
Structural studies have identified that the GAT domain of GGA3 contains two 
ubiquitin binding sites (Scott et al., 2004;Bilodeau et al., 2004;Kawasaki et al., 
2005) and in vitro binding of ubiquitin to the GAT domain can be significantly 
reduced by mutation of single residues (E250 and D284) in both sites (Kawasaki 
et al., 2005).  In yeast, a study has shown that gga∆ cells mislocalise Gap1p to 
the plasma membrane under poor nitrogen conditions, and this sorting defect is 
maintained on deletion of the ubiquitin-binding portions of the GAT domain, 
despite normal Gap1p ubiquitination (Scott et al., 2004).  This highlights the 
importance of the ubiquitin-GAT interaction in sorting yeast membrane proteins 
into the vacuolar degradation pathway. 
In mammalian cells the story is less clear cut.  GGA3 has been shown to have a 
role in sorting of ubiquitinated EGF receptor (Puertollano and Bonifacino, 2004).  
The EGF receptor is normally ubiquitinated on ligand stimulation at the plasma 
membrane, resulting in its internalisation and trafficking to the endosomal 
system (Stang et al., 2000).  If GGA3 is depleted via siRNA, the EGF receptor 
accumulates in an aberrant early endosomal compartment along with the cation-
independent mannose 6 phosphate receptor (CIMPR) (Puertollano and 
Bonifacino, 2004).   
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Most studies on mammalian GGA dependent sorting have tended to focus on the 
VHS and GAT domains in combination (Li and Kandror, 2005;Kakhlon et al., 
2006), or on the role of the VHS domain which sorts acidic dileucine motifs (Hirst 
et al., 2007;Doray et al., 2008).  However one study has highlighted that the 
GGA3 VHS-GAT domains in combination can bind ubiquitin and that GGA3 
interacts with TSG101 (Puertollano and Bonifacino, 2004).  TSG101 forms part of 
ESCRT I, so potentially GGAs perform a similar function to the ESCRT-0 complex 
as discussed in 1.2.1.  A recent study (Kang et al., 2010) has linked the GGA3 
dependent lysosomal sorting of beta-site APP cleaving enzyme 1 (BACE-1) to 
BACE-1 ubiquitination; mutation of the BACE-1 dileucine motif did not affect 
sorting, whereas mutation of its ubiquitination site at K501 prevented lysosomal 
sorting (Kang et al., 2010), as did expression of a full length GGA3 mutant which 
was impaired in its ability to bind ubiquitin (Kang et al., 2010).  
Indeed it remains unclear whether mammalian GGAs are functionally redundant 
as those of yeast are.  One study has suggested that GGA1 and 3 are capable of 
binding to the same intracellular membranes, as depletion of GGA1 resulted in 
increased membrane accumulation of GGA3 and vice versa (Hirst et al., 2009).  
Also, specific depletion of GGA2 results in the defective sorting of the lysosomal 
hydrolase cathepsin D, without altering the localisation of the classical GGA 
cargos of the mannose-6-phosphate receptors or GGA1 and 3 (Hida et al., 2007).  
In vitro studies have shown that GGA1 and 3 have a considerably higher affinity 
for ubiquitin than GGA2 (Shiba et al., 2004) indicating that GGA2 may have a 
different role to the odd-numbered GGAs.  The situation is further complicated 
by the fact that GGAs can themselves be ubiquitinated (Shiba et al., 2004); in 
the case of GGA3 ubiquitination, this can act as a signal for trafficking of the 
lysosomal protein LAPTM5 to the lysosome (Pak et al., 2006). 
 
1.3 Deubiquitinating enzymes (DUBs) 
Deubiquitinating enzymes or DUBs are responsible for the cleavage of ubiquitin 
from substrate proteins, and thus counteract the activity of the E1-3 enzyme 
cascade.  There are approximately 79 DUBs encoded by the human genome; 
these fall into five families – the ubiquitin C-terminal hydrolases (UCH), ubiquitin 
specific proteases (USPs), Josephins, Otubains (OTU) and JAB1/MPN/MOV34 
metalloenzymes (JAMM) (Komander et al., 2009;Reyes-Turcu et al., 2009).  UCH, 
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USP, Josephin and OTU enzymes are cysteine proteases whereas the JAMM family 
are zinc metalloproteases (Komander et al., 2009;Reyes-Turcu et al., 2009).   
DUBs play three key roles in ubiquitin metabolism – they cleave precursors to 
release free ubiquitin, remove ubiquitin from substrate proteins and trim 
polyubiquitin chains.  Although these three activities have wide ranging effects 
on many subcellular processes, including regulation of signalling cascades (Sun, 
2010), endoplasmic reticulum associated degradation (ERAD) (Hassink et al., 
2009) and remodelling of chromatin structure (Zhu et al., 2007) the most 
pertinent role of DUBs for this study is the role they play in determining the fate 
of membrane proteins. 
 
1.3.1 Role of DUBs in endocytic and endosomal traffic. 
As discussed in 1.2, ubiquitination is crucial for directing trafficking of 
membrane proteins, routing them from the plasma membrane to degradative 
compartments, or from the TGN to the endosomal system (Hicke and Dunn, 
2003).  Cleavage of ubiquitin modifications from target proteins can therefore 
modify their fate.  I will now consider several examples of how DUBs modulate 
the ubiquitination status of membrane proteins and alter their trafficking 
properties. 
In mammalian cells, multiple studies have identified that ubiquitination of 
plasma membrane receptors and channel proteins results in their internalisation 
(Geetha et al., 2005;Kamsteeg et al., 2006;Shin et al., 2006;Wooten and 
Geetha, 2006).  Members of the G-protein coupled receptor family (seven 
transmembrane receptors) are internalised on the basis of their ubiquitination 
and the levels of their signalling downregulated accordingly (Shenoy, 2007).  One 
well characterised example of the role of DUBs in this process concerns the β2-
adrenergic receptor (β2-AR).  The receptor is deubiquitinated by two redundant 
DUBs, USP33 and USP20 (Berthouze et al., 2009).  Simultaneous depletion of 
both proteins by siRNA dramatically increases lysosmal trafficking of β2-AR and 
therefore its degradation (Berthouze et al., 2009).  The recycling of the receptor 
to the cell surface is also reduced under these conditions which reduces 
downstream signalling as measured by accumulation of cyclic AMP – these 
phenotypes are also observed in cells co-expressing catalytically inactive forms 
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of USP33 and USP20 (Berthouze et al., 2009).  So in this case the DUBs are 
rescuing the receptor from degradation. 
Doa4p (degradation of alpha 4) is a yeast DUB which has been shown to interact 
with components of the yeast ESCRT machinery, specifically the ESCRT-III 
component Snf7, which along with its interacting partner Bro1 causes 
recruitment of the DUB to endosomes and multivesicular bodies.  It was initially 
thought that Doa4p’s main role was to maintain free ubiquitin levels, which 
seemed plausible given that deletion of DOA4 caused a reduction in ubiquitin 
levels in stationary phase yeast (Swaminathan et al., 1999) and that depletion 
could be compensated by blocking trafficking to the MVB (Swaminathan et al., 
1999).  Secondly, a ∆doa4 strain exhibited defective ubiquitin dependent sorting 
to the vacuole and this can be compensated by overexpression of ubiquitin 
(Losko et al., 2001).   
However, more recent work has suggested that Doa4p may play a more direct 
role in MVB sorting than merely maintaining the pool of free ubiquitin.  It 
appears that the massive overexpression of ubiquitin used in earlier studies 
resulted in bypassing of key components of the ESCRT machinery, and on more 
moderate expression of ubiquitin the trafficking of Gap1p is found to be 
defective in a ∆doa4 strain, localising to the plasma membrane even under 
conditions of optimal nitrogen supply (Nikko and Andre, 2007).  The same study 
also looked at the effect of DOA4 deletion on sorting of carboxypeptidase S 
(CPS), a biosynthetic cargo which traffics to the vacuole constitutively (Odorizzi 
et al., 1998).  If Doa4p is absent or a catalytically inactive version of the DUB is 
expressed CPS is localised to the vacuolar membrane and cannot enter the 
lumen of the vacuole (Nikko and Andre, 2007).  This suggests that the 
deubiquitination activity of Doa4p is required for entry of cargo proteins into the 
ILVs of MVBs, and thus entry into the vacuolar lumen. 
In mammals, the ESCRT-0 complex binds two DUBs, AMSH (McCullough et al., 
2004) and UBPY (Kato et al., 2000).  AMSH is a JAMM family DUB which can 
process K63 linked polyubiquitin chains and deubiquitinate the epidermal growth 
factor receptor (EGFR) in vitro (McCullough et al., 2004).  AMSH depletion 
results in an increased rate of EGFR degradation (McCullough et al., 2004), 
indicating that EGFR is stabilised by AMSH activity. 
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The second DUB, UBPY (also called USP8), has significant sequence similarity to 
yeast Doa4p (Clague and Urbe, 2006).  The role of UBPY in endocytosis is less 
clear, as recent work has shown that depletion of the DUB severely impairs 
degradation of EGF-R and the Met tyrosine kinase receptor (Clague and Urbe, 
2006;Row et al., 2006;Alwan and van Leeuwen, 2007).  Unlike AMSH, UBPY can 
cleave K48 and K63 linked polyubiquitin equally well.  siRNA mediated depletion 
of UPBY results in the formation of aberrant, enlarged endosomes and 
multivesicular bodies (Row et al., 2006).  UBPY may deubiquitinate cytosolic as 
well as membrane bound proteins – the current hypothesis is that UBPY may 
deubiquitinate and thus stabilise components of the ESCRT machinery; this has 
been readily demonstrated for STAM, which is destabilised on knockdown of 
UBPY, concordant with a redistribution of Hrs from a cytosolic and perinuclear 
distribution to solely perinuclear structures (Row et al., 2006).  In the fruit fly 
Drosophila melanogaster (Drosophila) UBPY has been shown to play a role in the 
trafficking of the Wingless (Wg; a Drosophila Wnt orthologue) receptor Frizzled 
(Mukai et al., 2010).  UBPY knockdown flies show abnormal wing development 
due to decreased Wnt signalling during development, caused by increased 
ubiquitination (and thus degradation) of the Frizzled receptor (Mukai et al., 
2010).  
 
1.4 GLUT4 and Type 2 diabetes. 
1.4.1 Glucose homeostasis and Type 2 Diabetes 
The activities of the hormone insulin allow clearance of glucose from the 
bloodstream following a meal.  Raised postprandial plasma glucose causes insulin 
to be released from the pancreatic β cells into the circulation, altering the 
activity of insulin responsive tissues such as adipose, muscle and the liver (Figure 
1.6).  This results in clearance of plasma glucose. 
The dysregulation of the insulin response is known as diabetes mellitus, or more 
generally diabetes.  In Type 1 diabetes, the form of the disease responsible for 
about 5 % of cases (source: World Health Organisation (WHO)), the immune 
system raises an autoimmune response against the β cells of the pancreas.  This 
Chapter 1  32 
destroys the cells, preventing insulin secretion and thus clearance of plasma 
glucose (Zimmet et al., 2001). 
Type 2 diabetes, by far the most common form of the disease, responsible for 
approximately 95 % of cases (WHO estimate), has a different aetiology.  Type 2 
diabetes is the pathogenic progression of a state known as insulin resistance, 
where insulin becomes less effective at stimulating adipose and muscle, 
preventing clearance of plasma glucose (Saltiel and Kahn, 2001;Zimmet et al., 
2001).  Type 2 diabetes tends to present at around 40 years of age after a 
prolonged period of insulin resistance, and has been linked to a sedentary 
lifestyle and high carbohydrate diet in at least 80 % of cases (Venables and 
Jeukendrup, 2009).  Type 2 diabetes is one component of the so-called 
metabolic syndrome, with other components including hyperinsulinaemia, 
visceral obesity, dyslipidaemia and hypertension (Zimmet et al., 2001). 
Both types of diabetes result in complications with the circulatory system, 
including retinopathy, neuropathy, and cardiovascular disease.  According to 
recent estimates there are approximately 220 million diabetics worldwide 
(Zimmet et al., 2001) and fatalities due to diabetic complications may reach 2.2 
million by 2030 (WHO estimate), with most of these cases being due to type 2 
diabetes.  Therefore to better to understand type 2 diabetes, it is vital to 
understand the biology of insulin responsive tissues. 
 
  
Figure 1.6 Regulation of glucose homeostasis by insulin. 
Adapted with permission from Macmillan Publishers Ltd from Rosen and Spiegelman, copyright 
(2006)  
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1.4.2 GLUT4 
One of the major actions of insulin is to increase the amount of the facilitative 
glucose transporter GLUT4 present at the cell surface of fat and muscle cells 
(Figure 1.7) and it is this response which is defective in Type 2 diabetes and 
insulin resistance (Saltiel and Kahn, 2001;Lin and Sun, 2010).  GLUT4 presence at 
the plasma membrane of muscle and adipose allows glucose to enter the cells by 
diffusion down its concentration gradient. GLUT4 is a twelve-transmembrane 
domain channel protein, part of a larger family of thirteen facilitative sugar 
transporters including GLUT1-12 and the H+ coupled myo-inositol transporter H-
MIT (Wood and Trayhurn, 2003). 
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Figure 1.7 Insulin stimulates translocation of GLUT4 from intracellular stores to the cell 
surface. 
3T3-L1 adipocytes expressing GLUT4 with a C-terminal GFP tag were treated with 100 nM insulin 
(lower panel) or not (upper panel) for 15 minutes and total GLUT4 detected by 
immunofluorescence.  Adapted with permission from Macmillan Publishers Ltd from Saltiel and 
Kahn, copyright  (2001).   
 
The insulin stimulated glucose transport activity in muscle and adipose was 
initially identified by two groups in 1980. One study used a subcellular 
fractionation approach and a cell free reconstitution of rat adipose glucose 
uptake activity to show that a glucose transport activity moved from the 
intracellular compartments of the plasma membrane to the cell surface on 
insulin stimulation (Suzuki and Kono, 1980).  The second study used the glucose 
transport inhibitor cytochalasin B inhibit glucose transport in rat adipocytes, and 
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found that insulin stimulation increased the amount of cytochalasin B sensitive 
glucose transport activity on these cells (Cushman and Wardzala, 1980).  This 
transport activity was associated with a channel protein in screens of cDNA 
libraries of insulin responsive tissues, identifying a transporter in rat adipose 
which shared some sequence similarity with the rat brain and liver glucose 
transporter.  The identity of this transporter as the insulin regulated glucose 
transporter was confirmed using the monoclonal antibody 1F8  (Birnbaum, 
1989;James et al., 1989;Fukumoto et al., 1989).  
 
 
1.4.3 GLUT4 traffic in insulin responsive cells 
The trafficking itinerary of GLUT4 is complex with several key questions 
remaining unresolved; however a picture of the process is beginning to emerge 
and I will discuss the findings underlying this model. 
The trafficking pathway occupied by cargoes such as the transferrin receptor 
(TfR) is known as the constitutive recycling pathway, and involves proteins 
cycling between the endosomes and the plasma membrane.  About 40 % of total 
cellular GLUT4 is found in this cycle under basal conditions, as demonstrated by 
endosome ablation analysis using HRP conjugated transferrin (Livingstone et al., 
1996).  The remainder of GLUT4 occupies a second cycle between the TGN and 
the endosomes.  This has been observed in several studies.  Shewan et al.  
(2003) demonstrated that GLUT4 cycles between the endosomes and a 
perinuclear compartment, which represented a subdomain of the TGN enriched 
in the SNARE proteins syntaxin 6 and 16.  Karylowski and colleagues (2004) 
showed that in the basal state an HA-GLUT4-GFP reporter cycles between 
endosomes and the perinuclear compartment without transiting the cell surface. 
Two models have been proposed to explain the mobilisation of GLUT4 in 
response to insulin.  The first model, termed dynamic exchange, suggests that 
most GLUT4 molecules occupy a constitutive recycling pathway between the cell 
surface and endosomal system, similar to that seen for TfR.  On insulin 
stimulation, the increase in plasma membrane GLUT4 is caused by an increase in 
the exocytic rate constant, and decrease in the endocytic rate constant, of 
GLUT4, with a net increase in the number of GLUT4 molecules at the plasma 
membrane (Karylowski et al., 2004;Martin et al., 2006).  
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The second model, known as static retention, suggests that GLUT4 is retained in 
an essentially static storage compartment in basal conditions, analogous to the 
secretory vesicles found in neurons.  On insulin stimulation GLUT4 discharged 
from this storage compartment into the cell surface recycling pathway, raising 
GLUT4 levels at the plasma membrane without any effect on exocytosis or 
endocytosis rates (Govers et al., 2004;Coster et al., 2004).  More recent work 
seems to suggest that both these mechanisms play a role in GLUT4 exocytosis in 
response to insulin, and that previous studies had biased the recycling kinetics of 
GLUT4 in their systems due to the cell culture conditions used; if 3T3-L1 
adipocytes are replated after transfection, there is an increase in the proportion 
of GLUT4 in the in the basal cycling pool, from 20% to almost 80 % (Muretta et 
al., 2008). 
Three key trafficking motifs have been identified within GLUT4 : an N-terminal 
FQQI motif (Verhey et al., 1995)and dileucine (Verhey and Birnbaum, 1994) and 
TELEY motifs, both close to the C terminus (Shewan et al., 2000).  Each motif 
appears to have its own role in the intracellular retention of GLUT4, and one 
study has investigated the role of all these motifs in retention in particular 
compartments (Blot and McGraw, 2008).  Mutation of the phenylalanine residue 
in the FQQI motif to tyrosine results in an accumulation of HA-GLUT4-GFP in a 
perinuclear compartment thought to represent the Stx16 positive compartment, 
whereas mutation of the same residue to alanine resulted in a decrease in basal 
retention of HA-GLUT4-GFP (Blot and McGraw, 2008).  This result relates to an 
earlier study, which implicates the FQQI motif in the AS160 (Akt substrate of 160 
kilodaltons, a Rab GAP) dependent intracellular retention of GLUT4 (Capilla et 
al., 2007).  Mutation of the TELEY motif to TALAY resulted in a decreased basal 
retention, which was additive to that of the AQQI mutation, suggesting that 
these two motifs regulate different aspects of the basal retention mechanism 
(Blot and McGraw, 2008).  Mutation of the dileucine motif to dialanine results in 
a reduction in the rate of return of surface HA-GLUT4-GFP to basal levels (Blot 
and McGraw, 2008).   
The model proposed by the authors of this study is that GLUT4 traffic is centred 
on the recycling endosome (Figure 1.8).  GLUT4 is internalised from the plasma 
membrane in a manner dependent on the dileucine motif, with a small number 
of GLUT4 molecules reaching the cell surface under basal conditions via the 
constitutive recycling pathway (Verhey et al., 1995;Blot and McGraw, 2008). In 
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basal conditions GLUT4 is retained intracellularly by slowly cycling between the 
endosomes and two specialised “storage compartments” – one being the Stx16 
positive region of the TGN (Shewan et al., 2003) which retains GLUT4 in an 
AS160 dependent manner via the FQQI motif and does not undergo insulin 
responsive translocation, and a second vesicular pool which retains GLUT4 via 
the TELEY motif and translocates in response to insulin,  (Blot and McGraw, 
2008).  The latter vesicular pool represents the insulin responsive compartment 
which has previously been named  GLUT4 storage vesicles (GSVs) (Bryant et al., 
2002). 
Stx16 positive
 
   
Figure 1.8 A model of GLUT4 traffic in insulin responsive cells.   
GLUT4 occupies two linked cycles in insulin responsive tissues.  Cycle 1 is the constitutive, rapid 
recycling pathway between the recycling endosome and the plasma membrane.  Cycle 2 is 
between the TGN and endosomes, and includes the slowly recycling, highly insulin responsive 
GLUT4 storage vesicles.  Reproduced with permission from Macmillan Publishers Ltd from Bryant 
et al., copyright (2002)  
 
1.4.4 GLUT4 Storage vesicles 
The population of subcellular compartments which represent GSVs have been 
defined as a subset of the low-density microsomal (LDM) fraction of adipocytes 
which lack the transmembrane protein cellugyrin (Kupriyanova et al., 
2002;Jedrychowski et al., 2010).  Cellugyrin was initially identified as a 
component of GLUT4 vesicles in 3T3-L1 adipocytes (Kupriyanova and Kandror, 
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2000).  However, use of a monoclonal antibody raised against cellugyrin showed 
that cellugyrin containing vesicles only contained about 40-50 % of total cellular 
GLUT4, with the remaining GLUT4 in other compartments (Kupriyanova and 
Kandror, 2000) – this figure is reminiscent of the relative amount of GLUT4 in the 
endosomal system compared to specialised compartments in earlier studies 
(Livingstone et al., 1996).  Also, the cellugyrin negative vesicles were shown to 
be much more insulin responsive than cellugyrin positive ones (Kupriyanova and 
Kandror, 2000) and this result was confirmed using a GLUT4 specific monoclonal 
antibody (Kupriyanova et al., 2002).  These data collectively suggest that 
cellugyrin negative vesicles from the LDM fraction of 3T3-L1 adipocytes 
represent insulin responsive GSVs. 
GSVs have several well-characterised protein components including the SNARE 
protein VAMP2 (vesicle associated membrane protein 2) (Cain et al., 1992;Martin 
et al., 1996), sortilin (Lin et al., 1997), the insulin responsive aminopeptidase 
IRAP (Ross et al., 1996;1997) and LRP1 (low density liposome receptor related 
protein 1) (Jedrychowski et al., 2010). 
Several of these proteins are required for formation of GSVs from donor 
membranes.  The sorting receptor sortilin was characterised as a 110 kD 
component of GSVs (Lin et al., 1997;Morris et al., 1998).  Sortilin has been 
shown to be essential and sufficient for formation of GSVs in 3T3-L1 cells.  
Sortilin is induced 2 days after adipocyte differentiation and this event coincides 
with formation of functional GSVs (Shi and Kandror, 2005).  siRNA mediated 
depletion of sortilin reduced formation of GSVs in an in vitro budding assay, and 
consequently reduced insulin stimulated glucose transport (Shi and Kandror, 
2005).  Expression of epitope tagged GLUT4 in the absence of sortilin in 
undifferentiated 3T3-L1 cells results in rapid degradation of the transporter; 
however co-expression of GLUT4 and sortilin resulted in formation of functional 
GSVs in the undifferentiated cell line (Shi and Kandror, 2005). 
The lumenal domains of IRAP and GLUT4 can interact with that of sortilin as 
demonstrated by cross-linking and yeast two-hybrid analysis (Shi and Kandror, 
2007).  The GLUT4-IRAP interaction appears essential for recruitment of IRAP 
into GSVs (Shi et al., 2008).  Also, co-expression of sortilin and GLUT4 in 
undifferentiated 3T3-L1 cells results in formation of an insulin-responsive 
compartment in these cells; this requires the lumenal interactions of sortilin, as 
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a sortilin mutant with a truncated lumenal domain can only partially 
reconstitute the insulin responsive compartment (Shi and Kandror, 2005;Shi et 
al., 2008)   
LRP1 is another GSV cargo which was identified in a recent proteomic analysis of 
immunoisolated cellugyrin-negative GSVs (Jedrychowski et al., 2010).  It 
interacts with GLUT4, IRAP and sortilin, and depletion of LRP1 results in the 
depletion of all three proteins (Jedrychowski et al., 2010).   
Two major questions remain unanswered concerning the regulated trafficking of 
GLUT4; firstly, what is the signal that causes GSVs to translocate in response to 
insulin; and secondly, how is GLUT4 loaded into the insulin responsive GSVs? 
There is a reasonable amount of evidence that has gone some way to answering 
the first of these questions.  It appears that the insulin signalling cascade results 
in phosphorylation of AS160 (Akt substrate of 160 kilodaltons – a RabGAP protein) 
by Akt/protein kinase B (Sano et al., 2003).  This phosphorylation event results 
in fusion of GSVs with the plasma membrane, in a manner dependent on the 
amino terminal FQQI motif of GLUT4 (Capilla et al., 2007).  LRP1, a GSV protein, 
can also recruit AS160 on its cytosolic domain, possibly providing a link from 
GSVs to the insulin signalling pathway (Jedrychowski et al., 2010).   
The overall aim of this thesis is to address the second question, contributing to 
the data discussed in this section and section 1.4.3 to better understand how 
GLUT4 enters the insulin responsive compartment. 
 
1.5 A role for ubiquitin in the trafficking of GLUT4? 
In recent years work in our laboratory has been focused on testing the 
hypothesis that GLUT4 is modified with ubiquitin and that this modification is 
essential for insulin-responsive trafficking of the transporter.  In this section I 
will discuss data that support this hypothesis. 
 
1.5.1 Ubiquitin-like proteins regulate GLUT4 traffic. 
Functional cloning approaches in Chinese hamster ovary cells have identified a 
putative regulator of GLUT4 trafficking, which colocalises with GLUT4 at GSVs.  
This regulator was termed TUG (tether, containing UBX domain, for GLUT4) 
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(Bogan et al., 2003).  TUG contains two ubiquitin like domains.  The first of 
these is a C-terminal UBX (ubiquitin regulatory X) domain, which is involved in 
interaction with the p79/VCP ATPase, a generic molecular motor (Bogan et al., 
2003;Tettamanzi et al., 2006). The long splice variant of TUG appears to be able 
to sequester GLUT4 within the cell in a manner dependent on this UBX domain 
(Bogan et al., 2003).  The second is an N-terminal ubiquitin-like (UBL) domain.  
The structure of this domain has been solved using NMR spectroscopy 
(Tettamanzi et al., 2006).  The data from this study suggest that TUG does not 
participate in protein conjugation as ubiquitin does as it lacks the key diglycine 
motifs and acceptor lysine residues to do so.  However a region of the molecular 
surface with high electrostatic potential and backbone mobility has 
characteristics of a region involved in protein-protein interactions, which is 
typical behaviour for UBL domain containing proteins which often function as 
adaptor molecules (Tettamanzi et al., 2006). 
TUG has also been shown to be essential for insulin-responsive GLUT4 trafficking 
(Yu et al., 2007) since RNAi mediated TUG depletion, or expression of a 
dominant negative TUG fragment, enhances glucose uptake by both basal and 
insulin stimulated 3T3-L1 adipocytes, and that this appears to be achieved by 
disrupting formation of the perinuclear GLUT4 compartment (Yu et al., 2007).  
Additionally, this study indicates that TUG is capable of interacting with the 
large cytosolic loop of GLUT4.  In the context of this thesis, the studies on TUG 
collectively suggest that a molecule with a high degree of structural similarity 
to, and the potential to interact with, ubiquitin has an important role in the 
insulin sensitivity of GLUT4. 
It has previously been demonstrated that GLUT4 is modified by addition of small 
ubiquitin-like modifier 1 (SUMO1) at lysine residues (Lalioti et al., 2002), and 
that overexpression of the SUMO conjugating enzyme mUbc9 increases levels of 
GLUT4 in cultured skeletal muscle cells which consequently increases glucose 
transport rates (Giorgino et al., 2000;Liu et al., 2007), while mUbc9 depletion 
has the opposite effect (Liu et al., 2007).  It is conceivable therefore that 
SUMOlation and, possibly, ubiquitin modifications are involved in regulating 
GLUT4 trafficking and glucose uptake in response to insulin.  Indeed, SUMOlation 
itself can act as a tag for ubiquitination, directing E3 ubiquitin ligases to target 
proteins in certain cases.  For example, in Schizosaccharomyces pombe (fission 
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yeast) the ubiquitin ligase complex Slx5-Slx8 is recruited to substrates by its 
ability to bind SUMO polymers (Mullen and Brill, 2008;Geoffroy and Hay, 2009). 
 
1.5.2 Evidence from yeast. 
Unpublished data from the expression of hGLUT4 in S. cerevisiae has shown that 
hGLUT4 is subject to the same nitrogen dependent trafficking as Gap1p (McCann 
R.K., 2007).  On rich nitrogen sources, hGLUT4 is directed constitutively to the 
proteolytically active endosomal system, and on poor nitrogen sources the 
transporter is stabilised (McCann R.K., 2007) in an similar fashion to Gap1p 
(Roberg et al., 1997), indicating that it is trafficked away from the 
proteolytically-active endosomal system.  However a ubiquitin-resistant mutant 
of hGLUT4 (GLUT4-7K/R) cannot be directed to the vacuole on rich nitrogen 
sources, and deletion of both yeast GGA genes recapitulates this phenotype 
(Lamb et al., 2010).  By both co-immunoprecipitation and using a GST pull-down 
approach, GLUT4 has been shown to be ubiquitinated in yeast (Lamb et al., 
2010).  These findings suggest that GLUT4 is subjected to ubiquitin-dependent 
trafficking to the vacuole in yeast, in a manner similar to Gap1p. 
 
1.5.3 Evidence from 3T3-L1 adipocytes 
 
Figure 1.9 A ubiquitin-resistant version of GLUT4 cannot exit the syntaxin 16 positive 
subdomain of the TGN in 3T3-L1 adipocytes. 
3T3-L1 adipocytes expressing HA-GLUT4 (wt) or HA-GLUT4 7K/R (7K/R) were stained for the HA 
epitope (GLUT4) and syntaxin 16 (Sx16) as a marker of the TGN.  Image used by permission of Dr. 
R. McCann. 
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Although the yeast studies provide evidence that ubiquitination of GLUT4 alters 
its trafficking, the analyses had to be extended to a more physiologically 
relevant mammalian cell line to draw any firm conclusions about the role of 
GLUT4 ubiquitination in vivo.  3T3-L1 adipocytes are a well established model 
system for studying the insulin responsive phenotype (Mackall et al., 1976).  HA-
GLUT4 7K/R cannot exit the Stx16 positive region of the TGN and is excluded 
from cytosolic puncta thought to represent GSVs (McCann R.K., 2007) (Figure 
1.9), and initial data suggested that HA-GLUT4 7K/R cannot translocate in 
response to insulin, unlike its wild type counterpart (McCann R.K., 2007).  
However, the translocation data can only be taken as preliminary as the 
retroviral HA-GLUT4 7K/R construct used in these studies expressed the mutant 
protein at much lower levels than the wild type HA-GLUT4 (Shewan et al., 2000) 
construct.  These data suggest that GLUT4 ubiquitination is involved in GLUT4 
entering the insulin responsive compartment. 
 
1.5.4 GGA proteins regulate GLUT4 entry into GSVs 
Two key studies have implicated the GGA family of clathrin adaptor proteins in 
GLUT4 sorting into GSVs from the TGN, and they both rely on expressing a 
dominant negative fragment of GGA (VHS-GAT) which contains the cargo binding 
domains and the Arf binding site required for membrane association, but none of 
the effector domains.  This GGA fragment was generated from GGA2 and is 
proposed to have dominant negative activity against all three mammalian GGAs 
(Li and Kandror, 2005). 
The first study from 2004 (Watson et al.) demonstrated that expression of VHS-
GAT resulted in reduced insulin stimulated GLUT4 translocation as assessed by 
confocal microscopy, and that the in vitro budding of GLUT4 containing vesicles 
is inhibited by the presence of VHS-GAT.  The second study (Li and Kandror, 
2005) demonstrated  that GLUT4 colocalises with GGA2 in a perinuclear 
compartment, likely the TGN.  This study also showed that VHS-GAT expressing 
cells cannot rapidly re-form the GSV compartment after stimulation with insulin, 
and that GLUT4 is loaded less effectively into the GSV enriched supernatant 
(produced from centrifugation of a 3T3-L1 adipocyte lysate at 16 000 xg for 20 
minutes) in VHS-GAT expressing cells. 
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One further finding of Li and Kandror (2005) is that GSVs can interact with GGA 
adaptors in vitro.  Although components of GSVs have been shown to have a 
requirement for dileucine sorting motifs interacting with the VHS domains of 
GGAs, notably IRAP (Hou et al., 2006) and sortilin (Nielsen et al., 2001;Shiba et 
al., 2002), there is no published evidence for GLUT4 interacting directly with 
GGAs.  Although GLUT4 does contain a dileucine motif at residues 489 and 490 
(Verhey and Birnbaum, 1994;Shewan et al., 2000) there seems to be little 
requirement for this motif in trafficking from the TGN to the GSVs; the motif 
appears to have a more important role in internalising the transporter (Verhey et 
al., 1995;Sandoval et al., 2000;Blot and McGraw, 2008). 
As the internalisation step is apparently not GGA dependent, there is a 
possibility that the GAT domain plays a role in GLUT4 traffic by interacting with 
ubiquitin moieties on GLUT4, as has been observed for yeast Gap1p (Scott et al., 
2004;Bilodeau et al., 2004).  This is certainly not excluded by the two studies 
which implicate the GGAs in sorting of GLUT4 (Watson et al., 2004;Li and 
Kandror, 2005) as they make use of a dominant negative VHS-GAT construct 
which would disrupt interactions with both cargo binding domains of endogenous 
GGAs. 
 
1.6 Is GLUT4 deubiquitination required for its insulin 
responsive traffic? 
So far evidence has been presented which supports the hypothesis that 
ubiquitination of GLUT4 is required for its loading into GSVs.  However, there is 
a potential flaw in the reasoning behind this hypothesis.  Ubiquitination of 
membrane proteins is canonically thought of as being a modification required for 
trafficking of proteins to the lysosome/vacuole compartment and their 
subsequent destruction by vacuolar hydrolases.  Also work from our laboratory 
has demonstrated that only 0.1 % of total GLUT4 is ubiquitinated in the cell at 
any one time (Lamb et al., 2010) which suggests the modification is a transient 
one.  There is therefore a potential requirement for a deubiquitination step in 
the post – TGN trafficking of GLUT4, to prevent its delivery to the lysosome, and 
to direct the transporter to GSVs.  As discussed in 1.3.1, DUBs can rescue their 
substrates from lysosomal degradation; could this be the case for GLUT4?  And if 
so, how are DUB(s) recruited to GSVs? 
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1.6.1 IRAP and Tankyrase 
As has previously been stated in section 1.4.4, GLUT4 shares GSVs with a number 
of other proteins and one of these is the insulin responsive aminopeptidase IRAP, 
also known as vp165 and gp160.  Although widely expressed, IRAP was 
characterized as a component of GSVs (Ross et al., 1996) and found to have an 
identical trafficking itinerary to GLUT4 in adipocytes (Ross et al., 1997).  
Subsequently IRAP has been localized to vesicles in neurons, where it colocalises 
with GLUT4 (Fernando et al., 2007;2008) and in cells of the immune system, 
where it plays a role in antigen presentation (Saveanu et al., 2009) which 
suggests the peptidase has broader roles in vesicle traffic than previously 
thought. 
In undifferentiated 3T3-L1 cells, IRAP is found primarily at the plasma membrane 
(Ross et al., 1998) but on differentiation it is sequestered in an intracellular 
compartment, resulting in an approximately 8-fold increase in plasma membrane 
localized IRAP on insulin stimulation (Ross et al., 1998).  As with GLUT4, the 
trafficking of IRAP is defective in adipocytes from Type 2 diabetics.  Less IRAP is 
found in the low density microsomal fraction (LDM) which contains GSVs, and 
insulin stimulated translocation of IRAP is severely impaired (Maianu et al., 
2001).  An IRAP knockout mouse line does exist and these animals exhibit normal 
glucose tolerance, despite having decreased tissue levels of GLUT4 and insulin 
responsive glucose uptake (Keller et al., 2002).  These data indicate a role for 
IRAP in maintaining GLUT4 stability. 
Work in 3T3-L1 adipocytes has demonstrated that IRAP depletion using siRNA 
impairs the insulin stimulated translocation of GLUT4; however the reverse is 
not true (Yeh et al., 2007;Jordens et al., 2010).  IRAP interacts with a poly-ADP 
ribose polymerase (PARP) known as tankyrase 1 (Chi and Lodish, 2000;Sbodio and 
Chi, 2002).  Tankyrase 1 was initially identified as a protein with in vitro PARP 
activity localised to telomeres (Smith et al., 1998).  It contains a C terminal 
catalytic domain, a sterile alpha motif (SAM) and a series of N-terminal ankyrin 
(ANK) repeats (Figure 1.10), and has a closely related homologue, tankyrase 2 
(Kaminker et al., 2001).  The ANK repeats contain the IRAP interaction domain, 
binding an RXXPDG motif within IRAP conserved in other tankyrase interacting 
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partners such as NuMa and TRAF1 which are involved in DNA replication (Chi and 
Lodish, 2000;Sbodio and Chi, 2002).  The domain of tankyrase 1 required for this 
interaction is the C-terminal region of the ANK repeat domain, named 
subdomain V (Chi and Lodish, 2000). 
In tankyrase depleted 3T3-L1 adipocytes, both GLUT4 and IRAP are redirected to 
denser membrane compartments and fail to translocate normally in response to 
insulin (Yeh et al., 2007).  Taken together these data suggest that IRAP may 
provide a “handle” on GSVs to which proteins regulating GLUT4 traffic, such as 
tankyrase 1, can associate.  Tankyrase 1 itself, with its capacity for protein-
protein interactions (via the ANK domains (Seimiya and Smith, 2002)) and 
oligomerisation (via the sterile alpha motif (Sbodio et al., 2002)) could 
potentially act as a scaffolding molecule, recruiting various factors to GSVs. 
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Figure 1.10 Schematic of tankyrase-1 and 2.  
Ankyrin repeat domains (ANK), sterile alpha motif (SAM) and catalytic poly-ADP ribose polymerase 
(PARP) domains are indicated. 
 
1.6.2 USP25: a candidate GLUT4 DUB 
From the data discussed in section 1.6.1 it would appear that IRAP and tankyrase 
form part of a complex that can regulate GLUT4 entry into GSVs (Chi and Lodish, 
2000;Yeh et al., 2007).  A link between these data and the hypothesis that 
GLUT4 deubiquitination is required for entry into GSVs is provided by data from 
the laboratory of Nai-Wen Chi (UCSD).  The deubiquitinase USP25 has been 
shown to interact with tankyrase in a yeast two hybrid screen, and contain a 
putative tankyrase binding motif (RTPADG) near the C-terminus (Sbodio and Chi, 
2002).  Co-immunoprecipitation experiments have also demonstrated that 
tankyrase and USP25 interact in vivo (N-W Chi, unpublished). 
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The USP25 gene was originally isolated as a locus within the short arm of 
chromosome 21 which was duplicated in Down’s syndrome patients (Valero et 
al., 1999).  The gene has three different protein products (Valero et al., 2001).  
USP25a is the ubiquitously expressed 1055 amino acid isoform.  USP25b is also 
broadly expressed at much lower levels than USP25a, but is not found in murine 
tissues.  USP25m is the largest isoform at 1087 amino acids, and restricted to 
striated muscle in both mice and humans (Valero et al., 2001;Bosch-Comas et 
al., 2006). 
USP25m has been shown to play a role in protein turnover in muscle.  The 
isoforms of USP25 expressed in muscle can interact readily with filamin-C, 
ACTA1 and MyBPC1 as demonstrated by yeast two hybrid analysis, in vitro pull-
down assays and co-immunoprecipitation experiments (Bosch-Comas et al., 
2006).  In fact, this study identifies MyBPC1 as a specific substrate of USP25; 
MyBPC1 is deubiquitinated and stabilised in HEK293 cells on overexpression of 
USP25 (Bosch-Comas et al., 2006). 
Several studies have shed light on the regulation of USP25 activity and its 
molecular architecture.  USP25 contains several key structural domains as shown 
in Figure 1.11. It contains three N terminal ubiquitin binding motifs (a single UBA 
and two UIM), a SUMO interacting motif (SIM), catalytic domains (USP1/2) and a 
long C-terminal coiled-coil region which appears to be required for catalysis 
(Meulmeester et al., 2008;Denuc et al., 2009). 
UBA UIM IV V IIIIII
SIM USP1 USP2
1 20 57 655 105514077 163 437 575
UIM
 
 
Figure 1.11 Schematic of USP25a.  
Key structural and catalytic domains are highlighted. 
 
USP25 can itself be post-translationally modified.  Meulmeester et al. (2008) 
demonstrated using mutagenic and mass spectrometry analyses that USP25 can 
be SUMOlated on two sites (lysines 99 and 141) within its two UIMs.  SUMOlation 
appears to have an inhibitory effect on USP25 activity (Meulmeester et al., 
2008)– the authors speculate that this is due to the SUMO moieties blocking 
access of ubiquitin to the UIMs and thus preventing access of ubiquitinated 
substrates. 
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USP25 can also be ubiquitinated, and auto-deubiquitinate, as reported by a 
second study (Denuc et al., 2009).  The authors identified K99 as the site of 
ubiquitination using mass spectrometry.  Mutation of this residue did not greatly 
reduce in vitro DUB activity of USP25.  The authors suggest that as K99 
SUMOlation is known to be an inactivating modification, mutation of K99 would 
be expected to result in an over-active form of USP25.  As this is not the case, it 
can be inferred that ubiquitination of USP25 at K99 is an activating mutation 
(Denuc et al., 2009).  Denuc et al. went on to present a model building on that 
of Meulmeester et al (2008) whereby SUMOlated USP25 is held in an inactive 
conformation by the interaction of the SUMO moiety at K99 with the SUMO 
interacting motif (SIM), and the K141 SUMO blocking access to the UIMs and thus 
preventing access of ubiquitinated substrates.  On ubiquitination at K99, 
ubiquitinated substrates are able to interact with the UIMs, resulting in efficient 
ubiquitin chain hydrolysis. 
De-SUMOlation
Ubiquitination
 
Figure 1.12 Model for USP25 regulation by SUMOlation and ubiquitination.  
SUMOlation prevents access of ubiquitinated substrates (left panel) whereas ubiquitination allows 
their access to UIMs and thus efficient ubiquitin chain hydrolysis.  Adapted from Denuc et al. (2009) 
 
Finally, USP25 has recently been shown to interact with SYK (spleen tyrosine 
kinase) in HEK 293 cells (Cholay et al., 2010).  The interaction is dependent on 
the C terminal SH2 domain of SYK and a C-terminal region of USP25 between 
residues 726 and 944, as demonstrated by yeast-2-hybrid analysis and co-
immunoprecipitation experiments (Cholay et al., 2010).  SYK is capable of 
phosphorylating USP25 at a tyrosine residue, possibly at residue Y740 as 
predicted by bioinformatic analyses (Cholay et al., 2010).  This phosphorylation 
of USP25 results in its downregulation; overexpression of SYK results in a 
decrease in USP25 cellular levels, which can be countered by addition of the 
kinase inhibitor piceatannol (Cholay et al., 2010). 
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From these data, it is clear that USP25 activity and abundance can be modulated 
by several different factors.  Taken together with the data on the interaction of 
tankyrase with USP25 (Sbodio and Chi, 2002), it is tempting to speculate that 
regulated USP25 DUB activity is required to deubiquitinate GLUT4 and prevent 
its lysosomal degradation. 
 
1.6.3 3T3-L1 adipocyte data versus knockout mice: a confusing 
picture. 
The story is complicated somewhat by the phenotypes observed in tankyrase 
deficient mice.  As discussed in section 1.6.1, IRAP knockout mice have less 
GLUT4 than wild type littermates, and reduced insulin stimulated glucose 
uptake, despite apparently normal glucose tolerance (Keller et al., 2002). 
However a recent study (Yeh et al., 2009) demonstrated that tankyrase 1 
knockout mice have reduced perirenal and epididymal adipose deposits, and 43% 
of normal plasma leptin levels which indicated an overall loss of adiposity 
consistent with their increased lipid utilisation; they also exhibit 
hyperinsulinaemia and a decrease in plasma glucose (Yeh et al., 2009).  The 
tankyrase knockout mice appear to have increased expression of GLUT4 which 
can account for this phenotype, and they exhibit an increased fold change in 
glucose transport in response to insulin (Yeh et al., 2009).  A second study shows 
that adipocytes isolated from mice deficient in tankyrase 1 or 2 both exhibit 
glucose uptake rates similar to wild type littermates (Chiang et al., 2008).   
This does not support the hypothesis that IRAP and tankyrase form a platform for 
USP25 recruitment, as a reduction in cellular GLUT4 and altered insulin 
stimulated glucose uptake would be expected in tankyrase deficient mice if this 
were the case, as observed for IRAP knockouts (Keller et al., 2002).  There is 
therefore still some confusion in the literature as to the roles that the two 
tankyrases play in GLUT4 traffic. 
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1.7 A model for ubiquitin dependent loading of GLUT4 
into GSVs. 
From the data presented so far we can present a model for the ubiquitin 
dependent loading of GLUT4 into GSVs (Figure 1.13).  Newly synthesized GLUT4 
at the TGN is ubiquitinated by an as yet unidentified ligase.  Ubiquitinated 
GLUT4 can then exit the TGN in a GGA dependent manner, reaching GSVs.  On 
entry into GSVs GLUT4 is deubiquitinated by a complex containing IRAP, 
tankyrase and USP25.  GLUT4 is thus rescued from lysosomal degradation and 
can respond to insulin. 
GSV IRAP
GLUT4
Tankyrase
USP25
GSV IRAP
GLUT4
Tankyrase
USP25
Ub
Trans-golgi network
GLUT4
GLUT4
GLUT4
Vesicle 
trafficking & 
fusion (GGA 
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Deubiquitination
(USP25 dependent)
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Figure 1.13 A model for ubiquitin dependent GLUT4 loading into GSVs. 
 
1.8 Aims of the project 
The aim of this study was to test the hypothesis that ubiquitination of GLUT4 is 
required for the GGA dependent sorting step from the TGN into GSVs; 
subsequent GLUT4 deubiquitination by USP25 then stabilises GLUT4 and prevents 
its trafficking to the lysosome.  This hypothesis was tested using S. cerevisiae 
and the insulin responsive 3T3-L1 adipocyte cell line as model systems. 
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2.1 Materials. 
2.1.1 Reagents, enzymes and media components. 
All chemicals were from Sigma-Aldrich (Poole, Dorset, UK), VWR (Poole, Dorset, 
UK) or Fisher Scientific (Leicester, UK).  DNA restriction endonucleases and Pfu® 
polymerase were from Promega (Southampton, UK).  T4 DNA ligase was from 
New England Biolabs (Hitchin, UK).  Platinum Pfx® polymerase and dNTPs were 
from Invitrogen (Paisley, UK).  Fast Start High Fidelity polymerase was from 
Roche diagnostics (Burgess Hill, West Sussex, UK).  Broad range protein markers 
were from Biorad (Hertfordshire, UK).  Bacterial and yeast media components 
were from either Melford Laboratories Ltd (Suffolk, UK), Difco laboratories Inc 
(Appleton Woods Laboratory Equipment and Consumables, Birmingham, UK) or 
Formedium (Hunstanton, Norfolk, UK).  Mammalian cell culture media 
components were from Invitrogen (Paisley, UK).  Mirus TransIT TKO® 
transfection reagent was from Geneflow Ltd (Fradley, Staffordshire, UK).  [3H]2-
deoxyglucose solution was from Perkin Elmer (Cambridge, UK). 
 
2.1.2 Bacterial and yeast strains 
The bacterial and yeast strains used in this study are listed in Table 2.6 and 
Table 2.7.  Plasmids were maintained and propagated in XL-1 Blue (Stratagene) 
or TOP10 (Invitrogen) E. coli.  Recombinant proteins were expressed in BL-21 
(DE3) cells (Invitrogen).  The parent strain of BHNY1 (YNL297C) was purchased 
from the Invitrogen Yeast GFP clone collection (Huh et al., 2003). 
 
2.2 Yeast cell culture 
Yeast strains were grown non-selectively in YPD (1 %(w/v) yeast extract 
(Formedium), 2 %(w/v) D-glucose, 2 %(w/v) peptone), and selectively in 
synthetic dextrose (SD) medium (0.67 % (w/v) yeast nitrogen base without amino 
acids, 2 % (w/v) glucose supplemented with appropriate amino acids).  To give a 
solid medium, 2 % (w/v) agar was added to the above mixtures prior to 
autoclaving. 
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2.2.1 Preparation of yeast competent cells 
Transformation competent yeast were prepared according to the lithium acetate 
method as described by Ito et al., (1983).  Routinely a 50 ml culture of the 
appropriate yeast strain was grown to an OD600 of 0.5 to 1.  Cells were harvested 
in a bench top centrifuge for 2 minutes at 640 xg.  The cells were resuspended in 
10 ml LiTE-Sorb (0.1 M LiOAc, 10 mM Tris-HCl (pH 7.6), 1.2 M sorbitol) and re-
pelleted.  The cell pellet was resuspended in 1 ml LiTE-Sorb and incubated at 30 
°C with shaking for 1 hour.  The cell suspension was incubated on ice for at least 
half an hour, and was subsequently transformed with the desired plasmid or 
stored at –80 °C with an equal volume of 40 % (v/v) glycerol/0.5 % (w/v) NaCl 
solution. 
 
2.2.2 Yeast transformation 
Approximately 10 ng plasmid DNA and 100 µl 70 % PEG-3350 was added to a 100 
µl aliquot of competent cells and mixed by inversion.  The mixture was 
incubated with shaking at 30 °C for 45 minutes, and cells were heat shocked at 
42 °C for 20 minutes.  Cells were pelleted in a bench top microfuge at 
approximately 6000 xg for 2 minutes, resuspended in 200 µl sterile H20 and 
plated onto selective media.  Plates were kept at 30 °C for 2 to 4 days until 
colonies appeared. 
 
2.2.3 Preparation of yeast cell lysates for SDS-PAGE and 
immunoblot. 
To analyse the protein composition of yeast cells by SDS-PAGE or immunoblot 
analysis, 5 OD600 units of each culture was harvested, resuspended in 50 µl TWIRL 
buffer (5 % SDS, 8 M urea, 10 % glycerol, 500 µM Tris-HCl pH 6.8, 0.2% 
bromophenol blue) and heated at 65 °C for 10 minutes.  15 µl (1.5 OD600 units) of 
each sample was resolved by SDS-PAGE and immunoblotted for the desired 
proteins. 
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2.2.4 Plasmid rescue from yeast 
Cultures were grown to stationary phase in 10 ml of selective media.  5 OD600 
equivalents of yeast cells were harvested in a microcentrifuge at 669 xg for 2 
minutes.  The cell pellet was resuspended in 0.5 ml buffer S (100 mM K2HPO4 
pH7.2, 10 mM EDTA, 50 mM β-mercaptoethanol, 50 µg/ml yeast lytic enzyme 
(prepared in 50 mM Tris-HCl pH 7.7, 1 mM EDTA, 50 % (v/v) glycerol) and 
incubated at 37 °C for 30 minutes.  The resulting spheroplasts were lysed by 
resuspended and briefly vortexed in 100 µl lysis buffer (25 mM Tris HCl pH 7.5, 
25 mM EDTA, 2.5% SDS), with subsequent heating at 65 °C  for 30 minutes.  166 
µl 3 M potassium acetate was added to the mixture followed by a 10 minute 
incubation on ice and centrifugation for ten minutes at 14 000 xg.  The resulting 
supernatant was transferred to a Promega Wizard® Plus SV miniprep column, 
and DNA isolated from the supernatant by following the manufacturer’s 
instructions.  The purified DNA was transformed into competent XL-1 Blue E. 
coli.  A selection of transformants was picked and plasmid identity was verified 
using DNA sequencing (University of Dundee). 
 
2.2.5 APNE assay. 
To screen yeast strains for Pep4p activity the APNE assay was used (Wolf and 
Fink, 1975).The strains under test were patched onto YPD agar and grown 
overnight at 30 °C.  The next day, 8 ml of reaction mixture (RxM; 0.2 M Tris-HCl 
pH 7.4, 0.8 mg/ml Fast Garnet GBC salt, 0.2 mg/ml N-acetyl-phenylalanine-β-
naphthyl-ester (APNE)) was overlaid onto the plates with the yeast patches.  The 
RxM was allowed to solidify and colour changes observed over several minutes; 
red indicated wild type cells, white pep4 mutants. 
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2.3 Mammalian cell culture techniques 
2.3.1 Cell culture of 3T3-L1 murine fibroblasts and adipocytes 
3T3-L1 fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % (v/v) newborn calf serum (NCS).  Fibroblasts were 
maintained as sub-confluent cultures at 37 °C in a 10 % CO2 humidified 
incubator.  The fibroblasts were grown to confluency and maintained for up to 
three days before induction of differentiation by addition of DMEM supplemented 
with 10 % (v/v) foetal calf serum (FCS), 0.25 µM dexamethosone, 0.5 mM 3-
isobutyl-1-methylxanthine and 1 µg/ml insulin.  After 3 days, the differentiation 
mixture was replaced with DMEM containing 10 % (v/v) FCS and 1 µg/ml insulin.  
Adipocytes were re-fed with medium containing 10 % (v/v) FCS at 2 to 3 day 
intervals and used for experiments between 8 and 12 days post differentiation. 
 
2.3.2 RNA oligonucleotide synthesis 
All RNA oligonucleotides used in this study were synthesised by Qiagen (Crawley, 
West Sussex) and are detailed in Table 2.4. 
 
2.3.3 Transfection of 3T3-L1 adipocytes with siRNA 
oligonucleotides. 
At day 6 and 7 post-differentiation, 3T3-L1 adipocytes were incubated with 50 
nM siRNA oligonucleotides (detailed in Table 2.4) complexed with TransIT-TKO® 
transfection reagent (Mirus, Madison, WI) using an adapted version of the 
manufacturer’s protocol.  For a 24 well plate, 6 µl TransIT-TKO® reagent and 
1.25 µl of 20 mM stock siRNA solution was combined in 100 µl of serum-free 
DMEM.  After 20 minutes, this mixture was added drop wise to a single well of a 
24 well plate.  This process was scaled up for larger culture dishes.  The siRNA 
treated adipocytes were then used for experiments on day 8 post 
differentiation. 
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2.3.4 Retroviral infection of 3T3-L1 fibroblasts 
Fibroblasts were seeded to give approximately 40 % confluency.  The next day, 
2ml of viral supernatant (produced as in 1.3.6) was combined with 2ml DMEM + 
10 % FCS, and 10 µg/ml polybrene.  This mixture was used to replace the 
fibroblast growth medium, and the cells were left to grow for 12 hours at 37 °C.  
Cells were subsequently maintained in DMEM + 10 % FBS with 2.5 µg/ml 
puromycin which selected for cells harbouring retrovirus.  On confluency the 
cells were differentiated as in 1.3.1 without drug selection, and then maintained 
in DMEM + 10% FBS with 2.5 mg/ml puromycin until required for experiments. 
 
2.3.5 Cell culture of Plat-E cells 
Plat-E cells were cultured in DMEM supplemented with 10 % (v/v) FCS, 1 µg/ml 
puromycin and 10 µg/ml blasticidine.  Cells were maintained as subconfluent 
cultures at 37 °C in a humidified 5 % CO2 incubator. 
 
2.3.6 Preparation of retrovirus using Plat-E cells. 
Cells were seeded at a density of 5 x 106 cells per 10 cm dish, with one dish per 
virus being produced, in DMEM + 10 % FCS.  On the following day, the cells were 
transfected with the appropriate retroviral constructs using Lipofectamine™ 2000 
reagent.  Following transfection, the cells were maintained in DMEM + 10 % FBS 
for 48 hours at 37 °C, and subsequently switched to 32 °C overnight to induce 
virus particle production.  The viral supernatant was harvested from the plates, 
clarified by a 5 minute centrifugation at 500 xg and stored at -80 °C until 
required. 
 
2.4 DNA manipulation 
Standard DNA manipulation procedures were used throughout the study 
(Sambrook et al., 1989). 
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2.4.1 Plasmid DNA purification 
Promega Wizard® Plus SV miniprep kits were routinely used to isolate DNA from 
small bacterial cultures (< 10 ml).  For larger preparations (> 50 ml) Qiagen® 
Plasmid Maxi kits were used.   
 
2.4.2 DNA oligonucleotide synthesis 
DNA oligonucleotides were synthesised by Yorkshire Biosciences Ltd (Heslington, 
York, UK) or VHbio Ltd (Gateshead, UK) and diluted in sterile double distilled 
water to a final concentration of 50 pmol/µl before use. 
 
2.4.3 Polymerase Chain Reaction 
 The high fidelity Platinum Pfx® polymerase (Invitrogen) was routinely used to 
PCR amplify desired DNA sequences. 
A typical PCR mixture consisted of: 
10 mM dNTPs    5 µl 
50 mM MgSO4    3 µl 
10x Pfx buffer    5 µl 
Enhancer solution    5 µl 
ddH20      28 µl 
Forward primer (50 pmol/µl stock) 1 µl 
Reverse primer (50 pmol/µl stock) 1 µl 
Plasmid DNA     1 µl 
Pfx DNA polymerase   1 µl 
And the conditions normally used were: 
1. 95 °C  1 minute 
2. 94 °C  90 seconds 
3. 56 °C  1 minute 
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4. 68 °C  1 minute/kb 
5. 68 °C  10 minutes 
6. 4 °C  Final hold 
 
Steps 2 to 4 were repeated 30 times during the course of the PCR. 
For amplification of larger templates and GC rich sequences the FastStart High 
Fidelity PCR system (Roche) was used.  The mixture in this case consisted of: 
10 mM dNTPs    1 µl 
10x Reaction buffer    5 µl 
DMSO      1-5 µl (2-10 %) 
Forward primer (50 pmol/µl stock) 4 µl 
Reverse primer (50 pmol/µl stock) 4 µl 
Template DNA    1 µl 
2.5 U FastStart High Fidelity enzyme  0.5 µl 
ddH20      to 50 µl 
For templates of less than 3 kb, a reaction profile essentially the same as that 
for Pfx was utilised.  For longer templates the following was used: 
 
1. 94 °C  2 minutes 
2. 94 °C  30 seconds 
3. 52 °C  30 seconds 
4. 68 °C  1 minute/kb 
5. 94 °C  30 seconds 
6. 52 °C  30 seconds 
7. 68 °C  1 min/kb (+ additional 20 seconds per cycle number) 
8. 68 °C  7 minutes 
9. 4 °C  Final hold 
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Steps 2-4 were repeated ten times during the course of the reaction, followed by 
25 cycles of steps 5-7. 
Electrophoresis was used to resolve DNA fragments generated by PCR through 
0.8 % (w/v) agarose in tris-acetate (TAE) buffer (40 mM Tris-acetate, 1 mM 
EDTA).  DNA fragments were extracted from agarose gels using the QIAquick® 
gel extraction kit (Qiagen). 
 
2.4.4 Site Directed Mutagenesis. 
Site directed mutagenesis (SDM) of DNA sequences was performed using Pfu® 
polymerase (Promega) according to the Stratagene QuikChange® method.  
Synthetic oligonucleotides, detailed in Table 2.5, were used to exchange one 
amino acid residue for another with the mutagenic codon at the approximate 
centre of the oligonucleotide.  A typical recipe for a SDM reaction was as 
follows: 
Purified template plasmid  50 ng 
Forward primer   125 ng 
Reverse primer   125 ng 
10x Pfu buffer   5 µl 
10 mM dNTPs   1 µl 
Pfu polymerase   1 µl 
ddH20     to 50 µl 
Typical reaction conditions for SDM were: 
1. 95 °C  1 minute 
2. 95 °C  50 seconds 
3. 60 °C  50 seconds 
4. 68 °C  16 minutes 
5. 68 °C  7 minutes 
6. 4 °C  Final hold 
Steps 2 to 4 were repeated 18 times during the course of the reaction. 
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On completion of the reaction, the mixture was treated with 1 µl (10 units) DpnI 
for 1 hour at 37 °C, to digest methylated template plasmid.  5 µl of the resultant 
mixture was transformed into competent XL-1 Blue E. coli, and transformants 
selected for on solid 2x YT (1.6 % tryptone, 1 % yeast extract, 0.5 % NaCl) + 2 % 
agar supplemented with 100 µg/ml ampicillin.  Several of the resultant colonies 
were picked, grown up in 10 ml of 2YT + 100 µg/ml ampicillin and plasmid 
purified.  Mutations were verified by DNA sequencing (Sequencing service, 
University of Dundee). 
 
2.4.5 Plasmid construction 
To generate a construct encoding a ubiquitin binding deficient version of the 
GST-Dsk2p UBA protein to act as a negative control in pull-down experiments, I 
took advantage of the published crystal structure of Dsk2p in complex with 
ubiquitin (Ohno et al., 2005), which identified the residues M342 and F344 
(numbering relative to the full length protein) as essential for ubiquitin binding. 
pGEX-DSK2UBA (Raasi et al., 2005) was subject to site directed mutagenesis using 
primer pair 352 and 353 (Table 2.5) to generate pCAL1, encoding GST-Dsk2p UBA 
M342R F344A (GST-UBAmut).  This work was carried out in collaboration with Dr. 
Rebecca McCann. 
pHAGLUT4 URA3 (pCAL4) was constructed by amplification of the HA-GLUT4 
open reading frame from pRM55 (constructed by Dr Rebecca McCann) using 
oligonucleotides 1 and 2 (Table 2.5).  This generated a product containing the 
GLUT4 ORF, with internal HA tag between residues 63 and 64, flanked by 
sequences homologous to the 3’ end of the CUP1  promoter and the 5’ end of the 
PHO8 3’ UTR.  The product was used to repair a gapped pNB701 (Struthers et al., 
2009), which encodes the ORF of RS-ALP (Piper et al., 1997) under the control of 
the copper responsive CUP1  promoter (Winge et al., 1985;Mascorro-Gallardo et 
al., 1996) and the 3’UTR of PHO8.   
pGEX-GGA3 VHS-GATmut (pCAL6) was constructed by site directed mutagenesis of 
pGEX-GGA3 VHS-GAT (a gift from Juan Bonifacino, (Dell’Angelica et al, 2000)). 
This was achieved by sequential site directed mutagenesis using primer pairs 
457/458 (E250N mutation) and 459/460 (D284G mutation), sequences detailed in 
Table 2.5. 
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pCAL10 was constructed by amplification of the GGA3 short isoform mRNA from 
the IMAGE clone 4814878 in pBluescriptR (a gift from Professor Margaret S. 
Robinson) using oligos 489 and 511 (Table 2.5) to introduce a 5’ myc tag and 
EcoRI site, and a 3’ Sal1 site. This approximately 2 kb fragment was subcloned 
into pCR2.1.  The myc-GGA3 fragment was excised from pCAL10 using EcoRI and 
SalI and ligated into simultaneously digested pBABE puro (Morgenstern and Land, 
1990),a gift from Professor David James, to generate pCAL11.  Mutation of the 
myc-GGA3 GAT domain was carried out in an identical fashion to that for pGEX-
GGA3 VHS-GAT, generating pCAL12. 
pCAL13 was constructed by site directed mutagenesis of pGEX-USP25 
(Meulmeester et al., 2008) using primer pair 559 and 560 to mutate the arginine 
at position 1049 within the putative tankyrase binding motif of USP25 (Sbodio 
and Chi, 2002) to alanine. 
 
2.5 Protein methods 
2.5.1 Elecrophoretic separation of proteins 
The separation of proteins by electrophoresis was carried out with discontinuous 
polyacrylamide gels (SDS-PAGE) following the basic method outlined by Laemmli 
(1970).  Proteins were separated on gels composed of a stacking layer (5 % (v/v) 
acrylamide in stacking buffer (0.25 M Tris-HCl (pH 6.8), 0.2 % (w/v) SDS) and a 
separating layer (normally 10% acrylamide in separating buffer; 0.75 M Tris-HCl 
(pH 8.8), 0.2 % (w/v) SDS).  A 30 % (v/v) acrylamide-bisacrylamide mixture 
(37.5:1 ratio, Severn Biotech Ltd, Worcestershire) was used to make the gels.  
The tris-glycine electrophoresis buffer used contained 25 mM Tris-HCl, 250 mM 
glycine, 0.1 % (w/v) SDS).  Resolved proteins were visualised on gels by agitating 
the gels in Coomassie Brilliant Blue solution (0.25 g Coomassie Brilliant Blue R250 
in methanol: H20: glacial acetic acid (4.5:4.5:1 v/v/v)) for 30 minutes, followed 
by overnight agitation in destain solution (5 % (v/v) methanol, 10 % (v/v) glacial 
acetic acid) to give clearly visible bands. 
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2.5.2 Transfer of proteins to nitrocellulose membranes 
A Bio-Rad Trans-Blot® SD cell was used to transfer proteins from polyacrylamide 
gels onto nitrocellulose membranes (Protran, 0.45 µm pore).  Gels and 
membranes were sandwiched between 6 pieces of Whatman 3M filter paper 
soaked in semi dry transfer buffer (50 mM Tris-HCl, 40 mM glycine, .037% (w/v) 
SDS, 10% methanol.  The assembly was subject to a constant 180 mA current for 
between 35 minutes (one gel) to one hour (three gels). 
 
2.5.3 Immunoblot analysis 
After protein transfer, unfilled sites on the nitrocellulose membrane were 
blocked using 5 % (w/v) non-fat dried milk in PBST (0.1 % (v/v) Tween-20 in PBS) 
or TBST (0.1 % (v/v) Tween-20 in TBST (0.1 % (v/v) Tween-20 in Tris-HCl 
buffered saline (TBS – 0.5 M NaCl, 10 mM Tris-HCl pH 7.6) according to the 
conditions required for each primary antibody.  The membranes were exposed to 
primary antibody for 2 hours at room temperature or at 4 °C overnight with 
agitation.  Primary antibodies were diluted as described in Table 2.1 in 1 % (w/v) 
non-fat dried milk in PBST/TBST, except anti-FAS which was diluted in 5 % (w/v) 
non-fat dried milk in PBST. 
The membrane was subsequently washed six times with PBST/TBST for five 
minutes each.  The membranes were exposed to secondary antibody at the 
concentrations described in Table 2.2 in 5 % (w/v) non-fat dried milk in 
PBST/TBST for between 1 and 2 hours at room temperature, with agitation.  A 
further six 5-minute washes in PBST/TBST were carried out and protein bands 
visualized using enhanced chemiluminescence (ECL). 
 
2.5.4 Antibodies 
Primary and secondary antibodies used in the study are detailed in Table 2.1 and 
Table 2.2 respectively.  Polyclonal antisera against USP25 was generated by 
Eurogentec (Liege, Belgium) using an 87 day protocol.  Briefly, two New Zealand 
white rabbits were immunised with 100 µg recombinant USP25 (generated as in 
2.5.6) at days 0, 14, 28 and 56 of the protocol.  Serum was collected from the 
Chapter 2  61 
rabbits before the first immunisation (pre immune), and on days 38, 66 and 87 
subsequently.  The sera were stored at -80 °C until use. 
 
2.5.5 Quantification of immunoblots. 
Immunoblots were scanned using Photoshop® (Adobe) and immunoreactive 
bands measured using ImageJ software (National institutes of Health, USA).  The 
integrated density of each band was measured and a background reading for an 
equally sized area of the image subtracted to give a numeric value for the band 
intensity. 
 
2.5.6 GST fusion protein preparation 
For pGEX-DSK2UBA and pGEX-GGA3 VHS-GAT based constructs, 10 ml of 2YT + 100 
µg/ml ampicillin was inoculated with E. coli BL-21 (DE-3) cells harbouring a 
plasmid encoding the appropriate GST fusion protein and incubated at 37 °C 
overnight with shaking.  The 10ml culture was inoculated into 400 ml Terrific 
Broth (1.2 % (w/v) tryptone, 2.4 % (w/v) yeast extract, 0.4 % (w/v) glycerol, 
0.05 M K2HPO4, 0.016 M KH2PO4) and grown until OD600 = 0.6.  Protein expression 
was induced with 1mM IPTG and the cells were incubated for a further 4 hours at 
37 °C with shaking.  The cells were harvested by centrifugation and resuspended 
in 19.5 ml phosphate buffered saline (PBS; 140 mM NaCl, 3 mM KCl, 1.5 mM 
KH2PO4, 8 mM Na2HPO4).  The cells were treated with lysozyme (1 mg/ml) on ice 
for 30 minutes and subsequently sonicated for five 30 second bursts with 30 
second iced pauses.  The lysate was spun at 17640 xg at 4 °C to remove insoluble 
components.  The lysate was incubated with 1ml of a 50 % glutathione-Sepharose 
bead slurry with rotation for 1 hour.  The beads were washed three times with 
cold PBS to remove non-specifically bound proteins, and stored at 4 °C in PBS 
supplemented with EDTA free protease inhibitor cocktail (Roche) (containing 
leupeptin, α2 macroglobulin, pefabloc SC, pepstatin, PMSF, chymostatin, E-64, 
bestatin, trypsin inhibitor) at a bead:buffer ratio of 1:1. 
For pGEX-USP25 and derivatives a similar protocol was used with several 
modifications.  Proteins were purified from 2 litres of culture rather than 400 
ml, and cells were lysed using a Microfluidizer M-110P cell disruptor set at 
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10,000 psi.  After binding of the fusion protein to the beads, they were washed 
three times with PBS + 1 % (v/v) Triton-X, three times with PBS + 0.5M NaCl and 
three times with PBS alone.  Thrombin cleavage of GST-USP25, releasing USP25 
from the beads, was performed by incubating the beads in thrombin cleavage 
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2.5 mM CaCl2) containing 0.04 units 
of thrombin per µl sample with rotation at room temperature for 2 hours. 
  
2.5.7 GST fusion protein concentration estimation 
20 µl of a 50 % (v/v) glutathione Sepharose bead suspension was pipetted into a 
microfuge tube, spun at 500 xg for 1 minute and the supernatant removed.  GST 
fusion protein was eluted from the beads by adding 400 µl 2 × LSB (4 % (w/v) 
SDS, 100 mM Tris-HCl pH6.8, 20 % (v/v) glycerol, 0.04 % (w/v) bromopbenol blue, 
10 % (v/v) β-mercaptoethanol), (i.e. a 1 in 40 dilution of the beads) and heating 
at 37 °C for 30 minutes.  20 µl of sample was run on a 10% SDS-PAGE gel with 
standard amounts of BSA (0.4, 1, 2 and 3 µg).  After staining with Coomassie and 
subsequent destaining, protein concentration on the beads could be estimated 
visually. 
 
2.6 GST fusion protein pull-down with yeast lysate 
400 ml cultures of the appropriate yeast transformants (expressing wt HA-
GLUT4) were grown to mid log phase – approximately 0.5 OD600 of cells/ml of 
culture.  Cells were collected by centrifugation and the pellets resuspended in 
40 ml YPD-Sorb (1.2 M sorbitol, 0.5 % yeast nitrogen base (Formedium), 1% D-
glucose, 1% peptone).  Cells were converted to spheroplasts by treatment with 
120 µl β mercaptoethanol and 400 µl 50 mg/ml yeast lytic enzyme in yeast lytic 
enzyme buffer (50 mM Tris pH 7.7, 1 mM EDTA, 50% glycerol) and incubation for 
1 hour at 30 °C.  Spheroplasts were collected by centrifugation for 5 minutes at 
1000 xg.  The spheroplasts were resuspended in 250 µl lysis buffer (200 mM 
sorbitol, 100 mM KOAc, 1% Triton-X, 50 mM KCl, 20 mM PIPES pH 6.8, 1 mM N-
ethyl maleimide (NEM)) supplemented with EDTA free protease inhibitor cocktail 
(Roche) and agitated for one hour to lyse spheroplasts.   
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Samples were subsequently centrifuged at 14000 xg for 15 minutes at 4°C to 
pellet insoluble material.  Lysates were equalized for protein concentration by 
the BCA assay (Thermo Fisher Scientific, Cramlington) if required to 
approximately 10 mg/ml.  Approximately 200 µl of the diluted lysate was added 
to 20 µg of glutathione-Sepharose beads with appropriate GST fusion proteins 
bound.  The beads were incubated with the fusion proteins with gentle agitation 
for 2 hours at 4 °C.  The beads were washed three times with lysis buffer, 
drained and bound proteins eluted in 40 µl 2x LSB for 15 minutes at 65 °C.  20 µl 
of each sample was run out on a 10% SDS-PAGE gel alongside 2.5% of input lysate 
for each yeast transformant, followed by immunoblotting with antibodies against 
specific proteins. 
 
2.7 GST fusion protein pull-down with 3T3-L1 adipocyte 
lysate. 
Adipocytes were starved of serum using serum-free DMEM for at least two hours 
prior to starting the procedure.  Two 10 cm plates were used per reaction 
condition.  Following treatment cells were kept on ice and washed three times 
with ice cold PBS.  Cells were scraped in 250 µl lysis buffer (50 mM Sodium 
HEPES, 150 mM NaCl, 5 mM EDTA, 1 mM NEM, 1 % Triton X-100, EDTA free 
protease inhibitor cocktail (Roche)) and homogenised using a syringe and needle 
(10 x 25 G, 2 x 26 G).  The homogenates were clarified by a 10 minute 
centrifugation at 500 xg and 4 °C.  The clarified homogenate was agitated at 4 
°C for a further hour to disrupt membranes, then centrifuged at 14 000 xg and 4 
°C for 15 minutes to pellet insoluble material.  If required, protein 
concentrations were equalized by using the Bradford assay.  An aliquot of lysate 
was retained and mixed with 2 X LSB (whole cell lysate). The remaining lysate 
was divided between the appropriate immobilized GST fusion proteins, with 
approximately 200 µl lysate per 20 µl bead suspension.   The bead/lysate mix 
was mixed gently at 4 °C for 2 hours to allow binding of proteins.  The beads 
were washed three times with lysis buffer and bound proteins eluted by addition 
of 2 x LSB with 10% beta-mercaptoethanol. 
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2.8 Indirect immunofluorescence with 3T3-L1 adipocytes. 
Cells were grown on sterilised coverslips in a 24 well plate.  Cells were starved 
of serum using serum-free DMEM for two hours prior to starting the procedure, 
and insulin stimulated (100 nM insulin for 15 minutes, 37 °C).  For surface 
epitope staining, cells were washed twice with PBS then cross-linked with 200 µl 
3 % (v/v) paraformaldehyde (PFA) for 30 minutes, washed twice with PBS then 
washed twice with 20 mM glycine (GLY) in PBS to quench free aldehyde groups.  
The coverslips were then incubated with 200 µl blocking solution (2 % (w/v) 
BSA/20 mM glycine in PBS (BSA/GLY)) for 20 minutes.  To incubate the cells with 
the primary antibody, the coverslips were placed cell side down onto a 40 µl 
drop of primary antibody preparation (dissolved in BSA-GLY) on parafilm for 45 
minutes, then washed four times with BSA/GLY.  Fluorophore conjugated 
secondary antibody in BSA/GLY was applied to the cells in a similar manner for 
30 minutes, then washed as previously.  The cells were returned to a 24 well 
plate, washed twice with PBS and surface bound antibodies fixed using 3 % (v/v) 
PFA for 30 minutes.  The coverslips were washed twice with PBS and the PFA 
quenched with GLY as previously.  The cells were blocked and permeablised 
using 200 µl 20 mM glycine, 2 % (w/v) BSA and 0.1 % (w/v) saponin in PBS 
(BSA/GLY/SAP) for twenty minutes.  The coverslips were incubated with primary 
antibody preparation in BSA/GLY/SAP for 45 minutes, washed in BSA/GLY/SAP, 
incubated with secondary antibody for 30 minutes and given four further 
BSA/GLY/SAP washes.  The coverslips were washed finally in PBS, dried and 
mounted onto slides using Immumount (Thermo).  The mounted coverslips were 
analysed using a 63 x oil immersion objective lens fitted to a Zeiss LSM Pascal 
Exciter confocal fluorescence microscope, and images overlaid using LSM 
software (Zeiss).  
 
2.9 [3H]2-Deoxyglucose uptake assays 
For these experiments cells were grown in 12 well plates.  After differentiation 
(as in 2.3.1) cells were serum starved for at least two hours.  Each twelve well 
plate was maintained at 37 °C and washed four times with Krebs Ringer 
Phosphate (KRP; 128 mM NaCl, 4.7 mM KCl, 5 mM NaH2PO4, 1.25 mM MgSO4, 1.25 
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mM CaCl2, pH7.4).  The wells of each plate were treated as follows for 30 
minutes at 37 °C: 
•  3 wells 475 µl KRP (Basal) 
•  3 wells 475 µl KRP + 1 µM insulin (Insulin) 
•   3 wells 475 µl KRP + 5 µM cytochalasin B (Basal CytoB) 
•  3 wells 475 µl KRP + 1 µM insulin +  5 µM cytochalasin B (Insulin CytoB) 
After the 30 minute incubation, 25 µl of [3H]2-deoxyglucose solution in KRP was 
added to the wells such that the final deoxyglucose concentration was 50 µM 
with 0.25 µCi per well.  Transport was allowed to proceed for 5 minutes after 
which time the contents of the wells was removed and the plates washed three 
times by immersion in ice cold PBS.  Cells were air dried for 1 hour at room 
temperature and solubilised in 1 ml 1 % Triton X-100 for 2 hours.  Solubilised 
cells were transferred into scintillation vials containing 5 ml scintillation fluid, 
and radioactivity associated with the cells measured using liquid scintillation 
spectrophotometry.  When results of these experiments are expressed as fold 
change of glucose uptake from basal cells, the calculation is: 
Fold change = (Insulin – Insulin CytoB)/(Basal – Basal CytoB) 
 
2.10 Isolation of low density microsomes from 3T3-L1 
adipocytes. 
 
2 x 10 cm2 plates of confluent adipocytes were washed twice with cold PBS and 
once with HES buffer (20 mM HEPES, 225 mM sucrose, 1 mM EDTA, pH 7.4) plus 
protease inhibitors (Roche) (HES+I).  The cells were subsequently scraped on ice 
in 1 ml HES+I and homogenised using a syringe and needle.  All further 
centrifugation steps were carried out at 4 °C. The homogenate was centrifuged 
at 500 xg for ten minutes in a chilled microcentrifuge (Beckman Coulter).  The 
supernatant was removed and centrifuged in a TLA-100 rotor at 5113 xg for 
twelve minutes to remove the plasma membrane, mitochondria and nuclei.  The 
supernatant was again centrifuged at 8795 xg for seventeen minutes to remove 
high density microsomes (HDM).  The final step involved centrifugation of the 
supernatant at 88760 xg for 75 minutes.  The resulting supernatant was removed 
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and the pellet resuspended in 0.4 ml HES+I to give the low density microsome 
fraction (LDM). 
 
2.11 Iodixanol gradient analysis of LDMs from 3T3-L1 
adipocytes. 
LDMs were isolated as in 2.10 from 2 x 10cm² plates of adipocytes expressing 
HA-GLUT4. This fraction was resuspended in iodixanol and HES+I to a final 
iodixanol concentration of 14 % (v/v).  The resulting mixture was transferred to 
Quickseal® polyallomer tubes (Beckman Coulter), sealed within the tubes and 
briefly vortexed to mix the sample.  The samples were transferred to a near 
vertical rotor (TLN-100) (Beckman-Coulter) and centrifuged at 295,000 xg at 4 
°C for 1 hour.  Fractions of approximately 300 µl were collected from the 
bottom of the gradient.  150 µl of each fraction was removed and mixed with 4 x 
Laemmli’s sample buffer (200mM Tris-HCl, 8 % (w/)v SDS, 0.4 % (w/v) 
bromophenol blue, 40 % (v/v) glycerol, 10 % (v/v) β-mercaptoethanol) and 
heated at 65 °C for ten minutes.  The fractions were subjected to SDS-PAGE on 
10 % (v/v) gels to allow detection of HA-GLUT4 by immunoblot analysis using the 
HA-11 antibody (Covance). 
 
2.12 Enrichment of GSVs using subcellular fractionation 
To produce a cellular fraction enriched in GLUT4 GSVs from differentiated 3T3-
L1 adipocytes a method similar to that published by Li et al. (2005) was used.  
Briefly, 2 10 cm plates per condition under test were scraped in 500 µl PBS, 
homogenised using 12 strokes of a syringe and needle (10 x 25 G, 2 x 26 G) and 
centrifuged at 500 xg and 4 °C for 10 minutes to pellet insoluble material.  The 
supernatant of this step was subjected to further centrifugation at 16 000 xg for 
20 minutes.  The pellets and supernatants from this step were collected and PBS 
added to both to equalise protein concentrations to approximately 2 mg/ml.  In 
the case of the HA-GLUT4 constructs, approximately 20 µg of supernatant and 5 
µg pellet fractions were routinely run on the gels (due to the higher 
concentrations of HA-GLUT4 in the pellet fraction). 
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Antigen Working 
dilution 
Description Reference/ 
Source 
A. v. GFP 1:1000 
(IB) 
Mouse monoclonal antibody (JL-8) 
raised against Aequorea victoria Green 
Fluorescent Protein (GFP). 
 
Living colors® 
FAS 1:200 
(IB) 
Mouse monoclonal antibody against 
residues 9-202 of human fatty acid 
synthase. 
BD biosciences. 
GAPDH 1:30,000 
(IB) 
Mouse monoclonal antibody (clone 6C5) 
against GAPDH. 
 
Ambion® 
GLUT4 1:1000 
(IB) 
Rabbit polyclonal antibody against C-
terminal 14 amino acids of GLUT4. 
 
(Brant et al., 1992) 
GLUT4 1:1000 
(IB) 
Rabbit polyclonal antibody against C-
terminal 14 amino acids of GLUT4. 
 
Synaptic Systems. 
HA 1:1000 
(IB) 
1:200 
(IF) 
Mouse monoclonal antibody (clone 
16B12) against an epitope from the 
human influenza haemagglutinin protein 
(YPYDVPDYA). 
 
Covance Research 
products 
IRAP 1:2000 
(IB) 
Mouse monoclonal antibody against 
IRAP 
 
Gift from Professor 
Paul Pilch 
IRS-1 1:1000 
(IB) 
Rabbit polyclonal antibody raised 
against the C-terminal 14 amino acids 
of rat liver IRS-1 (YASINFQKQPEDRQ) 
 
Upstate (New 
York) 
Myc 1:1000 
(IB) 
1:500 
(IF) 
Rabbit polyclonal antibody raised 
against the myc epitope (EQKLISEEDL) 
conjugated to KLH. 
 
Abcam 
Stx-4 1:3000 
(IB) 
Rabbit polyclonal antiserum raised 
against the cytosolic domain of rat 
syntaxin-4 
 
Synaptic Systems 
Tankyrase 
1/2 
1:300 
(IB) 
Rabbit polyclonal IgG raised against 
amino acids 745-1094 of Tankyrase -1 
of human origin 
 
Santa Cruz 
biotechnology 
(California) 
Ubiquitin 1:1000 
(IB) 
Mouse monoclonal antibody (clone 
P4D1) raised against denatured bovine 
ubiquitin. 
 
Covance Research 
products 
USP25 1:4000 
(IB) 
Rabbit polyclonal antibody raised 
against GST-USP25 
 
(Bosch-Comas et 
al., 2006) 
Vti1p 1:30,000 
(IB) 
Rabbit polyclonal antibody raised 
against Vti1p 
Generated by 
Eurogentec. 
 
Table 2.1 Primary antibodies used in this study.  
IB = immunoblotting, IF = Immunofluorescence. 
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 Working 
dilution 
Description Reference/ 
Source 
Anti Rabbit-
HRP 
 
1:5000 (IB) HRP conjugated whole IgG 
from donkey. 
GE Healthcare 
Anti Mouse-
HRP 
 
1:2000 (IB) HRP conjugated whole IgG 
from sheep. 
GE Healthcare 
Anti Mouse– 
Cy3 
 
1:200 (IF) Cy3 conjugated anti-mouse 
IgG from goat. 
Jackson 
Immunoresearch 
(Stratech) 
 
Anti Mouse- 
DyLight488 
 
1:200 (IF) DyLight488 conjugated anti-
mouse IgG from goat. 
Jackson 
Immunoresearch 
(Stratech) 
 
Anti Rabbit-
AlexaFluor 
488 
1:400 (IF) AlexaFluor 488 conjugated 
anti-rabbit IgG, from goat. 
Living Colours 
(Invitrogen) 
Table 2.2 Secondary antibodies used in this study. 
IB = immunoblotting, IF = immunofluorescence 
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Number Plasmid Description Reference 
1 pPLO2010 pep4-∆H3 allele in pRS306.  
Constructed by first subcloning a 
4.6kb SacI-SalI fragment containing 
the PEP4 gene into pRS306, then 
removing the 1.3-kbp HindIII 
fragment contained within the SacI-
SalI insert, generating the ∆H3 allele. 
 
(Nothwehr et al., 
1995) 
 
13 pNB701 Yeast expression plasmid (CEN, 
URA3) encoding Pho8p from the CUP1 
promoter 
 
(Struthers et al., 
2009) 
169 pBABE puro Retroviral expression vector, AmpR, 
puro 
(Morgenstern and 
Land, 1990) gift 
from Professor 
David James 
 
321 pRM4 Retroviral expression vector encoding 
HA-tagged GLUT4 7K/R 
Constructed by Dr 
R. McCann 
 
358 pHA-GLUT4 Retroviral expression vector encoding 
HA-tagged GLUT4 
(Shewan et al., 
2000) 
 
359 pGEX-
DSK2UBA 
E. coli expression vector encoding the 
UBA domain of S. cerevisiae Dsk2p 
(residues 328-373) fused to the C-
terminus of GST 
(Funakoshi et al., 
2002) 
 
 
 
390 pCAL1 As pGEX-DSK2UBA but with two point 
mutations M342R and F344A in the 
UBA domain. 
This study. 
399 pGEX GGA3 
VHS-GAT 
E. coli expression vector encoding the 
VHS-GAT domain of hGGA3  (residues 
1-146) fused to the C-terminus of 
GST 
 
(Mattera et al., 
2004) 
476 pCAL4 S. cerevisiae expression vector (CEN, 
URA3) encoding GLUT4 with an 
exofacial HA tag between residues 67 
and 68, based on pNB701  
 
This study 
482 pRM35 Retroviral expression vector encoding 
HA-tagged GLUT4 6K/R (K109) 
 
Constructed by Dr 
R. McCann 
483 pRM36 Retroviral expression vector encoding 
HA-tagged GLUT4 6K/R (K495) 
 
Constructed by Dr 
R. McCann 
487 pGEX6P-1 E. coli expression vector with N-
Terminal GST tag. 
 
GE Healthcare 
492 pCAL6 As pGEX GGA3 VHS-GAT with two 
point mutations in GAT domain 
(E250N D284G) 
This study 
 
498 pGEX USP25 E. coli expression vector encoding 
USP25 with an N terminal GST tag 
(Meulmeester et 
al., 2008) 
 
515 pRM55 Retroviral expression vector encoding 
HA-tagged GLUT4.  Constructed by 
excision of a PshAI-BglII fragment 
Constructed by Dr 
R. McCann 
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from pHA-GLUT4 and ligating this 
fragment into PshAI-BglII cut pRM36 
 
521 pCAL11 Retroviral expression vector encoding 
N terminally tagged myc-GGA3 short 
isoform. 
This study 
553 pCAL12 Retroviral expression vector encoding 
N terminally tagged myc-GGA3 short 
isoform with mutations in the GAT 
domain (E250N, D284G) 
 
This study 
597 pCAL13 Identical to pGEX-USP25 with a 
mutation in the putative tankyrase 
binding motif (R1049A) 
This study 
Table 2.3 Plasmids used in this study 
 
Name Target sequence Description 
Scrambled GACGAACAAACCGCCACATAT Scrambled control 
siRNA 
 
30825 CCTGCTGGTTTAGTGCAGTTA Targeted against 
USP25; sequence 
provided by Dr Nai-
Wen Chi (UCSD) 
 
30827 CCCAACGATCACTGCAAGAAA As above 
Table 2.4 siRNA target sequences used in this study 
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Table 2.5 DNA oligonucleotides used in this study 
 
 
Number Sequence (5’-3’) Description 
1 GATATTAAGAAAAACAAACTGTACAATCAAT
CAATCAATCATCACATAAAATGCCGTCGGGC
TTCCAACAGATA 
 
CUP1hGLUT4 
2 ATTATAACGTATTAAATAATATGTGAAAAAAG
AGGGAGAGTTAGATAGGGATCAGTCGTTCTC
ATCTGGCCCTAA 
 
3’UTRhGLUT4 
352 GACAACTAAACGACAGGGGCGCCTTCGATTT
CGATAGAA 
Mutation of residues 342 and 
344 of Dsk2p UBA domain 
from methionine to arginine 
and phenylalanine to alanine 
respectively (mutagenic 
codons underlined) 
 
353 GTTTCTATCGAAATCGAAGGCGCCCCTGTCG
TTTATTGGTC 
 
Reverse complement of 352 
489 GTGGTCGACTCATAGGTTCCCCCACTGTTCC SalI GGA33’ 
 
511 TGAATTCATGGAACAAAAACTTATTTCTGAAG
AAGATCTGGCGGAGGCGGAAGGGGAAACG 
 
EcoRI myc GGA3 5’.  
520 TCTTCCATCCGCGCCGTCTCTC 
 
pBABE sequencing primer. 
559 CATGTTGTCCCTCAGTGCAACTCCTGCTGAT
GG 
Mutation of residue 1049 of 
human USP25 from arginine 
to alanine (forward primer, 
mutagenic codons 
underlined) 
 
560 CCATCAGCAGGAGTTGCACTGAGGGACAAC
ATG 
 
Reverse complement of 559 
565 GACAGAGAGCTGATGAAGAACCTGTTTGATC
AGTGTGAGAAC 
Mutation of residue 250 of 
GGA3 GAT domain from 
glutamic acid to asparagine 
(forward primer, mutagenic 
codon underlined) 
 
566 GTTCTCACACTGATCAAACAGGTTCTTCTTCA
TCAGCTCTCTGTC 
 
Reverse complement of 457 
 
567 CTGCAAGCCAGTGGGAACCTCTCCCGGGTC Mutation of residue 284 of 
GGA3 GAT domain from 
aspartic acid to glycine 
(forward primer, mutagenic 
codon underlined) 
 
568 GACCCGGGAGAGGTTCCCACTGGCTTGCAG Reverse complement of 459 
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Name Genotype Source 
BL-21(DE3) F– ompT hsdSB(rB
–, mB
–) gal dcm (DE3)  
 
Invitrogen 
TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 
recA1 ara139 (ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG 
 
Invitrogen 
 
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZ∆M15 Tn10 (Tetr)] 
 
Stratagene 
Table 2.6 E. coli strains used in this study. 
 
Name Genotype Source 
SF838-9Dα MATα leu2-3, 112 ura3-52 his4-519 ade6 gal2 
pep4-3 
(Rothman et al., 
1989) 
 
YNL297C MATa his3∆::pFA6aMON2-GFP leu2∆0 met15∆0 
ura3∆0 
 
Invitrogen, (Huh 
et al., 2003) 
BHNY1 MATa his3∆::pFA6aMON2-GFP leu2∆0 met15∆0 
ura3∆0 pep4-3 
This study 
Table 2.7 S. cerevisiae strains used in this study. 
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trafficking of GLUT4 
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3.1 Introduction 
GLUT4 is a 12-transmembrane domain-containing transporter protein, part of the 
larger family of GLUTs, which allows passive diffusion of glucose down a 
concentration gradient (Wood and Trayhurn, 2003).  Insulin signalling results in 
an increase in the number of GLUT4 molecules at the cell surface, thus 
increasing the rate at which glucose enters the cell (Birnbaum, 1989;James et 
al., 1989).  This activity is responsible for the insulin-induced clearance of 
glucose from the bloodstream after a meal.  In the absence of insulin, GLUT4 is 
retained intracellularly, continually cycling through compartments of the 
TGN/endosomal system including GLUT4 storage vesicles or GSVs (Bryant et al., 
2002).  GSVs are defined as the compartment(s) from where GLUT4 is mobilised 
to the cell surface in response to insulin (discussed in more detail in sections 
1.4.3 and 1.4.4).  Although GSVs remain somewhat poorly defined, they are 
known to contain many proteins other than GLUT4.  Notable amongst these are 
the insulin responsive aminopeptidase IRAP (Ross et al., 1996;Ross et al., 1997), 
the sorting receptor sortilin (Lin et al., 1997;Morris et al., 1998) and the SNARE 
protein VAMP2 (Cain et al., 1992;Martin et al., 1996). 
The trafficking itinerary of GLUT4 bears some similarities to that of the yeast 
amino acid permease Gap1p (Roberg et al., 1997;Bryant et al., 2002) as 
discussed in section (1.5.2).  When yeast cells are grown on optimal nitrogen 
sources such as glutamate, the transporter is delivered to the endosomal system.  
On less favourable nitrogen sources such as proline, the channel is directed to 
the plasma membrane to allow uptake of amino acids (Roberg et al., 
1997;Soetens et al., 2001;Risinger and Kaiser, 2008). 
The nitrogen-regulated trafficking of Gap1p is controlled by ubiquitination of the 
transporter by the ubiquitin ligase Rsp5p (Helliwell et al., 2001), and subsequent 
Gap1p-Ub interaction with the coat proteins Gga1p/Gga2p (Scott et al., 
2004;Bilodeau et al., 2004).  Work in our laboratory has built upon the parallels 
between the regulated trafficking of Gap1p and GLUT4 to form the hypothesis 
that ubiquitination of GLUT4 plays a role in its trafficking in insulin-sensitive 
cells.  A previous PhD student in the lab expressed human GLUT4 in yeast and 
found that it could only be detected by immunoblot analysis in cells lacking 
active vacuolar proteases, suggesting that it is trafficked to the proteolytically 
active endosomal system (McCann R.K., 2007). Indirect immunofluorescence 
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found that GLUT4 expressed in yeast displays a punctate staining pattern 
reminiscent of that reported for Gap1p (McCann R.K., 2007).  This staining 
colocalises with the TGN marker Kex2p (McCann R.K., 2007).  Proteins localise to 
the yeast TGN by continually cycling through a prevacuolar/endosomal 
compartment (Bryant and Stevens, 1997), an exaggerated form of which 
accumulates in the class E vps mutants (Raymond et al., 1992). Consistent with 
its TGN localisation, GLUT4 localises to the class E compartment that 
accumulates in vps27∆ cells (McCann R.K., 2007)  Again, this bears similarity to 
findings reported for Gap1p whose punctate distribution (on rich media) 
collapses into the class E compartment of vps4 and vps27 mutant cells (Rubio-
Texeira and Kaiser, 2006). 
The endosomal delivery of Gap1p on rich media is regulated by ubiquitination of 
the transporter (Soetens et al., 2001).  Ubiquitinated Gap1p is recognised by the 
Gga coat proteins, and trafficked from the TGN into the endosomal system 
(Scott et al., 2004).   
Immunoblot analysis of GLUT4 immunoprecipitated from yeast reveals that it is 
ubiquitinated in a lysine-dependent manner (McCann R.K., 2007).  Ubiquitination 
of GLUT4 appears to be both necessary and sufficient for delivery into the 
proteolytically active endosomal system in yeast since a ubiquitin-resistant 
version (with all 7 cytosolically disposed lysine residues mutated to arginines) is 
not degraded by vacuolar proteases in yeast, whereas an in-frame version of 
ubiquitin to this mutant restores its trafficking (McCann R.K., 2007).  In addition, 
as reported for Gap1p (Scott et al., 2004), the ubiquitin-dependent delivery of 
GLUT4 to the yeast endsomal system requires the ubiquitin-binding Gga proteins 
(McCann R.K., 2007) (Figure 3.1).   
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Figure 3.1 hGLUT4 expressed in yeast requires ubiquitin acceptor sites to enter the 
proteolytically active endosomal system.  
Wild type (wt) GLUT4 expressed in yeast is conjugated to HA-Ub (A) and endogenous Ub (B) when 
expressed in vacuolar protease deficient SF838-9Dα yeast, whereas a ubiquitin resistant mutant 
(K/R) is not. (C) Yeast grown on rich media traffic wt GLUT4, but not GLUT4 7K/R, into the 
proteolytically active endosomal system, resulting in its degradation.  GLUT4 is stabilized on rich 
media when expressed in a gga∆ strain.  Image used with permission from Dr. Rebecca McCann. 
 
These studies were extended to the more physiologically relevant 3T3-L1 
adipocyte cell line.  Initial results suggested that GLUT4-7K/R does not enter 
GSVs and does not translocate to the cell surface in response to insulin.  
However the constructs used in these studies expressed wild type HA-GLUT4 at a 
significantly higher (approximately 20 fold greater) level than the ubiquitin 
resistant HA-7K/R, making it impossible to be sure that the differences seen in 
the trafficking of these molecules was due to differences in their ubiquitination 
status.   
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Figure 3.2 Schematic of GLUT4 in the plasma membrane with cytosolic lysines (putative 
ubiquitination sites) indicated.  
Adapted with permission from Macmillan Publishers Ltd from Bryant et al., copyright (2002)  
 
Another caveat with these experiments is that five of the seven potential 
ubiquitination sites (i.e. lysine residues that are predicted to be cytosolically 
disposed) (Birnbaum, 1989;James et al., 1989) in GLUT4 are in the large 
intracellular loop (Figure 3.2).  This portion of GLUT4 has been reported to 
interact with the ARF GAP protein ACAP1, and it has been proposed that this 
interaction is required to form functional clathrin coats on GSVs and permit 
recycling of GLUT4 (Li et al., 2007). One of the important sites identified by Li 
et al. (2007) is a KR motif at residues 245-246, mutation of which to AA results in 
decreased interaction between GLUT4 and ACAP1.  It is therefore possible that 
mutation of the five lysine residues within the loop results in impaired insulin-
regulated trafficking of due to disruption of interaction with ACAP1.  This 
chapter describes work performed by me to address the above concerns. 
 
3.2 Aims of the chapter. 
The aims of the work in this chapter were twofold; firstly, I set out to equalise 
expression of wild type HA-GLUT4 and the ubiquitin resistant HA-GLUT4 7K/R 
from their respective retroviral expression vectors; and secondly, I wanted to 
address concerns that impaired insulin-regulated trafficking of ubiquitin-
resistant HA-GLUT4 7K/R may not be due to its lack of ubiquitination, but 
structural changes in the large intracellular loop, which may in turn disrupt 
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interactions with effector proteins required for the insulin regulated trafficking 
of GLUT4, such as ACAP1 (see above). 
In order to investigate the latter point, I built on previous work that 
demonstrated that GLUT4 expressed in yeast can be ubiquitinated on any one of 
its seven cytosolically disposed lysine residues, and that ubiquitination of any 
one of these lysines is sufficient to direct GLUT4 delivery to the endosomal 
system (McCann R.K., 2007).  I reasoned that if the same is true in adipocytes 
then I could test whether the mutations in the large intracellular loop were 
impairing the trafficking of HA-GLUT4 7K/R by creating versions in which single 
lysine residues outwith the large intracellular loop, at positions 109 or 495, had 
been reintroduced. 
3.3 Expression of HA-GLUT4 and HA-GLUT4 7K/R 
The HA-GLUT4 expression construct (pHA-GLUT4) used in our lab’s initial studies 
on GLUT4 (described above) was generated in an earlier study (Shewan et al., 
2000).  The cDNA from which the HA-GLUT4 fragment was generated contained 
22 bases of untranslated sequence 5’ to the GLUT4 coding region (Fukumoto et 
al., 1989;Quon et al., 1994) which may play a role in transcriptional and/or 
translational regulation of the GLUT4 coding sequence.  A comparison of pHA-
GLUT4 and wild type GLUT4 coding sequence is shown in Figure 3.3. 
The HA-GLUT4 7K/R expression vector (pRM4) was generated from the GLUT4-
7K/R open reading frame present in a yeast expression vector for GLUT4-7K/R. 
This construct lacked the 22bp upstream sequence and its expression was solely 
controlled by the retroviral CMV promoter in the pBABE vector backbone 
(Morgenstern and Land, 1990).  In order to create a retroviral expression vector 
that produces levels of wild-type HA-GLUT4 similar to those obtained for pHA-
GLUT4 7K/R, I set out to remove the 22 bp, non-coding sequence found 
upstream of the coding sequence in pHA-GLUT4. 
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1                                            50
GLUT4 human    (1) ------------------------------------------ATGCCGTC
pHA-GLUT4    (1) GGATCCTCTAGACTCGACCGCGTCCAGCTCTTCTAAGACGAGATGCCGTC
51                                           100
GLUT4 human    (9) GGGCTTCCAACAGATAGGCTCCGAAGATGGGGAACCCCCTCAGCAGCGAG
pHA-GLUT4   (51) GGGCTTCCAACAGATAGGCTCCGAAGATGGGGAACCCCCTCAGCAGCGAG
101                                          150
GLUT4 human   (59) TGACTGGGACCCTGGTCCTTGCTGTGTTCTCTGCGGTGCTTGGCTCCCTG
pHA-GLUT4  (101) TGACTGGGACCCTGGTCCTTGCTGTGTTCTCTGCGGTGCTTGGCTCCCTG
151                                          200
GLUT4 human  (109) CAGTTTGGGTACAACATTGGGGTCATCAATGCCCCTCAGAAGGTGATTGA
pHA-GLUT4  (151) CAGTTTGGGTACAACATTGGGGTCATCAATGCCCCTCAGAAGGTGATTGA
201                        230
GLUT4 human  (159) ACAGAGCTACAATGAGACGTGGCTGGGGAG
pHA-GLUT4  (201) ACAGAGCTACAATGAGACGTGGCTGGGGAG
 
Figure 3.3 DNA sequence alignment of HA-GLUT4 from pHA-GLUT4 and the hGLUT4 
sequence.   
The BamHI site used to subclone HA-GLUT4 is indicated in blue, homologous sequences are in 
red. Sequences were aligned using Vector NTI (Invitrogen). 
 
Also present in the lab at this time were HA-GLUT4 expression vectors (pRM35 
and 36) encoding GLUT4 mutants with single cytosolic lysine residues (K109 and 
K495 respectively), constructed by Dr R. K. McCann.  These constructs were 
based on pHA-GLUT4 7K/R and thus lacked the upstream sequence present in 
pHA-GLUT4 (Fukumoto et al., 1989;Quon et al., 1994).  The presence of these 
reagents in the lab provided a straightforward way to generate wild type HA-
GLUT4 in a background lacking the 5’ upstream sequence (detailed in Figure 
3.4), with the hope of obtaining vectors to produce comparable amounts of wild 
type HA-GLUT4, HA GLUT4 7K/R and the two “add back” mutants in 3T3-L1 
adipocytes.  A PshAI-BglII fragment of HA-GLUT4 from base pairs 70-1469 of the 
GLUT4 coding sequence was excised from pHA-GLUT4 and inserted into PshAI-
BglII digested pRM36 which encoded HA-GLUT4 6K/R (495).  The presence of the 
fragment was verified using a diagnostic restriction digest with TthIIII. This work 
was carried out in collaboration with Dr. Rebecca McCann. 
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Figure 3.4 Construction of pRM55.   
pHA-GLUT4 and pRM36 (encoding HA-GLUT4 6K/R K495) were simultaneously digested using 
PshII and BglII restriction enzymes.  The resulting fragment of HA-GLUT4 was ligated into gapped 
pRM36, generating pRM55.  Relative positions of codons for cytosolically disposed lysine (K) and 
arginine (R) are indicated, the 22 bp 5’ untranslated sequence is represented by the grey box in 
pHA-GLUT4. 
 
All four HA-GLUT4 constructs (wild type, 7K/R and 6K/R 109 and 495), now in 
the same background (i.e. lacking the 22 bp sequence found in pHA-GLUT4) were 
transfected into Plat-E packaging cells to generate recombinant retrovirus as 
described in 2.3.4 and the resulting viruses were used to infect subconfluent 
3T3-L1 fibroblasts.  The fibroblasts were grown to confluency, differentiated 
into adipocytes and their HA-GLUT4 content analysed by immunoblotting.  As 
shown in Figure 3.5 the expression of all four HA-GLUT4 variants was similar 
(using comparison to endogenously expressed GAPDH to control for loading).  
Having established conditions to express these 4 versions of HA-GLUT4 to similar 
levels in adipocytes, it was now possible to proceed with further 
characterisation of their trafficking without being concerned that any observed 
differences might be due to altered expression levels. 
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Figure 3.5 Expression of HA-GLUT4 and mutants in 3T3-L1 adipocytes.   
Subconfluent 3T3-L1 fibroblasts were infected with recombinant retrovirus harbouring expression 
vectors encoding HA-GLUT4, HA-GLUT4 7K/R, HA-GLUT4 6K/R K495 and HA-GLUT4 6K/R 109, 
grown to confluency under selection with 2.5 µg/ml puromycin and differentiated as previously 
described.  Between days 8 and 12 post-differentiation cells from one 10 cm plate were harvested 
in lysis buffer and the lysates equalized for protein content to approximately 5 mg/ml.  The lysates 
were subjected to SDS-PAGE on 10 % (v/v) gels and immunoblotted for the HA epitope and 
GAPDH as a loading control. 
 
3.4 A single ubiquitination site is sufficient to permit 
insulin-stimulated translocation of GLUT4. 
3.4.1 HA-GLUT4 6K/R K109 and K495 are ubiquitinated in 3T3-L1 
adipocytes. 
As stated in 3.1, one of the major concerns with the use of the 7K/R mutant was 
that mutation of the five lysine residues within the large intracellular loop of 
GLUT4 may affect the structure of this region so that the altered trafficking of 
this mutant may be for reasons other than its altered ubiquitination status.  To 
address this concern I made use of the observation that when present as the sole 
cytosolic lysine, any one of the seven lysines mutated in the 7K/R mutant serves 
as a ubiquitin acceptor site in yeast (McCann R.K., 2007).  The two lysines 
located outside the large cytosolic loop are K109, located within the first 
intracellular domain, and K495, located within the C-terminal cytosolic region of 
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GLUT4 (Figure 3.2), a region known to contain several important GLUT4 
trafficking motifs (Verhey et al., 1995;Shewan et al., 2000;2003).  As discussed 
above, our lab has retroviral constructs (pRM35 and pRM36) to express versions 
of GLUT4 harbouring either one of these as the sole cytosolic lysine (HA-GLUT4 
K109 and 495) that produce these proteins in 3T3-L1 adipocytes at levels 
comparable to HA-GLUT4 and HA-GLUT4 7K/R from their retroviral expression 
vectors (Figure 3.5) Recombinant retroviral particles were produced containing 
these two constructs and used to infect 3T3-L1 fibroblasts.  These cells were 
grown to confluency in 10 cm dishes and differentiated into adipocytes.   
To ask whether the presence of either K109 or K495 is sufficient for to restore 
the ubiquitination of HA-GLUT4 7K/R I used a GST-pull-down approach.  The 
Dsk2p-UBA has been studied extensively and binds both mono- and poly-ubiquitin 
with high affinity (Funakoshi et al., 2002;Ohno et al., 2005;Raasi et al., 2005).  
The molecular determinants of ubiquitin recognition by the UBA domain have 
been identified in an NMR solution structure of Dsk2p UBA in complex with 
ubiquitin (Funakoshi et al., 2002), demonstrating the two residues within the 
UBA essential for interaction are methionine 342 and phenylalanine 344 
(numbering relative to full length Dsk2p).   
A fusion protein of Dsk2p UBA and glutathione-S-transferase (GST) had been 
generated in another study (GST-UBA) (Raasi et al., 2005), and could be used to 
pull ubiquitinated proteins out of solution.  Work in our lab by myself and others 
sought to use GST-UBA to detect ubiquitinated GLUT4 in 3T3-L1 adipocytes. As a 
negative control for these experiments I used site-directed mutagenesis to 
mutate M342 and F344 in the context of the GST-UBA fusion, generating GST-
UBA M342R F344A (GST-UBAmut).  In collaboration with another member of our 
group (Dr. R.K. McCann) I used GST-UBA and GST-UBAmut in pull-down assays to 
ascertain the ubiquitination status of endogenous GLUT4 in 3T3-L1 adipocytes.  
The results of these experiments are shown in Figure 3.6. 
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Figure 3.6 GLUT4 is ubiquitinated in 3T3-L1 adipocytes.   
3T3-L1 adipocytes (two 10 cm plates per condition) were lysed in a buffer containing 1 % (v/v) 
Triton-X 100, 1 mM NEM and 1 mM EDTA, equalized for protein concentration to 5 mg/ml and 2 
mg lysate protein incubated with 20 µl of a 50 % (v/v) slurry of GST-UBA immobilised on 
glutathione-Sepharose beads for two hours.  After 3 washes in lysis buffer, bound protein was 
eluted from the beads with 15 µl 2xLSB at 65 °C for 10 minutes.  The eluate was su bjected to SDS-
PAGE on a 10 % (v/v) gel alongside 1.25 % (v/v) of the input lysate and immunoblotted for the HA 
epitope, IRS-1 as a control for ubiquitination and syntaxin 4 as a negative control.  Equal loading of 
GST-UBA and GST-UBAmut is shown in the Coomassie stained gel.   
 
These results not only show that GST-UBA can bind endogenous ubiquitinated 
proteins such as IRS-1 (Zhande et al., 2002), and this binding can be ablated by 
the M342R F344A mutation, but also that a  proportion of GLUT4 is ubiquitinated 
in 3T3-L1 adipocytes, represented by the protein recognised by an anti-GLUT4 
antibody at just above 50 kD in the GST-UBA pulldown lane in Figure 3.6.  The 
small increase in molecular weight would suggest that GLUT4 is modified with a 
single ubiquitin moiety, as endogenous GLUT4 has an apparent molecular weight 
of 45 kD by SDS-PAGE (James et al., 1989) and ubiquitin has a molecular weight 
of approximately 8 kD (Ciechanover, 2005).   Armed with this assay for detection 
of GLUT4 ubiquitination, I proceeded to analyse the ubiquitination status of HA-
GLUT4, HA-GLUT4 7K/R and the two “add-back” mutants. 
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Figure 3.7 Ubiquitination of HA-GLUT4 variants in 3T3-L1 adipocytes.   
3T3-L1 adipocytes expressing the indicated retroviral constructs (two 10 cm plates per construct) 
were lysed in a buffer containing 1 % (v/v) Triton-X 100, 1 mM NEM and 1 mM EDTA, equalized for 
protein concentration to 5 mg/ml and 2 mg lysate protein incubated with 20 µl of a 50 % (v/v) slurry 
of GST-UBA immobilised on glutathione-Sepharose beads for two hours.  After 3 washes in lysis 
buffer, bound protein was eluted from the beads with 15 µl 2xLSB at 65 °C for 10 minutes.  The 
eluate was subjected to SDS-PAGE on a 10 % (v/v) gel alongside 1.25 % (v/v) of the input lysate 
and immunoblotted for the HA epitope and IRS-1 as a control for ubiquitination.  Blots are 
representative of 2 independent experiments.   
 
As demonstrated in Figure 3.7, similar amounts of HA-GLUT4 and the two 6K/R 
variants are pulled down by GST-UBA, which suggests that they are ubiquitinated 
to a similar extent.  As anticipated from the yeast studies, HA-GLUT4 7K/R is not 
detected in the pull-down, indicating that it is not ubiquitinated.  As a control 
the blots were also probed for insulin receptor substrate-1 (IRS1) which is an 
abundant, endogenous adipocyte protein known to be ubiquitinated (Zhande et 
al., 2002). These data are in agreement with the findings from yeast (McCann 
R.K., 2007) that all seven cytosolic lysines represent potential sites of 
ubiquitination and also validates using K109 and 495 to test the sufficiency of a 
single ubiquitination site outside the large intracellular loop for GLUT4 
translocation. 
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3.4.2 HA-GLUT4 7K/R cannot translocate in response to insulin. 
As described in 3.1, the relatively low expression of HA-GLUT4 7K/R compared 
to its wild-type counterpart made interpretation of previously generated data 
showing that HA-GLUT4 7K/R does not translocate in response to insulin 
problematic, as its altered trafficking may simply be due to its lower expression 
levels.  Having normalised expression levels between HA-GLUT4, HA 7K/R and 
the two 6K/R “add back” mutants (K109 and K495), I could now compare the 
translocation of the wild type ubiquitinated and ubiquitin resistant transporters.  
pRM4 (HA-7K/R), pRM55 (HA-GLUT4), pRM35 (HA-GLUT4 K109) and pRM36 (HA-
GLUT4 K495) were transfected into Plat-E cells to generate recombinant 
retrovirus and the virus used to infect 3T3-L1 fibroblasts.  The fibroblasts were 
grown to confluency and differentiated into adipocytes on sterile coverslips.  
The adipocytes were stimulated with 200 nM insulin or left in the basal 
condition, fixed and processed for confocal microscopy.  The fixed cells were 
first stained for the HA epitope with out permeablisation to detect HA-GLUT4 
localised at the adipocyte plasma membrane (as the HA tag is located in the first 
extracellular loop of GLUT4 (Quon et al., 1994)), followed by permeablisation 
and a second round of anti-HA staining to detect total HA-GLUT4.  This 
technique shows the extent to which HA-GLUT4 and the three mutants can 
translocate in response to insulin. 
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Figure 3.8 HA-GLUT4 7K/R cannot translocate in response to insulin.  
Subconfluent 3T3-L1 fibroblasts were infected with the retroviral constructs encoding the indicated 
HA-GLUT4 variants, grown to confluency on sterile coverslips under selection with 2.5 µg/ml 
puromycin and differentiated into adipocytes.  Between days 8 and 12 post differentiation, the cells 
were either treated with 200 nM insulin for 15 minutes (Insulin) or not (Basal), fixed using 3 % (v/v) 
paraformaldehyde and stained for surface (magenta) and total HA epitope (green).  Images are 
representative of three independent experiments.  Scale bar = 20 µm. 
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 Basal Insulin 
HA-GLUT4 0 90.97 (±1.69) % 
HA-GLUT4 7K/R 0.55 (±0.55) % 22.12 (±4.36) % (*) 
HA-GLUT4 6K/R (495) 0.62 (±0.62) % 91.32 (±6.06) % 
HA-GLUT4 6K/R (109) 1.23 (±1.23) % 86.17 (±2.96) % 
 
Table 3.1 Percentage translocation of HA-GLUT4 and mutants thereof in response to 200 nM 
insulin.   
At least 50 cells from three fields of view (prepared as in Figure 3.8) were scored for the presence 
or absence of cell surface HA immunoreactivity (rim fluorescence) as a measure of HA-GLUT4 
translocation.  Results shown in the table are the mean of three experiments, expressed as 
percentage of counted cells exhibiting rim fluorescence.  * p < 0.001 compared to the HA-GLUT4 
insulin stimulated condition, student’s unpaired T-test. 
 
The upper four panels of Figure 3.8 compare the insulin regulated translocation 
of wild type and 7K/R HA-GLUT4.  HA-GLUT4 7K/R exhibits severely impaired 
translocation in response to 200 nM insulin stimulation, whereas HA-GLUT4 
translocates readily.  The immunofluorescence data is quantified in Table 3.1, 
and show that while approximately 90 % of cells expressing HA-GLUT4 exhibit 
translocation in response to 200 nM insulin, only 20 % of those expressing HA-
GLUT4 7K/R do.  These data indicate that ubiquitination of GLUT4 is essential 
for its insulin responsive translocation.  However, they still left open the 
possibility that the 5K/R mutations in the large central loop of HA-GLUT4 7K/R 
were affecting its translocation, rather than the lack of target lysines per se, 
due to the inability of ACAP1 to bind the loop and induce clathrin coat formation 
(Li et al., 2007). 
 
3.4.3 HA-GLUT4 6K/R K109 and K495 translocate readily in 
response to insulin stimulation. 
Having determined that the two HA-GLUT4 6K/R “add back” mutants are 
ubiquitinated (Figure 3.7), I was able to use the translocation assay described in 
3.4.2 to observe whether they can still respond to insulin with a single intact 
ubiquitination site outwith the large intracellular loop.  The results of these 
experiments are shown in the lower four panels of Figure 3.8.  Both HA-GLUT4 
6K/R variants translocate readily in response to 200 nM insulin, in a manner 
indistinguishable from HA-GLUT4 (upper two panels).  These data demonstrate 
that a single site of ubiquitination of GLUT4 permits its insulin responsive 
translocation, and that despite mutation of residues within the large cytosolic 
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loop in both 6K/R variants there is no effect on translocation.  This argues that if 
ACAP1 binding is required for sorting into and thus clathrin coat formation on 
GSVs (Li et al., 2007) is not affected by the 5K/R mutations introduced into the 
large intracellular loop.   
The mutations introduced into the large cytosolic loop of GLUT4 by Li et al. 
(2007) were alanine scanning mutations, so the basic lysine residue with a bulky 
R-group was being replaced with neutral alanine which has a much smaller R 
group.  However in the present study the lysines were being replaced with 
another bulky basic residue, arginine, which would be expected to alter the 
charge and structure of the large intracellular loop much less significantly. 
 
3.5 Does the 7K/R mutation affect loading of GLUT4 into 
the insulin responsive compartment? 
In insulin responsive tissues GLUT4 occupies two overlapping trafficking cycles.  
Cycle 1 is a prototypical recycling pathway between the endosomes and the cell 
surface; cycle 2 is a much slower pathway between the trans-Golgi network 
(TGN) and endosomes (discussed extensively in 1.4.3).  As part of this cycle, 
GLUT4 occupies GLUT4 storage vesicles (GSVs); the compartment from where 
GLUT4 is mobilised to the cell surface in response to insulin (Bryant et al., 
2002).  GSVs are a component of the low density microsome (LDM) fraction of 
adipocytes and contain various proteins aside from GLUT4; these include sortilin 
(Lin et al., 1997), the insulin responsive aminopeptidase IRAP (Ross et al., 
1996;Ross et al., 1997) and LRP1 (low density lipoprotein receptor related 
protein 1) (Jedrychowski et al., 2010).  Translocation of GSVs is largely 
responsible for the approximately 11-fold increase in plasma membrane GLUT4 
on insulin stimulation (Yang et al., 1992;Ross et al., 1998;Kupriyanova et al., 
2002). 
The hypothesis that HA-GLUT4 7K/R is not trafficked into GSVs was formed 
following colocalisation studies between HA-GLUT4, HA-GLUT4 7K/R and the 
TGN resident SNARE syntaxin 16 (McCann R.K., 2007).  HA-GLUT4 is present in 
the TGN and punctate cytoplasmic structures which represent GSVs (Martin et 
al., 2000).  However, while HA-GLUT4 7K/R, like its wild type counterpart, 
colocalises with syntaxin 16 to the TGN, it is conspicuously absent from these 
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puncta.  Although the data presented in Figure 3.8 support the hypothesis that 
HA-GLUT4 7K/R is not trafficked into GSVs, it is also a possibility that the 
mutant’s defective translocation arises due to impaired trafficking from GSVs to 
the cell surface.   
To distinguish between these possibilities I undertook subcellular fractionation 
to separate GSVs from other GLUT4 containing membranes of adipocytes 
expressing HA-GLUT4 and mutants thereof.  One approach that was initially 
considered was that of iodixanol gradient centrifugation.  This process as 
described by Hashiramoto and James (2000), involves isolating a LDM fraction 
from 3T3-L1 adipocytes in a high sucrose buffer (HES) and subjecting this to high 
velocity centrifugation in a self forming iodixanol gradient.  Thirteen fractions 
are collected from the gradient and fractions 2-13 immunoblotted.  GLUT4 
fractionates into a “heavy” and “light” peak in fractions 2-6 and 7-12 
respectively – the GLUT4 content of the heavy peak is depleted on insulin 
stimulation which indicates that these fractions contain the insulin responsive 
compartment (Hashiramoto and James, 2000). 
I initially set out to use this approach on basal adipocytes expressing HA-GLUT4.  
However it proved difficult to obtain consistent fractionation profiles for even 
the wild-type protein.  Three example gradients for HA-GLUT4 are shown in 
Figure 3.9 and indicate the lack of consistency between experiments –the 
protein was generally located primarily in one or another peak, rather than 
being evenly distributed between the two.  This variation meant it would be 
difficult to ascertain whether the fractionation profile of any of the HA-GLUT4 
mutants was altered when compared to the wild type. 
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Figure 3.9 Three example iodixanol gradient fractionation profiles of HA-GLUT4 in 3T3-L1 
adipocytes.   
Low density microsomes from serum-starved 3T3-L1 adipocytes were resuspended in HES buffer 
and centrifuged at 295 000 xg for 1 hour on a self-forming iodixanol gradient.  Thirteen fractions 
were collected from the bottom of the gradient, combined with sample buffer and fractions 2-12 
subjected to SDS-PAGE on a 10 % gel.  The fractions were then immunoblotted with an anti-HA 
antibody to detect HA-GLUT4. 
 
Another method for isolating the insulin responsive compartment has been 
developed in the laboratory of Konstantin Kandror (Boston University School of 
Medicine).  As outlined in several publications (Xu and Kandror, 
2002;Kupriyanova et al., 2002;Li and Kandror, 2005;Li et al., 2007), a subcellular 
fraction enriched in GSVs can be obtained from adipocytes homogenised in PBS 
and subjected to a 20 minute centrifugation at 16 000 xg.  The resultant pellet 
contains heavy membranes including the lysosomes, Golgi membranes, 
endoplasmic reticulum and plasma membrane, whereas the supernatant contains 
the GSV compartment and transport vesicles (Xu and Kandror, 2002;Kupriyanova 
et al., 2002). 
I employed this method to analyse the partitioning of HA-GLUT4, HA-GLUT4 7K/R 
and the two 6K/R (K109 and K495) mutants between the pellet and GSV 
containing supernatant fractions.  Basal adipocytes were fractionated using the 
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protocol outlined in 2.12 and subsequently immunoblotted for the HA epitope 
and IRAP as a marker for GSVs.  The results of these experiments are shown in 
Figure 3.10.  From three independent experiments there was a consistent 
reduction in the amount of HA-GLUT4 7K/R in the supernatant fraction 
compared to HA-GLUT4 (31 % ± 1.02 % compared to 53.8 ± 0.57 %), indicating 
that HA-GLUT47K/R is impaired in its ability to reach GSVs.  This correlates with 
the unpublished data concerning the absence of HA-GLUT4 7K/R from the 
cytosolic puncta thought to represent GSVs (McCann R.K., 2007).  It also provides 
an explanation as to why HA-GLUT4 7K/R cannot translocate in response to 
insulin (as demonstrated in Figure 3.8) as the mutant is impaired in its ability to 
reach GSVs. 
Importantly, both the 6K/R mutants are partitioned between the pellet and 
supernatant fractions in a manner similar to HA-GLUT4 (HA-GLUT4 6K/R (495) 
53.5 % ± 3.9 %, HA-GLUT4 6K/R (109) 54.2 % ± 2.4% in supernatant fraction).  
These data support the hypothesis that a single ubiquitination site on GLUT4 is 
sufficient to allow the entry of the transporter into the insulin responsive 
compartment, and provides further evidence that mutation of the 5 lysine 
residues within the large intracellular loop does not affect the loading of GLUT4 
into GSVs. 
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Figure 3.10 HA-GLUT4 7K-R cannot enter the insulin responsive compartment.   
Adipocytes were homogenised with 12 strokes with a syringe and needle then centrifuged at 2000 
xg for 10 minutes.  The soluble phase of this step was subject to further centrifugation at 16 000 xg 
for 20 minutes.  The pellet and supernatant from this centrifugation step were analysed by 
immunoblotting (A), loading 5 µg pellet protein and 20 µg supernatant protein. B. The partitioning of 
HA-GLUT4 between pellet and supernatant was compared using image analysis software (ImageJ, 
NIH) to quantify the optical density of the bands on the blot.  The percentage of total HA-GLUT4 in 
the supernatant fraction is plotted.  n = 3, * statistically significant difference (p < 0.001, unpaired 
Student’s T-test).  Error bars ± standard error of the mean. 
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3.6 Chapter discussion 
The aim of the experiments in this chapter was to test the hypothesis that 
ubiquitination of GLUT4 is required for its insulin responsiveness.  To test this 
hypothesis, I initially set out to equalise the levels of HA-GLUT4 and HA-GLUT4 
7K/R expression from their retroviral expression vectors as previous studies in 
our lab had used vectors which expressed HA-GLUT4 at much higher levels than 
HA-7K/R.  The second aim was to use these new constructs to study the 
trafficking of HA-GLUT4, HA-GLUT4 7K/R and two “add back” mutants with 
single cytosolic lysines (i.e. potential ubiquitination sites) outwith the large 
intracellular loop (K109 and K495).  This would indicate whether a single 
ubiquitination site is sufficient for entry into GSVs and thus insulin responsive 
GLUT4 translocation, and whether mutation of the five lysine residues within the 
large intracellular loop alters GLUT4 trafficking. 
Removal of sequences 5’ of the HA-GLUT4 coding sequence in pHA-GLUT4 using 
subcloning techniques resulted in HA-GLUT4 and HA-GLUT4 7K/R being 
expressed at similar levels (Figure 3.5), addressing concerns that any difference 
in their trafficking properties might be due to differences in their expression 
levels.  Going forward with these new reagents, I demonstrated that HA-GLUT4 
7K/R is not be ubiquitinated in 3T3-L1 adipocytes (Figure 3.7) and that 
translocation of this mutant in response to insulin is blunted compared to the 
wild type protein (Figure 3.8).  The ability of HA-GLUT4 7K/R to enter the GSV 
compartment is also significantly impaired, as shown by a subcellular 
fractionation approach (Li and Kandror, 2005) (Figure 3.10), which indicates that 
the lack of HA-GLUT4 7K/R translocation is due to its inability to enter the 
insulin responsive compartment rather than a defect in exit from GSVs. 
A recent study indicated that the large intracellular loop, specifically the 245-
246 KR motif, is involved in recruitment of the Arf6 GAP ACAP1 which plays a 
role in GLUT4 recycling (Li et al., 2007).  Potentially, the 5K/R mutations 
located within the large cytosolic loop could disrupt the binding interface 
between the ACAP1 and GLUT4, raising concerns that the defective insulin 
regulated trafficking of the 7K/R mutant was not due to its loss of 
ubiquitination.  This led to the use of two “add back” mutants which have single 
ubiquitin-acceptor sites outwith the large intracellular loop (HA-GLUT4 6K/R 109 
and 495).  Both these mutants behaved in a manner similar to HA-GLUT4 – they 
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were ubiquitinated in adipocytes (Figure 3.7), enter GSVs (Figure 3.10) and 
translocate to the cell surface in response to insulin (Figure 3.8) and.  It is 
therefore possible to say that mutation of the lysine residues within the large 
intracellular loop does not affect GLUT4 traffic in itself.  From these data it can 
also be stated that the exact residue on which GLUT4 is ubiquitinated is not 
important; any of the single cytosolic lysine residues can provide a suitable 
substrate for ubiquitination and subsequent development of insulin 
responsiveness.  This corroborates unpublished data from yeast where 
immunoprecipitation experiments demonstrated that GLUT4 can be 
ubiquitinated to the same extent on any one of its seven cytosolically disposed 
lysine residues (McCann R.K., 2007). 
The finding that a single GLUT4 ubiquitination site is sufficient for its 
ubiquitination and translocation may seem surprising.  However, previous studies 
attempting to map the ubiquitination sites of other protein substrates using 
lysine to arginine mutations has shown that these mutants retain almost wild 
type levels of ubiquitination.  Examples include the T cell receptor ζ subunit 
(Hou et al., 1994) and c-Jun (Treier et al., 1994). 
How does my data correlate with previous findings?  Work on other receptors and 
channel proteins in mammalian cells has shown ubiquitination is a signal for 
internalisation and degradation, rather than sorting from the TGN to a secretory 
compartment (Geetha et al., 2005;Kamsteeg et al., 2006;Shin et al., 
2006;Shenoy, 2007).  Examples of proteins being sorted into secretory 
compartments in a ubiquitin dependent manner are rare.  One example is Fas 
ligand (FasL) which is secreted by cytotoxic leukocytes and natural killer cells to 
induce apoptosis (Zuccato et al., 2007).   FasL is secreted from compartments 
known as secretory lysosomes, which are highly vesiculated structures with the 
intralumenal vesicle membranes containing FasL.  A combination of 
phosphorylation and ubiquitination is required to sort FasL into the intralumenal 
vesicles of secretory lysosomes (Zuccato et al., 2007).  However this sorting 
process may have more in common with ESCRT dependent multivesicular body 
sorting than formation of classical secretory compartments such as GSVs (Blott 
and Griffiths, 2002).  The finding that ubiquitination of GLUT4 is required for its 
sorting into the insulin responsive compartment is, therefore, novel in the 
context of mammalian cells. 
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Previously, parallels have been drawn between the nitrogen-regulated 
trafficking of S. cerevisiae Gap1p and GLUT4 traffic (Roberg et al., 1997;Bryant 
et al., 2002).  Gap1p is sorted to the cell surface when yeast are grown on poor 
nitrogen sources such as proline, but diverted to the endosomal system when 
yeast are provided with a rich nitrogen source such as glutamate (Roberg et al., 
1997).  GLUT4 is directed to the cell surface in response to insulin, whereas in 
the absence of insulin it is retained intracellularly in a cycle containing GSVs 
(Bryant et al., 2002;Muretta et al., 2008) – in both cases an extracellular 
stimulus is determining whether the transporter remains intracellular or reaches 
the plasma membrane. 
The data presented in this chapter highlight the differences between the two 
systems.  Gap1p is only ubiquitinated in response to optimum nitrogen sources 
(e.g. glutamate), whereupon it traffics directly from the trans-Golgi network to 
the endosomal system (Soetens et al., 2001;Magasanik and Kaiser, 2002) whereas 
it appears that GLUT4 is constitutively ubiquitinated to reach GSVs.  Unpublished 
data from our laboratory has also shown that the ubiquitination status of GLUT4 
is unchanged on stimulation with 100 nM insulin (Lamb et al., 2010). 
Collectively, the data presented in this chapter support the hypothesis that 
GLUT4 requires ubiquitination to enter the insulin responsive compartment.  The 
molecular mechanisms underlying how ubiquitination has this effect will be 
investigated in subsequent chapters. 
  
 
 
 
 
Chapter 4 - The ubiquitin binding GAT domain of 
GGA3 in ubiquitin mediated GLUT4 traffic. 
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4.1 Introduction 
The GGA proteins are a family of clathrin adaptor proteins which sort proteins 
based on their ubiquitination status at the trans-Golgi network (Mattera et al., 
2004;Pelham, 2004;Scott et al., 2004;Kawasaki et al., 2005).  They have a 
conserved modular structure, with (from N to C terminus) a VHS domain (Vps27, 
Hrs and STAM) which interacts with acidic dileucine motifs, a GAT domain(GGA 
and Tom1) which has binding sites for Arf-GTP and ubiquitin, a clathrin binding 
hinge region and a C-terminal γ adaptin ear (GAE) which binds accessory factors 
such as epsin related proteins (Bonifacino, 2004;Pelham, 2004) (Figure 1.5).  The 
structural basis of the GAT-ubiquitin interaction was resolved independently by 
two groups for the GGA3 GAT domain (Bilodeau et al., 2004;Kawasaki et al., 
2005).  The latter study carried out mutagenic analyses which suggested that 
residues 250 and 284 (glutamic acid and aspartic acid respectively) were vital for 
the Ub-GAT interaction, as substitution of both residues resulted in loss of 
ubiquitin binding. 
The prototypical Gga cargo in yeast is the general amino acid permease Gap1p.  
When yeast are grown on rich nitrogen sources, Gap1p is trafficked to the 
endosomal system in a ubiquitin and Gga dependent manner where it is 
degraded by vacuolar proteases (Roberg et al., 1997;Soetens et al., 
2001;Magasanik and Kaiser, 2002).  In contrast to wild type cells, in the absence 
of Ggas the endosomal sorting of Gap1p is delayed on a shift from a poor 
nitrogen source (proline) to a rich one (glutamate) and when the only Gga 
protein present lacks the GAT domain, Gap1p is trafficked to the vacuole via the 
plasma membrane (Scott et al., 2004).  Collectively these data show that Ggas 
sort ubiquitinated Gap1p into the endosomes via their GAT domain when yeast 
are grown on a rich nitrogen source.  Intriguingly a version of Gga2p which has 
the GAT domain of human GGA3 can rescue the sorting defects observed in gga∆ 
cells (Bilodeau et al., 2004), suggesting that the ubiquitin binding function of 
GGAs is conserved from yeast to mammals. 
The sorting of ubiquitinated substrates by mammalian GGAs is less well 
characterized.  It has been known for some time that GGAs, notably GGA3, can 
interact with components of the ESCRT machinery such as TSG101 (Puertollano 
and Bonifacino, 2004;Mattera et al., 2004), which sorts ubiquitinated substrates 
to the lysosome (Raiborg and Stenmark, 2009), and that sorting of ubiquitinated 
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substrates such as the EGF receptor from the TGN to early endosomes is 
perturbed by depletion of GGA3 (Puertollano and Bonifacino, 2004).   
Another example of GGA dependent protein sorting is beta-site amyloid 
precursor protein-cleaving enzyme 1 (BACE1), involved in the production of the 
toxic beta-amyloid protein thought to be responsible for Alzheimer’s disease 
(Tesco et al., 2007).  Depletion of GGA3 through caspase activation or RNAi 
stabilizes BACE1 (Tesco et al., 2007), due to defective lysosomal sorting of the 
enzyme (Tesco et al., 2007).  More recent data has demonstrated that 
ubiquitination of BACE1 is required for its GGA3 dependent sorting to the 
lysosome (Kang et al., 2010).  Mutation of the putative BACE1 ubiquitination site 
at K501 or expression of a ubiquitin binding deficient mutant of GGA3 both result 
in impaired sorting of BACE1 to the lysosome (Kang et al., 2010).  These data 
demonstrate that GGA and ubiquitin dependent sorting of proteins is conserved 
from yeast to mammals. 
The GGAs have been implicated in the sorting of GLUT4 into GSVs.  Expression of 
a fragment of GGA2 which has dominant interfering effects for all three GGAs 
(VHS-GAT) in 3T3-L1 adipocytes alters the fractionation profile of GLUT4 , with 
significantly less being found in a fraction enriched in GSVs (Li and Kandror, 
2005).  VHS-GAT also causes a block in budding of GSVs in vitro (Li and Kandror, 
2005). Consistent with these findings, adipocytes expressing VHS-GAT display a 
blunted translocation of GLUT4 to the cell surface in response to insulin (Li and 
Kandror, 2005).   The acquisition of insulin responsiveness of newly synthesised 
GLUT4 is severely impaired in 3T3-L1 adipocytes (Watson et al., 2004), however 
translocation of endogenous GLUT4 already present in GSVs is unaffected 
(Watson et al., 2004).  These data indicate that the GGAs are involved in sorting 
newly synthesised GLUT4 from the TGN into GSVs. 
On expression in yeast, ubiquitin dependent GLUT4 sorting into the 
proteolytically active endosomal system is impaired in a gga∆ strain (Lamb et 
al., 2010).  Taking the above data supporting a role for the GGA proteins in the 
sorting of GLUT4 from the TGN into GSVs, together with the data presented in 
the previous chapter supporting a role for GLUT4 ubiquitination in GLUT4 sorting 
into GSVs, it seems plausible that the GGAs recognize the ubiquitin modification 
on GLUT4 at the TGN and sort it into GSVs. 
 
Chapter 4  99 
4.2 Aims of the chapter. 
The aim of the work presented in this chapter was to investigate the role of the 
ubiquitin-binding GAT domain of GGA3 in the sorting of GLUT4 into GSVs.  GGA3 
was selected for study as it has the highest affinity for ubiquitin of all three 
mammalian GGAs (Shiba et al., 2004), and published structural data for the 
GGA3 GAT domain in complex with ubiquitin was available to facilitate analysis 
of the interaction (Bilodeau et al., 2004;Kawasaki et al., 2005).  I utilised two 
approaches in this investigation: firstly, an in vitro pull-down approach to 
determine whether GLUT4 can interact with GGAs and whether this interaction 
is dependent on the ubiquitin binding function of the GAT domain; and secondly 
an in vivo approach, expressing an epitope-tagged versions of wild-type and a 
ubiquitin binding deficient mutant of GGA3 in 3T3-L1 adipocytes, to investigate 
their effect on GLUT4 sorting into GSVs. 
 
4.3 Ubiquitin and GLUT4 interaction with the GGA3 GAT 
domain. 
4.3.1 Mutagenesis of the GAT domain ablates ubiquitin binding in 
vitro. 
As has been previously discussed, studies have indicated that the GAT domain of 
GGAs is the region of the proteins which binds ubiquitin (Scott et al., 
2004;Bilodeau et al., 2004;Kawasaki et al., 2005).  The lab was previously gifted 
a construct encoding recombinant GST-GGA3 VHS-GAT (pGEX GGA3 VHS-GAT 
(Dell'Angelica et al., 2000)), and I planned to use this construct to study the 
interactions between GGAs and GLUT4.  I first carried out site directed 
mutagenesis of this construct to mutate the two key residues implicated by 
Kawasaki et al.(2005) in ubiquitin binding, generating pCAL6 (Table 2.3) which 
encodes recombinant GST-GGA3 VHS-GAT E250N D284G (referred to as GST-VHS-
GATmut; please see section 2.4.5 for a detailed description of how this construct 
was made and the oligonucleotide pairs used).   
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Figure 4.1 Purification of GGA3 VHS-GATmut.   
A. BL-21 (DE3) E. coli were transformed with pCAL6 and grown to an OD600 of 0.6 in 400 ml 
Terrific Broth (1).  The cells were induced for 4 hours with 1 mM IPTG (2), then lysed by treatment 
with 1 mg/ml lysozyme (4 °C for 30 minutes) and sub sequent sonication.  The lysates were 
centrifuged at 17000 xg to separate insoluble (3) and soluble (4) components.  The soluble proteins 
were incubated with glutathione-Sepharose beads for 1 hour with continual mixing.  The flow 
through was collected from this incubation (5) and several washes with PBS were also performed 
(6-8).  Bound protein was eluted from the beads at a 1 in 400 dilution (9) and 5 µl of all samples run 
on a 10% SDS-PAGE gel.  B.  GST-VHS-GAT and GST-VHS-GATmut were expressed and purified 
as in A, and run on a 10% SDS-PAGE gel with samples containing known amounts of BSA to allow 
an estimation of fusion protein concentration. 
   
Although the expression of GST-VHS-GAT has already been reported, I analysed 
the expression of the newly generated GST-VHS-GATmut as demonstrated in 
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Figure 4.1.  Panel A shows aliquots taken at various stages of the expression and 
purification process of GST-VHS-GATmut from BL-21 E. coli.  A band of 
approximately 60 kD is induced after 4 hours of induction with IPTG, 
corresponding to the predicted molecular weight of the GGA3 VHS-GAT domains 
fused to GST (Dell'Angelica et al., 2000).  The majority of this protein remains in 
the soluble fraction of the lysate.  Although some of GST-VHS-GATmut remains in 
the flow through (lane 5), a large amount binds to the beads (lane 9).  In panel B 
equivalent dilutions of GST-VHS-GAT and GST-VHS-GATmut are run on the same 
gel as a set of BSA standards.  This demonstrates that GST-VHS-GAT and GST-
VHS-GATmut can be expressed, purified and immobilised on glutathione-
Sepharose beads at similar levels, allowing for comparisons in their ability to 
bind proteins to be made. 
pGEX GGA3 VHS-GAT and pCAL6 were transformed into BL-21 E. coli and the 
recombinant proteins purified as described in 2.5.6, immobilised on glutathione 
Sepharose beads.  The proteins were used in pull-down assays from lysates of 
3T3-L1 adipocytes.  Immobilised material was subsequently immunoblotted using 
antibodies raised against ubiquitin (Figure 4.2). 
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Figure 4.2 Mutation of the GAT domain ablates ubiquitin binding in vitro.   
Recombinant GST-GGA3 VHS-GAT and GST-GGA3 VHS-GATmut were immobilised on glutathione 
Sepharose beads and 20 µl of the bead suspension exposed to detergent lysates of 3T3-L1 
adipocytes for 2 hours.  After three washes with 1 ml lysis buffer the pull-downs and 2.5% of the 
input lysates were subjected to SDS-PAGE on a 10% gel and immunoblotted for ubiquitin.  Blot is 
representative of two independent experiments. 
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The immuoblot in Figure 4.2 demonstrates GST-VHS-GATmut does not pull down 
the smear of ubiquitinated proteins seen for GST-VHS-GAT from an adipocyte 
lysate.  This result indicates that mutation of E250 and D284 in the context of 
GST-VHS-GAT severely impairs the ability of the protein to bind ubiquitinated 
proteins, as expected from the published structures of the GGA3 GAT domain 
(Bilodeau et al., 2004;Kawasaki et al., 2005).   
 
4.3.2 Expression of HA-GLUT4 and HA-GLUT4 7K/R in yeast. 
Given that our lab has demonstrated that GLUT4 expressed in yeast is 
ubiquitinated (Lamb et al., 2010) I decided to use this system to investigate the 
binding between GLUT4 and the GGA3 constructs generated above.  Our lab has 
also found that the heterologously expressed transporter traffics in a nitrogen 
responsive manner (R. McCann and N. Bryant, unpublished).  This bears 
considerable similarity to the trafficking of the nitrogen-regulated amino acid 
transporter Gap1p (Roberg et al., 1997;Bryant et al., 2002).  Gap1p has been 
shown to require at least one of the two yeast GGAs for its ubiquitin-dependent 
post-Golgi trafficking to the endosomal system when yeast are grown on rich 
nitrogen sources (Scott et al., 2004).  The sorting of Gap1p and Gga1/2p 
depends on the presence of a ubiquitin binding GAT domain (Bilodeau et al., 
2004). 
Importantly, replacement of the two yeast GGAs with a single chimaeric protein 
consisting of yeast Gga2p with its GAT domain replaced with that of hGGA3 can 
fully complement the loss of the yeast Ggas in a gga1/gga2∆ strain (Bilodeau et 
al., 2004) which suggests that the ubiquitinated cargo binding function of this 
domain is conserved from yeast to mammals.  With this in mind I set out to 
express an epitope tagged form of GLUT4 in yeast cells. 
I used PCR with primers 1 and 2 (Table 2.5) on plasmids harbouring cDNAs 
encoding human GLUT4 with haemagglutinin epitope tags (HA) in the first 
extracellular loop (pRM55; Table 2.3) to amplify the cDNAs with the 3’UTR of 
PHO8 and a 5’ region homologous to the 3’ end of the CUP1 promoter.  The PCR 
product was transformed into SF838-9Dα yeast, along with the gapped pNB701 
plasmid.   pNB701 contains the ORF for RS-ALP (Struthers et al., 2009).  By 
gapping the plasmid within the RS-ALP ORF using a XhoI/SalI restriction digest 
Chapter 4  103 
this allowed the GLUT4-HA and GLUT4 7K/R-HA fragments to repair the plasmid 
by homologous recombination.  The whole scheme is illustrated in Figure 4.3. 
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Figure 4.3 Generation of pCAL4.  
A. The ORF of HA-GLUT4 was amplified from pRM55 using oligonucleotide primers 1 and 2 
(detailed inTable 2.5).  B.  Schematic of homologous recombination in yeast.  pNB701 was gapped 
by a restriction digest using  XhoI and SalI restriction enzymes, co-transformed into SF838-9Dα 
yeast with the PCR products from A allowing homologous recombination and plasmid repair to take 
place, generating pCAL4. 
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pCAL4 harbours the ORF of HA-GLUT4 under the control of the CUP1 promoter.  
The CUP1 gene encodes a metallothionein protein which mediates yeast cell 
resistance to high concentrations of Cu2+ (Winge et al., 1985;Mascorro-Gallardo 
et al., 1996), and its promoter region is more effective with higher 
concentrations of copper – thus resulting in titrateable expression of genes from 
this promoter.  SF838-9Dα cells, deficient in vacuolar protease activity (Table 
2.7) transformed with pCAL4 grown in selective media supplemented with 100 
µM CuSO4 produce a HA-immunoreactive protein of approximately 42 kD (Figure 
4.4), which corresponds to the molecular weight of GLUT4 expressed in yeast 
(Kasahara and Kasahara, 1997;Lamb et al., 2010). 
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Figure 4.4 Expression of HA-GLUT4 in yeast.   
SF838-9Dα cells harbouring pNB701 (empty vector), pCAL4 or pCAL5 were grown overnight in 
selective media in the presence of 100 µM CuSO4, resuspended in TWIRL buffer as in 2.2.3.  
Equivalent amounts of cells were subjected to SDS-PAGE on a 10 % acrylamide gel and 
immunoblotted for the HA epitope and Vti1p. 
 
4.3.3 Construction of the yeast strain BHNY1. 
The reagents generated in 4.3.1 and 4.3.2 provide a basis on which to test the 
requirement for ubiquitination to mediate the interaction between the GAT 
domain of GGA3 and heterologously expressed GLUT4.  As an initial test for 
whether mutation of the ubiquitin binding GAT domain would affect the ability 
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of GST-VHS-GAT to interact with GLUT4 I carried out a pull-down assay from 
lysates prepared from SF8389Dα yeast expressing HA-GLUT4.  The results of this 
are shown in Figure 4.5.  HA-GLUT4 is detected at the expected molecular 
weight of approximately 42 kD in both GST-VHS-GAT and GST-VHS-GATmut pull-
downs.  However a higher band is present that may be caused by the excess of 
recombinant GST tagged protein in the lanes.  Most interestingly there is a 
decrease in the amount of HA-GLUT4 pulled out of the yeast lysate when the 
GAT domain is mutated. 
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Figure 4.5 HA-GLUT4 expressed in yeast interacts with GST-VHS-GAT.   
A 400ml culture of SF8389Dα yeast harbouring pCAL4 (HA-GLUT4) were grown to mid log phase 
in selective media supplemented with 100 µM CuSO4.  The cells were harvested by centrifugation, 
converted to spheroplasts and lysed in 500 µl of a buffer containing 1 % Triton-X100 and 1 mM 
NEM.  250 µl of the resulting lysates were incubated with 20 µl of a 50 % GST-VHS-GAT or GST-
VHS-GATmut bead slurry for 2 hours with continual mixing.  After three washes with lysis buffer 
bound protein was eluted from the beads by heating for 10 minutes in 20 µl 2xLSB.  Eluted proteins 
were subjected to SDS-PAGE alongside 2.5 % input lysate and immunoblotted for the HA epitope, 
 
These initial data from SF8389Dα yeast suggest that GLUT4 interacts with GGA3 
in a manner that is at least partially ubiquitin dependent; however this 
preliminary experiment would benefit from further controls.  An ideal control 
for this experiment would be a yeast protein that can interact with GGAs via the 
VHS domain alone with no ubiquitin dependence.  Although several mammalian 
proteins are known to bind the GGA VHS domain through their acidic dileucine 
sorting motifs, including sortilin and the mannose-6-phosphate receptors 
(Nielsen et al., 2001;Tortorella et al., 2007) only a single yeast protein has been 
shown to exhibit VHS domain binding.  This protein is Mon2p (Monensin 
sensitivity), also known as Ysl2p, a trans-Golgi resident protein related to Arf 
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GTP-exchange factors, which is involved in maintenance of Golgi architecture 
and has been shown to bind isolated VHS and VHS-GAT domains (Efe et al., 
2005;Gillingham et al., 2006;Singer-Kruger et al., 2008).   
I utilized the commercially available yeast strain YNL297C expressing green 
fluorescent protein (GFP) tagged Mon2p (Invitrogen; (Huh et al., 2003)).  In 
order to detect GLUT4 in yeast grown on rich media, it is necessary to inactivate 
vacuolar proteases as the transporter is delivered to the proteolytically active 
endosomal system (Lamb et al., 2010). 
The PEP4 gene product, which activates many of the proteases present in the 
yeast vacuole (van den Hazel et al., 1992), was disrupted in GFP-Mon2p 
expressing YNL297C using the loop in/loop out method by transforming the cells 
with EcoRI digested (linearised) pPLO2010, which contains the URA3 gene 
flanked with sequences homologous to PEP4 and further sequences which permit 
looping out of the URA3 cassette (Nothwehr et al., 1995).  Integration of this 
fragment was selected for by plating transformants onto solid SD-URA media.  To 
select for transformants which had looped out the URA3 cassette, they were 
plated onto media containing 5-fluoroorotic acid (5-FOA).  The URA3 gene 
product is orotine-5’monophosphate dicarboxylase, which converts 5-FOA to 
toxic fluorodeoxyuridine (Boeke et al., 1984).  Therefore only those cells lacking 
URA3 survive on 5-FOA containing media. 
A selection of 5-FOA resistant colonies were collected and tested for the pep4-3 
mutation in the APNE overlay assay (Wolf and Fink, 1975).  This assay detects 
the activity of carboxypeptidase Y (CPY) which is activated by the PEP4 gene 
product proteinase A (van den Hazel et al., 1992).  CPY activity releases β-
napthol from APNE.  β-napthol reacts with the Fast Garnet GBC salt present in 
the overlay mixture producing an insoluble red dye; thus strains which secrete 
CPY are red, whereas strains that missort (and thus do not activate) CPY remain 
white due to a lack of active CPY. 
A single 5-FOA resistant pep4-3 colony was selected in this manner and named 
BHNY1. 
 
Chapter 4  107 
4.3.4 An in vitro interaction between GLUT4 and GST-GGA3-VHS-
GAT is partly ubiquitin dependent. 
Armed with the reagents generated in 4.3.1, 4.3.2 and 4.3.3 I set out to test 
whether there is a ubiquitin dependent in vitro interaction between hGLUT4 
expressed in yeast and GST-GGA3-VHS-GAT.  400 ml cultures of BHNY1 yeast 
transformed with pCAL4 or 5 (encoding HA-GLUT4 and HA-GLUT4 7K/R 
respectively) were grown to an OD600 of 0.5, harvested and lysates prepared.  
The lysates were incubated with GST-VHS-GAT and GST-VHS-GATmut immobilized 
on beads.  Bound proteins were eluted from the beads and subject to SDS-PAGE 
alongside a sample of the input lysate. 
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Figure 4.6 GLUT4 expressed in yeast interacts with GST-VHS-GAT in a ubiquitin dependent 
manner.   
400ml cultures of BHNY1 yeast harbouring pCAL4 (HA-GLUT4) were grown to mid log phase in 
selective media supplemented with 100 µM CuSO4.  The cells were harvested, lysed and used in 
pull-down assays as described for Figure 4.5.  Eluted proteins were subjected to SDS-PAGE 
alongside 2.5 % input lysate and immunoblotted for the HA epitope, GFP and ubiquitin.  Results 
are representative of three independent experiments.  
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A typical result for this experiment is shown in Figure 4.6.  As observed for 
SF8389Dα yeast, HA-GLUT4 expressed in BHNY1 shows a detectable interaction 
between HA-GLUT4 and GST-VHS-GAT, and there is a less pronounced interaction 
between HA-GLUT4 and GST-VHS-GATmut.  However as previously discussed the 
GST fusion proteins distort the HA-GLUT4 band due to the high levels of fusion 
protein present in the pull-down reactions making these experiments somewhat 
difficult to interpret. 
These data suggest that there is an interaction between heterologously 
expressed HA-GLUT4 and the VHS-GAT domain of GGA3 and this interaction is at 
least partially dependent on the presence of a functional ubiquitin-binding site 
in the GAT domain of GST-VHS-GAT.  As expected, and demonstrated in Figure 
4.2, there is reduced binding of ubiquitin to GST-VHS-GATmut (compared to GST-
VHS-GAT) in these experiments. One caveat with this result is that although 
BHNY1 expresses detectable amounts of Mon2p-GFP (input lane) there is no 
detectable interaction observed with either GST-VHS-GAT or GST-VHS-GATmut.  
Previous studies have suggested that isolated VHS domain alone interacts more 
readily with Mon2p than VHS-GAT (Singer-Kruger et al., 2008), so perhaps the 
level of interaction between Mon2p and GST-VHS-GAT is undetectable because 
of this effect. 
I decided to extend this study to insulin responsive 3T3-L1 adipocytes to 
investigate whether an interaction between endogenous GLUT4-Ub and GST-VHS-
GAT can be detected.  The results of this experiment are shown in Figure 4.7.  
Although, as was previously demonstrated in Figure 4.2, GST-VHS-GAT readily 
pulls down a smear of ubiquitinated substrates, there is no discernible 
interaction between endogenous GLUT4 and GST-VHS-GAT.  
Although there was no interaction detected between endogenous GLUT4 and 
recombinant GGA3-VHS-GAT in adipocytes, the data from yeast suggested that 
the ubiquitin binding GAT domain of GGA3 could interact with a small pool of 
GLUT4.  Ubiquitinated species are enriched in the BHNY1 strain due to an 
absence of vacuolar proteases (4.3.3) and previous data from our lab has 
indicated that in 3T3-L1 adipocytes approximately 0.1 % of the total GLUT4 pool 
is ubiquitinated (Lamb et al., 2010). Coupled with the relatively low affinity of 
the GGA3 GAT domain for ubiquitin (Kd
 = 231 µM)(Kawasaki et al., 2005) this is 
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likely to make detection of ubiquitinated GLUT4 binding to GST-VHS-GAT by a 
pull-down method rather challenging. 
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Figure 4.7 GST-VHS-GAT pull-down assay on 3T3-L1 adipocyte lysates.   
4 plates of 3T3-L1 adipocytes were serum starved for 2 hours and lysed in a buffer containing 1 % 
Triton-X100 and 1 mM NEM.  500 µl of the clarified lysates was incubated with with 20 µl of a 50 % 
GST-VHS-GAT or GST-VHS-GATmut bead slurry for 2 hours with continual mixing.  After three 
washes with lysis buffer bound protein was eluted from the beads by heating for 10 minutes in 20 
µl 2xLSB.  Eluted proteins were subjected to SDS-PAGE alongside 1.25 % input lysate and 
immunoblotted for GLUT4 and ubiquitin.  Results are representative of three independent 
experiments.  
 
4.4 Expression of a ubiquitin-binding mutant of myc-
GGA3 in 3T3-L1 adipocytes. 
As the biochemical approaches I had initially set out to use were not suitable for 
detecting an effect on interaction of endogenous GLUT4-Ub with GGA3, I 
decided to express epitope tagged versions of wild type, full length GGA3 and a 
mutant version predicted to abolish ubiquitin binding (harbouring the same 
E250N D284G substitutions as the the recombinant GST-VHS-GATmut used in 
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4.3.4) in 3T3-L1 adipocytes and observe any effect of overexpression of these 
proteins on GLUT4 loading into GSVs and/or the ability of insulin to stimulate 
glucose transport into the cells.  Expression of a dominant negative GGA 
construct (EGFP-VHS-GAT) resulted in reduced budding of GLUT4 vesicles in an 
in vitro assay, impaired loading of GLUT4 into GSVs, and reduced insulin 
responsiveness of the transporter (Watson et al., 2004;Li and Kandror, 2005).  
Therefore if the ubiquitin binding function of the GGA proteins is required to 
sort GLUT4 into GSVs, I would predict that expression of the non-ubiquitin-
binding myc-GGA3mut would reduce GLUT4 loading into GSVs and thus impair 
insulin stimulated glucose uptake. 
To test this, I generated a chimeric gene incorporating a 5’ sequence encoding 
the myc epitope tag fused to the GGA3 short isofom cDNA in the pBABE puro 
retroviral expression vector (Morgenstern and Land, 1990) (pCAL11), and used 
site directed mutagenesis of pCAL11 to produce a construct encoding myc-GGA3 
E250N D284G (myc GGA3mut) (pCAL12) which is predicted to be impaired in 
ubiquitin binding function according to data from this and previous studies 
(section 4.3.1, (Bilodeau et al., 2004;Kawasaki et al., 2005)). 
pCAL11, pCAL12 (encoding myc-GGA3 and myc-GGA3mut respectively) and pBABE 
puro (as an empty vector control) were transfected into Plat-E packaging cells 
(Morita et al., 2000), resulting in production of retroviral particles.  3T3-L1 
fibroblasts were stably infected with each of the viruses, grown to confluency 
and differentiated into adipocytes.  Lysates were subsequently prepared for 
western blot analysis.  Blotting for the myc epitope and GAPDH (as a loading 
control) showed that cells infected with pCAL11 and 12 retroviruses exhibited an 
immunoreactive band at approximately 85 kD as has been previously reported 
for the GGA3 short isoform (Wakasugi et al., 2003).  However, myc-GGA3mut was 
consistently detected at much higher levels than the wild type protein (Figure 
4.8). 
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Figure 4.8 Expression of myc-GGA3 and myc-GGA3mut in 3T3-L1 adipocytes.   
3T3-L1 fibroblasts were infected with the retroviral constructs pBABE puro (pBABE), pCAL11 (myc 
GGA3) and pCAL12 (myc-GGA3mut), plated onto 2 10 cm plates per construct, grown to confluency 
and differentiated into adipocytes.  Cells were harvested in 250 µl PBS supplemented with 
protease inhibitors per plate, homogenised with 12 strokes through a syringe and needle (10 x 
25G, 2 x 26G) and the homogenate clarified by centrifugation.  The homogenates were equalized 
for protein content and 20 µg protein subjected to SDS-PAGE on 10 %(v/v) gels, followed by 
immunoblotting for the myc epitope and GAPDH as a loading control.  Blots are representative of 
three independent experiments. 
 
This difference in levels of the wild type and mutant versions of myc-GGA3 has 
several possible explanations.  It may be that the myc-GGA3mut viral stock infects 
3T3-L1 fibroblasts more readily, or that myc-GGA3mut is more stable than myc-
GGA3. To address whether the observed difference was due to differing levels of 
retroviral infection I performed a titration of the retroviral stock used to stably 
infect the 3T3-L1 cells.  The pCAL11 (myc-GGA3) and pCAL12 (myc-GGA3mut) 
virus stocks were used in a series of six tenfold dilutions (10-1 to 10-6) to infect 
3T3-L1 fibroblasts on 6 well plates.  After a week of selection using DMEM 
supplemented with 10 % FBS and 2.5 µg/ml puromycin, the number of colonies 
present on the highest dilution plate was recorded.  The pCAL11 viral stock gave 
1 x 106 colony forming units per ml (cfu/ml) whereas the pCAL12 stock gave 9 x 
105 cfu/ml.  This result suggests that the observed differences in expression 
between myc-GGA3 and myc-GGA3mut are not due to differences in the ability of 
the two viruses to infect 3T3-L1 cells, but may be due to post-infection events 
such as the relative stability of the myc-GGA3 and myc-GGA3mut proteins.  This 
possibility will be discussed in more detail at the end of the chapter. 
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Figure 4.9 Localisation of myc-GGA3 and myc-GGA3mut expressed in 3T3-L1 adipocytes. 
3T3-L1 fibroblasts infected with either empty pBABE puro (pBABE), pCAL11 (myc-GGA3) or 
pCAL12 (myc-GGA3mut) virus were grown to confluency on sterile coverslips, differentiated into 
adipocytes and processed for confocal microscopy, staining for the myc epitope and nuclear DNA 
with DAPI.  Images are representative from three experiments.  Scale bar = 20 µm 
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To address whether the two constructs have differences in subcellular 
localisation, the infected cells were plated onto coverslips and stained for the 
myc epitope and DAPI to mark the nucleus.  When visualized by confocal 
microscopy (Figure 4.9) both myc-GGA3 and myc-GGA3mut exhibited the 
perinuclear localization characteristic of the GGAs (Dell'Angelica et al., 
2000;Hirst et al., 2000).  Qualitatively there appears to be an increase in the 
amount of perinuclear staining in cells expressing myc-GGA3mut.  This suggests 
that despite the relatively high expression level of myc-GGA3mut there is no 
change in the subcellular localisation of the mutant compared to the wild type 
protein. 
 
4.4.1 Does expression of myc-GGA3 and myc-GGA3mut alter 
GLUT4 loading into the insulin responsive compartment? 
To assess the functional consequences of expressing myc-GGA3 and myc-GGA3mut 
in 3T3-L1 adipocytes I first used a subcellular fractionation approach, as detailed 
in 3.5, to assess the proportion of GLUT4 loaded into the GSV enriched 16,000 xg 
supernatant of 3T3-L1 cells (Xu and Kandror, 2002;Kupriyanova et al., 2002;Li 
and Kandror, 2005).  Previously, expression of dominant negative EGFP-VHS-GAT 
has been shown to impair loading of GLUT4 into GSVs using this system (Li and 
Kandror, 2005).  If either myc-GGA3 or myc-GGA3mut had a dominant negative 
effect on GLUT4 loading into GSVs, I would anticipate a lower proportion of 
GLUT4 would be found in the supernatant fraction.  The results of this 
experiment are detailed in Figure 4.10.  40.3 % (± 3.5 %) of the total GLUT4 was 
found in the supernatant fraction in cells harbouring pBABE puro.  The situation 
was similar in cells expressing myc-GGA3 - although 44.7 % (± 2 %) of total GLUT4 
was found in the supernatant, this increase did not reach statistical significance 
(p = 0.18, Student’s T-test).  However on expression of myc-GGA3mut in 
adipocytes only 30.6 % (± 2.4 %) of total GLUT4 was found in the supernatant, 
which was significantly different from both cells expressing empty pBABE puro (p 
< 0.05) and those expressing myc GGA3 (p < 0.01). 
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Figure 4.10 GLUT4 loading into the 16,000 xg supernatant is reduced by expression of myc-
GGA3mut.   
(A) 3T3-L1 adipocytes (2 10 cm plates per construct) harbouring empty pBABE puro (pBABE), 
pCAL11 (myc-GGA3) or pCAL12 (myc-GGA3mut) retrovirus were homogenised in 250 µl PBS 
supplemented with protease inhibitors (PBS + I) per plate by passage through a syringe and 
needle (10 x 25G, 2 X 26G) and insoluble components removed by centrifugation at 2000 xg for 10 
minutes at 4 °C.  The resulting supernatants were c entrifuged at 16,000 xg for 20 minutes at 4 °C, 
separating pellet (P) and supernatant (S) fractions.  The pellet was resuspended in 500 µl PBS + I 
and both fractions equalized for protein content. 30 µg of both pellet and supernatant was subject 
to SDS-PAGE on 10 % (v/v) gels and blotted for IRAP and GLUT4. Blots are representative of 
three independent experiments. (B) The percentage of total GLUT4 present in the supernatant 
fraction was measured from three independent experiments using image analysis software 
(ImageJ, NIH) and plotted. * significantly different from cells harbouring pBABE (p < 0.05, Student’s 
T-test) 
 
As a control, the pellet and supernatant fractions were also blotted for the 
insulin responsive aminopeptidase IRAP.  IRAP is another GSV cargo which 
occupies the same trafficking itinerary as GLUT4 (Ross et al., 1997).  The 
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distribution of IRAP between supernatant and pellet fractions was not altered 
significantly by expression of myc-GGA3 or myc-GGA3mut, with the greater 
proportion of IRAP found in the pellet fraction for all three groups of cells. 
This result is interesting in that expression of the ubiquitin-binding deficient 
myc-GGA3mut appears to have a mild dominant negative effect on GLUT4 loading 
into GSVs, reducing the amount of total GLUT4 found in the 16,000 xg 
supernatant by 10 % relative to controls.  myc-GGA3 could still potentially have 
an effect on GLUT4 traffic; however its low expression level in this system may 
mask any possible phenotypes. 
 
4.4.2 Does expression of myc-GGA3 and myc-GGA3mut alter 
insulin responsive [3H]2-deoxyglucose uptake? 
As GLUT4 loading into the insulin responsive 16,000 xg supernatant is impaired 
by mutation of the GAT domain in the context of myc-GGA3, I wanted to test 
whether this altered loading translated to impaired insulin responsive GLUT4 
translocation.  It would be technically challenging to use the HA-GLUT4 
translocation assay as it would involve co-infection of 3T3-L1 cells with two 
different retroviruses. I therefore decided to use an indirect measure of GLUT4 
translocation, namely the [3H]2-deoxyglucose uptake assay (Millar et al., 1999).  
This assay measures the uptake of the radiolabelled glucose analogue [3H]2-
deoxyglucose into cells with and without insulin stimulation.  As previously 
discussed in 1.4.2 the increase in glucose uptake on insulin stimulation is almost 
entirely due to GLUT4 translocation (Saltiel and Kahn, 2001) so a perturbation in 
[3H]2-deoxyglucose uptake would indicate altered GLUT4 translocation. 
A reduction in insulin stimulated glucose uptake on expression of EGFP-VHS-GAT 
in 3T3-L1 adipocytes compared to cells harbouring an empty vector control has 
previously been reported (Li and Kandror, 2005). To test whether this would also 
be the case for overexpression of myc-GGA3mut, I carried out [
3H]2-deoxyglucose 
uptake assays on cells stably infected with pBABE puro, pCAL11 and pCAL12 
(encoding myc-GGA3 and myc-GGA3mut respectively). 
As shown in Figure 4.11, expression of myc-GGA3 does not alter insulin 
stimulated glucose uptake compared to cells harbouring empty vector.  There is 
a slight decrease in insulin stimulated glucose uptake on expression of myc-
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GGA3mut; however this does not reach statistical significance when compared to 
cells harbouring empty vector (p = 0.18, Student’s T-test).  It is difficult to draw 
any firm conclusions from this assay due to the variability of results between 
experiments.  The mean values for glucose uptake (in pmoles/min/cell) for each 
of the 4 replicate experiments are detailed in Appendix I and illustrate the 
variability between experiments, ranging from 0.0118 to 0.0713 
nmoles/min/well in the case of myc-GGA3.  This suggests great variation in the 
glucose uptake between batches of cells which was unexpected as the cell lines 
used in these experiments were all products of a single infection, with each 
experiment being from a different passage number of the same cell line. 
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Figure 4.11 Insulin stimulated glucose uptake rate is not affected by expression of myc-
GGA3 or myc-GGA3mut.   
12 well plates of 3T3-L1 adipocytes harbouring either pBABE puro (pBABE), pCAL11 (myc-GGA3) 
or pCAL12 (myc-GGA3mut) were either stimulated with 100 nM insulin (Insulin) or not (Basal) for 30 
minutes, followed by incubation with 50 µM [3H]2-deoxyglucose per well for 5 minutes.  After the 
incubation excess [3H]2-deoxyglucose was washed from the cells using cold PBS.  The plates were 
dried, cells lysed in 1 ml 1 % (v/v) Triton X-100 and cell associated radioactivity measured using 
liquid scintillation spectrophotometry.  n = 4, results are presented ± standard error of the mean. 
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4.5 Chapter Discussion 
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Figure 4.12 Recombinant GGA3 proteins used in this chapter.   
Glutathione S-transferase (GST) purification and myc epitope tags are indicated.  Black vertical 
bars in GAT domain indicate sites of E250N and D284G mutations. 
 
In this chapter I set out to investigate whether GGA ubiquitin binding is required 
for their role in sorting GLUT4 into the insulin responsive compartment.  To do 
this I took advantage of the published crystal and solution structures of the 
GGA3 GAT domain in complex with ubiquitin (Bilodeau et al., 2004;Kawasaki et 
al., 2005), to generate mutant versions of GGA3 which are severely impaired in 
their ability to bind ubiquitin. 
I first used site directed mutagenesis to mutate E250 and D284 of the GGA3 GAT 
domain in the context of a fusion protein consisting of GST fused to the VHS-GAT 
domains of GGA3 (GST-VHS-GATmut).  As shown in Figure 4.2, GST-VHS-GATmut 
could not pull ubiquitinated proteins out of a 3T3-L1 adipocyte cell lysate.  I 
then set out to test whether HA-GLUT4 expressed in yeast could interact with 
immobilised GST-VHS-GAT.   
As shown in Figure 4.6, HA-GLUT4 can bind GST-VHS-GAT.  This interaction 
appears to be partially dependent on the ubiquitin binding function of the GAT 
domain as it is decreased when the GAT domain of the fusion protein is mutated.  
Despite the VHS domain of both GST-VHS-GAT and GST-VHS-GATmut being intact, 
as the original GST-VHS-GAT expression construct (pGEX GGA3 VHS-GAT) was 
generated from the long isoform of GGA3 (Dell'Angelica et al., 2000), no 
interaction was observed between either fusion protein and GFP tagged Mon2p, 
which is the only S. cerevisiae protein known to interact with GGA VHS domains 
(Singer-Kruger et al., 2008).  However the interaction between the VHS domain 
and Mon2p is less effective when the GAT domain is also present (Singer-Kruger 
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et al., 2008) which could explain the lack of binding observed in this 
experiment. 
Unfortunately I was not able to extend this in vitro study of GLUT4 and GGA3 
GAT interaction to 3T3-L1 adipocytes.  The low affinity of the GAT domain for 
ubiquitin (Kawasaki et al., 2005) in combination with the low abundance of 
ubiquitinated GLUT4 in 3T3-L1 cells (Lamb et al., 2010), will likely prove 
technically challenging in using this pull-down approach to studying the 
interaction further.  
I next went on to clone myc-GGA3 and generate a ubiquitin-binding deficient 
mutant thereof (myc-GGA3mut) and express these constructs in 3T3-L1 cells, 
using the pBABE puro retroviral expression system (Morgenstern and Land, 1990).  
Despite infection of 3T3-L1 fibroblasts with similar numbers of viral particles 
harbouring pCAL11 and pCAL12 (section 4.4), the expression of myc-GGA3 was 
much lower than myc-GGA3mut when compared by Western blotting.  Although 
myc-GGA3mut was relatively overexpressed both proteins had a similar 
perinuclear localisation (Figure 4.9). 
What possible explanations are there for the observed difference in expression?  
The answer may lie with ubiquitination of GGA3 itself.  Previous studies have 
shown that GGA3 is ubiquitinated (Shiba et al., 2004;Pak et al., 2006) and that 
this ubiquitination depends on the ubiquitin binding ability of the GAT domain, 
as single amino acid substitutions introduced within the ubiquitin binding portion 
of the GAT domain severely impair GGA3 ubiquitination (Shiba et al., 2004). This 
study did not report an increase in the levels of GGA3 expression as a 
consequence of GAT mutation; however the GGA3 expression constructs used by 
Shiba et al. were for transient expression of GGA3.  As I was using the pBABE 
retroviral system (Morgenstern and Land, 1990) to stably express myc-GGA3 and 
myc-GGA3mut in polyclonal pools of cells, it is hard to compare the two sets of 
data and further investigation of the role of the GAT domain in GGA3 stability 
would certainly be valuable.  It may be that myc-GGA3 is more readily 
ubiquitinated than myc-GGA3mut and is thus degraded more rapidly by the 
proteasome, although without further analysis this remains purely speculation. 
I went on to analyse the phenotypic effects of myc-GGA3 and myc-GGA3mut 
expression in 3T3-L1 adipocytes.  Firstly I used a subcellular fractionation 
approach to isolate a GSV enriched vesicular fraction from 3T3-L1 adipocytes (Xu 
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and Kandror, 2002;Li and Kandror, 2005) harbouring either an empty vector 
control, pCAL11 or pCAL12 retrovirus.  On expression of myc-GGA3 the loading of 
GLUT4 into the 16,000 xg supernatant is unaffected, however expression of myc-
GGA3mut lowers the proportion of total GLUT4 present in the supernatant 
fraction, from 40.3 % (± 3.5 %) to 30.6 % (± 2.4 %) (Figure 4.10). These data 
substantiate the previous study outlining a role for GGAs in the sorting of GLUT4 
into the insulin responsive compartment (Li and Kandror, 2005), as this study 
found that expressing a dominant negative version of GGA (EGFP fused to the 
VHS-GAT domains of GGA2) reduced the proportion of GLUT4 present in the GSV 
fraction compared to cells harbouring an empty vector. 
The dominant negative effect of myc-GGA3mut expression is less than that 
observed for EGFP-VHS-GAT (Li and Kandror, 2005).  The most obvious 
explanation is the structure of the two mutants.  EGFP-VHS-GAT was derived 
from human GGA2, and thus would be expected to bind VHS domains more 
readily than ubiquitin modifications (Nielsen et al., 2001;Puertollano and 
Bonifacino, 2004;Shiba et al., 2004), whereas myc-GGA3mut was derived from the 
short isoform of GGA3 (see Figure 4.12).  It has been predicted that the short 
isoform of GGA3 cannot bind dileucine motifs; the crystal structure of GGA1 VHS 
in complex with the C-terminal acidic dileucine motif of the cation independent 
mannose-6-phosphate receptor has been published, and GGA1 VHS residues 
involved in this interaction identified (Shiba et al., 2002).  These residues are 
conserved in full length GGA3, however they are absent from GGA3 short 
(Wakasugi et al., 2003).   
Therefore in terms of dominant negative activity, EGFP-VHS-GAT can interfere 
with the recruitment of endogenous GGAs to membranes (via Arf-GTP 
recruitment) and interaction with dileucine motifs. myc-GGA3mut (derived from 
GGA3 short) would be predicted to block membrane association of endogenous 
GGAs and to sequester factors which bind to the hinge region and GAE domain; 
these include clathrin and the BAR domain containing protein enthprotin, which 
are involved in formation of clathrin coated vesicles (Hirst et al., 2001;Mills et 
al., 2003). 
IRAP and sortilin are two acidic dileucine-containing proteins which can bind 
GGA VHS domains and are present in GSVs (Nielsen et al., 2001;Hou et al., 
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2006).  More recently, the sortilin, IRAP and GLUT4 lumenal domains have been 
shown to interact physically  (Shi and Kandror, 2007;Shi et al., 2008).   
From these data I propose a model for GGA binding to GSV cargoes at the TGN 
(Figure 4.13).  Sortilin (or IRAP) and GLUT4-Ub cluster together at the TGN, 
brought into close proximity by their lumenal interactions.  The GGAs, with their 
modular structure, can bind to GLUT4-Ub via the GAT domain, and to the acidic 
dileucine motifs present in the other cargo molecules, recruiting clathrin and 
accessory proteins resulting in vesicle budding.  This model would account for 
the larger effect EGFP-VHS-GAT expression on GLUT4 loading into GSVs, as 
EGFP-VHS-GAT would prevent endogenous GGAs from interacting with GLUT4-
Ub, ARF:GTP and the cytosolic domains of IRAP or sortilin. 
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Figure 4.13 A model for GGA function in GSV cargo recruitment.   
Sortilin and GLUT4 are brought into proximity by their lumenal interactions.  GGAs bind to the 
ubiquitinated GLUT4 cytosolic domain and the acidic dileucine motif in the sortilin cytoplasmic tail, 
resulting in clathrin coat formation and vesicle budding. 
 
The proposed model is supported by work with truncation mutants of sortilin.  A 
full length version of sortilin co expressed with GLUT4 in 3T3-L1 fibroblasts 
induces formation of an insulin responsive compartment in these normally non 
insulin responsive cells (Shi and Kandror, 2005).  However a version of sortilin 
lacking the lumenal domain, and therefore not capable of interacting with the 
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lumenal region of GLUT4, can only partially recapitulate this effect (Shi and 
Kandror, 2005). 
In cells expressing myc-GGA3mut there is a slight reduction in insulin stimulated 
glucose uptake, however this reduction does not reach statistical significance 
(Figure 4.11).  As discussed in section 4.4.2, there is large variability in the 
results for insulin stimulated glucose uptake for all three constructs.  As the 
effect of myc-GGA3mut on GLUT4 loading into the GSV enriched 16,000 xg 
supernatant is apparently quite small with only a 10 % loss of total GLUT4 from 
this fraction, the large variability in the glucose transport assay data may be 
masking any effect of myc-GGA3mut expression on glucose uptake.   
In summary, the data presented in this chapter implicate the ubiquitin binding 
region of the GAT domain of GGA3 in the sorting of GLUT4 into the insulin 
responsive compartment.  When taken together with data from the preceding 
chapter that GLUT4 sorting into GSVs requires its ubiquitination, and data from a 
study by our group implicating the yeast Ggas in ubiquitin dependent sorting of 
GLUT4 from the TGN to the proteolytically active endosomal system (Lamb et 
al., 2010), this lends weight to the hypothesis that GLUT4 ubiquitination is one 
of the signals required for GGA dependent sorting of GLUT4 into the GSV 
compartment. 
  
 
 
 
 
 
Chapter 5 - Deubiquitination and GLUT4 traffic. 
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5.1  Introduction 
Although work in our group (this study, Chapter 3, (McCann R.K., 2007;Lamb et 
al., 2010)) has implicated ubiquitin in the loading of GLUT4 into GSVs, one 
potential flaw in the hypothesis that ubiquitination is required to sort GLUT4 
into GSVs is that ubiquitination of membrane proteins is canonically thought of 
as a modification resulting in protein degradation at the lysosome (Hicke and 
Dunn, 2003;Urbe, 2005).  Ubiquitin dependent delivery of proteins to the 
lysosome is facilitated through MVBs, with ubiquitin acting as a signal for ESCRT-
dependent sorting of membrane proteins into the intralumenal vesicles of MVBs 
(Wollert et al., 2009;Raiborg and Stenmark, 2009).  Work from our group has 
shown that a constitutively ubiquitinated version of GLUT4 (GLUT4 7K/R-Ub) is 
effectively trafficked into the yeast endosomal system (McCann R.K., 2007) 
indicating that the modification is sufficient for GGA dependent sorting into the 
endosomal system. 
While it is clear that ubiquitination of GLUT4 is required for the transporter to 
become insulin sensitive, our lab estimates that only about 0.1 % of cellular 
GLUT4 is ubiquitinated in 3T3-L1 adipocytes (Lamb et al., 2010).  This suggests 
that the ubiquitin modification on GLUT4 is a transient one, and introduces the 
possibility that deubiquitinating enzymes may play a role in GLUT4 traffic. 
Deubiquitinating enzymes (DUBs) function at various levels of cellular regulation, 
including maintenance of free ubiquitin levels and promotion of protein stability 
(Komander et al., 2009;Reyes-Turcu et al., 2009).  In the endosomal system, 
DUBs have been shown to play a role in receptor recycling and resensitisation; 
examples include the β2 adrenergic receptor which is deubiquitinated by USP20 
and USP33 (Berthouze et al., 2009), and the Drosophila Wnt receptor Frizzled 
which is deubiquitinated by USP8 (Mukai et al., 2010).  In both these cases, a 
proportion of the internalised receptor is deubiquitinated, thus being rescued 
from lysosomal degradation and returned to the cell surface for further 
stimulation.  I therefore reasoned that DUB activity may be required to remove 
the ubiquitin modification from GLUT4 after interaction with GGA proteins had 
sorted it into the endosomal system, allowing it to avoid lysosomal trafficking. 
The GSV resident insulin responsive aminopeptidase (IRAP) traffics in an 
identical manner to GLUT4 under both basal and insulin stimulated conditions in 
fat and muscle cells (Ross et al., 1997).  siRNA mediated depletion of IRAP in 
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3T3-L1 cells has been shown to blunt insulin stimulated GLUT4 translocation, 
however GLUT4 depletion does not seem to have the same effect on IRAP (Yeh 
et al., 2007;Jordens et al., 2010).  Intriguingly, IRAP knockout mice show a 
significant decrease in relative amounts of total GLUT4 (Keller et al., 2002).  
These data implicate IRAP in GLUT4 sorting into the insulin responsive 
compartment, and also suggest that IRAP may form part of a cellular machinery 
to maintain the stability of GLUT4.  Could this include a deubiquitinating 
enzyme? 
A potential link between IRAP and a DUB has been identified through the work of 
Nai-Wen Chi (UCSD) and colleagues over a number of years. IRAP has been shown 
to bind the poly-ADP ribose polymerase (PARP) tankyrase, via a minimal 
tankyrase binding motif (RXX(P,A)DG) (Chi and Lodish, 2000;Sbodio and Chi, 
2002).  Tankyrase 1 was initially localized to the nucleus where it plays a role in 
telomere maintenance and spindle assembly (Smith et al., 1998;Hsiao and 
Smith, 2008).  In 3T3-L1 adipocytes a proportion of tankyrase 1 is also Golgi 
resident (Chi and Lodish, 2000) and siRNA mediated depletion of tankyrase 1 
blunted insulin stimulated GLUT4 translocation in a manner similar to IRAP 
depletion (Yeh et al., 2007). 
Tankyrase has been shown, via yeast two hybrid analysis, to interact with the 
deubiquitinating enzyme USP25 (which contains a putative tankyrase binding 
motif) (Sbodio et al., 2002).  USP25 has three isoforms in humans; the 
ubiquitously expressed USP25a and b, and the muscle specific USP25m; USP25b 
is absent in murine tissues (Valero et al., 2001) and has also been shown to 
modulate the levels of a specific substrate, MyBPC1, on the basis of USP25 
catalytic activity (Bosch-Comas et al., 2006).  From these data a model can be 
inferred whereby tankyrase acts as a scaffold, linking USP25 to GSVs via IRAP.   
My hypothesis for this part of the project is that USP25 serves to deubiquitinate 
GLUT4 once it has been sorted into the endosomal system and thus regulates 
GLUT4 entry into GSVs as part of a complex with IRAP and tankyrase.  This 
deubiquitination of GLUT4 prevents its traffic to the lysosome and thus the 
transporter becomes localised to GSVs marked by IRAP (which localises USP25 to 
this compartment).  
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5.2 Aims of the chapter 
I sought to substantiate the published data of a yeast two hybrid interaction of 
USP25 and the tankyrases by carrying out in vitro pull-down assays using 
immobilized USP25, and to determine whether the interaction was dependent on 
the putative tankyrase binding motif of USP25 (Sbodio and Chi, 2002).  I also 
employed transient siRNA mediated depletion of USP25 to test the hypothesis 
that USP25 is required to deubiquitinate GLUT4 thus stabilizing the transporter, 
allowing it to reach GSVs and preventing its traffic to the lysosome.  I will also 
discuss my efforts to generate a USP25 antiserum for use in Western blotting. 
 
5.3 In vitro interaction of USP25 with tankyrase 1. 
Studies over the last decade have identified a number of tankyrase binding 
partners, including IRAP, TAB182 (tankyrase 1 binding protein of 182 
kilodaltons), NuMA (nuclear/mitotic antigen 1) and TRF1 (telomere repeat 
binding factor 1) (Chi and Lodish, 2000;Sbodio and Chi, 2002).  All these proteins 
include a tankyrase binding motif RXX(P,A)DG (Sbodio and Chi, 2002).  Human 
USP25 has also been found to contain this motif (RTPADG) one amino acid 
removed from the C terminus of the protein, and an interaction between 
tankyrase and USP25 has been demonstrated using yeast 2-hybrid analysis 
(Sbodio and Chi, 2002).  The RTPADG motif, and its positioning, appears to be 
conserved in vertebrates.  Figure 5.1 shows an alignment between known USP25 
protein sequences from human and mouse databases, and predicted sequences 
for rat, Xenopus laevis and Danio rerio. 
Unpublished data from our collaborator’s laboratory (Nai-Wen Chi, UCSD) has 
shown, using a co-immunoprecipitation approach, that USP25 and tankyrase 1 
and 2 interact in vivo – however this interaction may not be direct and could 
require a “bridging” molecule.  In order to corroborate this data I sought to 
determine whether USP25 and tankyrase could interact directly in an in vitro 
pull-down assay, and whether any interaction observed is dependent on the 
putative tankyrase binding motif. 
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USP25 human  (1034) HELCERFARIMLSLSR--TPADGR
Usp25 Danio rerio (1049) LELFERFGRVMTSLTMGRTPADGR
Usp25 Xenopus laevis (1025) HELCERFARIMLSLSR--MPADGR
Usp25 mouse  (1034) HELCERFARIMLSLSR--TPADGR
Usp25 rat  (1034) HELCERFARIMLSLSR--TPADGR
 
Figure 5.1 Protein sequence alignment of vertebrate USP25.   
The C-termini of known sequences for human and mouse USP25, and predicted sequences for rat, 
frog (Xenopus laevis) and zebrafish (Danio rerio) from the UniProt database were aligned using 
Vector NTI (Invitrogen).  The tankyrase binding motif is in green text. 
 
 
 
 
5.3.1 Expression and purification of recombinant GST-USP25. 
The GST-USP25 expression vector used in this study was a gift from the 
laboratory of Frauke Melchior (University of Gottingen).  The vector was 
transformed into BL-21 DE3 E. coli and GST-USP25 purified as described in 2.5.6.  
A sample gel of the purification is shown in Figure 5.2.  A major band of the 
correct molecular weight for GST-USP25 (approximately 165 kD) is observed in 
lane 1.  Some of this protein seems to be lost in the insoluble fraction (lane 3), 
however after binding to glutathione-Sepharose beads and several wash steps 
(lanes 6-8) a large amount of this protein is bound to the beads (lane 9).  There 
is also a second major band at approximately 25 kD (lane 9); this may represent 
an incomplete translation product of GST-USP25, or a degradation product, as 
the pGEX USP25 vector used in these studies contains a protease cleavage site C 
terminal to the GST tag. 
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Figure 5.2 Coomassie stained SDS-PAGE gel of GST-USP25 purification.   
A. BL-21 DE-3 E. coli were transformed with pGEX USP25 and grown to an OD600 of 0.6 in 2 l 
Terrific Broth (1).  The cells were induced for 4 hours with 1 mM IPTG (2), then lysed using a 
Microfluidizer M-110P cell disruptor set at 10,000 psi.  The lysates were centrifuged at 17000 xg to 
separate insoluble (3) and soluble (4) components.  The soluble proteins were incubated with 
glutathione-Sepharose beads for 1 hour with rotation.  The flow through was collected from this 
incubation (5) and nine wash steps were performed – 3 x PBS + 1 % Triton-X (6), 3 x PBS + 0.5 M 
NaCl (7) and 3 x PBS (8).  Bound protein was eluted from a 20 µl sample of the beads after the 
wash steps by heating at 65 °C in 20 µl 2xLSB for 1 0 minutes (9). 
 
 
 
5.3.2 Pull-down assay on adipocyte lysates using GST and GST-
USP25 
To control for nonspecific interactions with the GST tag I included GST in the 
experiments.  As a much smaller, soluble protein (Sassenfeld, 1990) GST is much 
more highly expressed than GST-USP25, so this protein was purified from 200 ml 
of culture in an effort to equalize amounts of the two immobilized proteins.  
Nevertheless, GST alone had an approximately fivefold higher expression than 
GST-USP25, as shown in Figure 5.3. 
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Figure 5.3 Comparison of GST-USP25 and GST protein expression levels.   
GST and GST USP25 were purified as in 5.3.1 from 200 ml and 2 l of BL-21 (DE3) E. coli culture 
respectively.  20 µl of bead suspension was heated at 37 °C in 200 µl 2xLSB for 30 minutes to 
elute bound proteins.  20 µl of each elution was subjected to SDS-PAGE on a 10 % gel.  
Additionally, 4 µl of the GST elution was run alongside (GST (1:5)). 
 
The immobilized fusion proteins were used in pull-down assays from 3T3-L1 
adipocyte lysates as described in section 2.7.  To overcome the problem of GST 
being highly expressed compared to GST-USP25, proteins from the GST pull-down 
were eluted in a fivefold greater volume of 2 x LSB than the GST-USP25 one, and 
equal volumes of each eluate immunoblotted for tankyrase 1 and 2 using an 
antibody that recognised both proteins (Table 2.1).  This experiment was carried 
out in collaboration with Iain Adamson, a placement student in the lab. 
Figure 5.4 shows a representative result for one of these experiments.  It 
appears that in this system only tankyrase 1 binds to USP25; a lower molecular 
weight band is observed but it does not coincide with the molecular weight of 
tankyrase 2 (compare band marked by lower arrowhead in GST-USP25 lane with 
the lower band, representing tankyrase 2, in the input lane).  A similar result 
was observed if the pull-downs were eluted in the same volume of 2 x LSB.  The 
data presented here corroborate the yeast 2-hybrid studies (Sbodio and Chi, 
2002) and the in vivo immunoprecipitation data (N-W Chi, personal 
communication) that USP25 and tankyrase interact. 
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Figure 5.4 Pull-down assay on adipocyte lysates using immobilised recombinant GST and 
GST-USP25.   
20 µl of each recombinant protein immobilized on glutathione-Sepharose beads was incubated with 
400 µl 3T3-L1 adipocyte lysate (approximately 10 mg/ml protein content) for 2 hours with rotation.  
The beads were washed with lysis buffer and bound proteins eluted.  15 µl of each eluate was 
subjected to SDS-PAGE on a 10 % (v/v) gel and immunoblotted for tankyrase 1 and 2, alongside a 
sample of the input lysate.  Representative of three independent experiments 
 
5.3.3 Does mutation of the putative tankyrase binding motif of 
USP25 disrupt the in vitro interaction with tankyrase? 
As discussed in 5.3, USP25 is one of a number of proteins which contain a 
tankyrase binding motif (Chi and Lodish, 2000;Sbodio and Chi, 2002).  Previously 
mutational analyses have shown that disruption of this motif ablates tankyrase 
binding to human IRAP, TRF1 and TAB182 in in vitro pull-down assays and 
immunoprecipitation of epitope tagged proteins  (Sbodio and Chi, 2002).  I 
therefore reasoned that mutation of the RTPADG motif in USP25 would prevent 
its in vitro interaction with tankyrase 1 as described in 5.3.2, and thus set out to 
mutate its conserved arginine residue using site directed mutagenesis. 
Site directed mutagenesis of pGEX-USP25 using primer pair 555 and 556 (detailed 
in Table 2.5) generated pCAL13, encoding a GST-USP25 variant with the 
conserved arginine residue at position 1049 mutated to alanine (GST-USP25 
R1049A).  Both pGEX-USP25 and pCAL13 were transformed into BL-21 E. coli and 
recombinant GST-USP25 and GST-USP25 R1049A purified as detailed in Figure 
5.2.  Figure 5.5 shows the results of this purification, indicating that GST-USP25 
and GST-USP25 R1049A can be purified at similar levels. 
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Figure 5.5 Quantification of purified GST-USP25 and GST-USP25 R1049A.   
BL-21 (DE3) E. coli were transformed with pGEX-USP25 and pCAL13, and recombinant fusion 
proteins purified as in 5.3.1.  10 µl of 1 in 10 dilutions of the immobilised fusion proteins were 
subject to SDS-PAGE on 10 % (v/v) gels, alongside samples of BSA at standard concentrations. 
 
Both immobilized GST fusions were introduced into the pull-down assay 
described in 5.3.2, and bound proteins subjected to SDS-PAGE and 
immunoblotted with tankyrase specific antibodies.  A typical result for this 
experiment is shown in Figure 5.6.  It appears that binding of tankyrase 1 to 
GST-USP25 is ablated on mutation of the conserved R1049 within the tankyrase 
binding motif.  This result is consistent with previous data for other tankyrase 
binding motif-containing proteins, such as IRAP, TAB182 and TRF1 (Chi and 
Lodish, 2000;Sbodio and Chi, 2002;Sbodio et al., 2002), as shortening or point 
mutation of the conserved RXX(A,P)DG motif in these proteins results in loss of 
tankyrase 1 interaction. 
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Figure 5.6 Mutation of the conserved arginine residue in the USP25 tankyrase binding motif 
prevents interaction with tankyrase 1.   
Pull-down assays were performed as in Figure 5.4, using immobilised GST-USP25 and GST-
USP25 R1049A.  Eluted proteins were subject to SDS-PAGE on 10 % (v/v) gel alongside 1.25 % of 
the input lysate, and immunoblotted for tankyrase 1 and 2.  Arrows indicate molecular weights of 
tankyrase 1 (upper) and 2 (lower). Result is representative of three independent experiments. 
 
5.4 siRNA mediated depletion of USP25 in 3T3-L1 
adipocytes reduces GLUT4 stability 
 
RNA interference (RNAi) using short interfering RNAs (siRNA) is a well established 
method for depleting proteins of interest in cells without having to knock out or 
inactivate the corresponding gene (Elbashir et al., 2001).  I attempted to 
deplete USP25 using the Mirus TransIT-TKO ® transfection system (see 2.3.3) and 
two oligonucleotide duplexes (siRNA25 and siRNA27, detailed in Table 2.4), the 
sequences for which were identified by our collaborator (Nai-wen Chi, UCSD, 
personal communication).  3T3-L1 adipocytes were transfected with 50 nM siRNA 
on days 6 and 7 post differentiation and subsequently harvested on day 8 in PBS 
supplemented with protease inhibitors.  Equal amounts of proteins were run on 
10 % SDS-PAGE gels prior to immunoblot analyses with antibodies against USP25, 
GLUT4, Fatty acid synthase (FAS) and GAPDH.  The immunoblots were quantified 
using ImageJ software by normalizing the intensities of USP25, GLUT4 and FAS 
against GAPDH (which served as a loading control).  The results are shown in 
Figure 5.7. 
These data indicate that USP25 is substantially depleted by both siRNA 25 and 27 
when compared to a scrambled siRNA control to 35 % ± 3.3 % and 19 % ± 3 % 
respectively.  A concomitant reduction is observed for GLUT4 which is reduced 
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to 69 % ± 5.8 % (siRNA25) and 75% ± 8.8 % (siRNA27) of control levels.  These 
reductions are statistically significant when compared to the alteration of 
amounts of the untargeted protein FAS (USP25: p < 0.01, GLUT4: p < 0.05 for 
both duplexes, unpaired Student’s T-test).  These data indicate that USP25 has a 
role in maintaining GLUT4 stability. 
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Figure 5.7 siRNA mediated depletion of USP25 results in a reduction in GLUT4 protein 
levels.   
(A) 3T3-L1 adipocytes were treated with 50 nM of the indicated siRNA using Mirus TransIT TKO 
Transfection reagent on days 6 and 7 post-differentiation, harvested on day 8 and blotted for the 
indicated proteins.  (B) Levels of USP25, GLUT4 and FAS were quantified using ImageJ software 
and normalized against GAPDH. Levels of USP25 and GLUT4 were compared to the non-targeted 
FAS using an unpaired student’s T-test (* - p < 0.05, ** - p < 0.01).  Error bars represent ± standard 
error of the mean, n = 4. 
 
5.4.1 Is GLUT4 redirected to the lysosome as a consequence of 
USP25 depletion? 
The depletion of GLUT4 observed in Figure 5.7 are consistent with the 
hypothesis stated at the beginning of this chapter, in that they are consistent 
with a model in which GLUT4 is trafficked to the lysosome in response to USP25 
depletion.  However, the mechanism by which GLUT4 is degraded in the 
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knockdown cells is not identified.  Canonically, ubiquitinated membrane protein 
are degraded at the lysosome (Urbe, 2005).  This led me to attempt to 
investigate whether lysosomal degradation is the fate of GLUT4 in USP25 
depleted cells by inhibiting the lysosomal peptidases of the knockdown cells.  
Treatment of cultured cells with weak bases such as ammonium chloride (NH4Cl) 
raises the pH of acidic compartments (including the lysosome) due to 
accumulation of protonated forms of the base.  This pH rise inactivates 
lysosomal hydrolases (Amenta and Brocher, 1980). 
To test whether GLUT4 in USP25 depleted cells was being redirected to the 
lysosome, I set out to inhibit the activity of lysosomal proteases using 15 mM 
ammonium chloride.  Previous studies have shown this concentration of NH4Cl to 
be effective in blocking peptidase activity in 3T3-L1 cells (Chandler and Ballard, 
1983).  The results of this experiment are shown in Figure 5.8.  There appears to 
be knockdown of USP25 for cells transfected with siRNA27, however this is not 
observed for cells transfected with siRNA25.  For both siRNAs there appears to 
be a relative increase in GLUT4 levels compared to cells transfected with 
scrambled control siRNA. 
Although this initial experiment seemed to suggest that GLUT4 could be rescued 
from degradation by addition of NH4Cl (at least in the case of siRNA27), 
repetition of the experiment proved problematic as USP25 knockdown appeared 
compromised in the cells treated with NH4Cl.  This may have been due to the 
method used to transfect siRNA duplexes into mature 3T3-L1 adipocytes.  The 
transfection reagent (Mirus TransIT-TKO®) uses a polycation based method to 
allow siRNA to enter cells.  This type of method relies on endocytosis of 
nanoparticles formed of siRNA duplexes and polycations from the reagent, and 
subsequent dissociation of the complex as the endosomal lumen acidifies, 
leading to release of the siRNA into the cytosol (Gary et al., 2007).  Inhibition of 
the acidification of the endosomal system by using NH4Cl would prevent uptake 
of siRNA and therefore severely compromise the efficiency of knockdown.   
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Figure 5.8 Treatment of siRNA transfected 3T3-L1 adipocytes with 15 mM NH4Cl.   
On days 6 and 7 post differentiation, 3T3-L1 adipocytes were transfected with siRNA duplexes as 
described in Figure 5.7, and simultaneously treated with 15 mM NH4Cl.  On day 8 cells were 
harvested and immunoblotted for USP25, GLUT4, FAS and GAPDH as a loading control (lower 
GAPDH blot is the loading control for FAS and GLUT4 blots) 
 
5.4.2 Is glucose uptake affected by depletion of USP25? 
As my hypothesis states that USP25 is required to sort GLUT4 into GSVs, it is 
important to identify whether depletion of USP25 affects the insulin stimulated 
uptake of glucose into adipocytes.  If the insulin stimulated increase in glucose 
transport is impaired it would suggest there is reduced loading of GLUT4 into 
GSVs.  To address this, [3H] 2-deoxyglucose transport assays (Millar et al., 1999) 
were carried out on 12 well plates of 3T3-L1 adipocytes treated with the two 
siRNA duplexes against USP25 and the scrambled control. 
As shown in Figure 5.9, there is a reduction in fold change in [3H] 2-deoxyglucose 
uptake on insulin stimulation in USP25 depleted cells.  Results are expressed as 
fold change rather than absolute values due to the transient transfection method 
used (detailed in section 2.3.3).  Unlike a cell line stably expressing an siRNA or 
shRNA construct there may be varying knockdown efficiencies and levels of 
cytotoxicity between batches of cells used for each experiment; this means it is 
more meaningful to compare the transport activities of cell populations within 
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experiments rather than use absolute values, however these are recorded in 
Appendix II. 
The reduction in [3H] 2-deoxyglucose uptake in USP25 depleted cells, coupled 
with the data from Figure 5.7, indicates that the reduced stability of GLUT4 in 
USP25 depleted cells is responsible for their reduced glucose uptake capacity. 
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Figure 5.9 Fold change in [3H] 2-deoxyglucose uptake is reduced on insulin stimulation of 
USP25 depleted 3T3-L1 adipocytes.   
12-well plates of 3T3-L1 adipocytes were treated with the indicated siRNA as described, and 
assayed for uptake of [3H] 2-deoxyglucose on day 8 post differentiation.  Results were analysed 
using an unpaired student’s T-test. * - p < 0.05.  Error bars represent ± standard error of the mean, 
n = 3.  The raw data for this figure are presented in Appendix II. 
 
5.5 Generation and characterisation of USP25 antisera. 
The anti-USP25 antibody used in this study was a gift from the laboratory of 
Gemma Marfany (Universitat di Barcelona).  To allow larger scale experiments to 
be carried out I set out to generate antisera against USP25 which could be used 
in future experiments.  
I initially produced recombinant GST-USP25 on glutathione-Sepharose beads as 
described in 5.3.1, and cleaved untagged USP25 from the beads using thrombin.  
The pGEX 4T-1 vector used in these experiments contains a thrombin cleavage 
site at the C-terminus of the GST tag.   
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Figure 5.10 Thrombin cleavage of GST-USP25.   
Recombinant GST-USP25 was purified as described in 5.3.1 on glutathione-Sepharose beads.  
The beads were treated with 0.04 units/µl thrombin in thrombin cleavage buffer (50 mM Tris-HCl 
pH 8.0, 150 mM NaCl, 2.5 mM CaCl2) for 2 hours at room temperature, and untagged USP25 
collected in the supernatant after brief centrifugation at 500 xg and 4 °C.  20 µl samples of beads 
before cleavage (GST-USP25 beads), supernatant (Cleavage product) and beads after cleavage 
were heated at 37 °C for 30 minutes with 20 µl 2xLS B and 20 µl of the eluate subjected to SDS-
PAGE on a 10 %(v/v) gel.  Bands were visualized by Coomassie staining and subsequent 
destaining. 
 
The untagged USP25 was used to immunize two New Zealand white rabbits, with 
serum collected at the time points described in Materials and Methods section 
2.5.4.  I tested the sera for immunoreactivity against purified GST and GST-
USP25.  The results of this experiment are shown in Figure 5.11 As expected, the 
pre immune serum from both rabbits does not detect GST-USP25.  The small 
bleed from 2198 detects GST-USP25 at a low level.  However the large and final 
bleeds of both 2198 and 2199 show increased immunoreactivity against GST-
USP25.   Importantly the large and final bleeds from 2199 show the least cross-
reaction with the GST purification tag (visible at approximately 25 kD) which 
suggests that the sera from 2199 may be more suited for use in future 
experiments. 
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Figure 5.11 Sera from rabbits 2198 and 2199 tested against recombinant GST and GST-
USP25.   
Pre-immune, small, large and final bleeds of rabbits 2198 and 2199 were tested for 
immunoreactivity against 1 µg of either GST or GST USP25, subjected to SDS-PAGE on 10 % 
(v/v) gels, immunoblotted and incubated with each of the sera at 1:1000 dilution overnight at 4 °C 
 
I went on to analyse whether the 2198 and 2199 sera could be used to detect 
USP25 from a mammalian cell lysate.  I ran two sets of 3T3-L1 adipocyte lysate 
samples, with decreasing amounts of protein, and probed them with a 1:1000 
dilution of both 2198 and 2199 sera from the final bleed.  After ECL 
visualization, the same membranes were stripped and reprobed with the two 
antisera, this time incubated with 8 µg GST-USP25.  As this fusion protein 
contains the antigen against which 2198 and 2199 was raised its presence would 
be expected to reduce the immunoreactivity of endogenous USP25 on the blots 
by competing for USP25 specific antibodies. 
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Figure 5.12 Testing sera 2198 and 2199 against 3T3-L1 adipocyte lysates.   
Decreasing amounts of 3T3-L1 adipocyte lysates (30, 20 and 10 µg protein added) were subject to 
SDS-PAGE and blotted with 2198 and 2199 antisera at 1:1000 dilution (left panels).  After 
visualization, the membranes were stripped using stripping buffer (100 mM glycine, 150 mM NaCl, 
pH 2) for 20 minutes, blocked and re probed with the two antisera in the presence of 8 µg GST-
USP25 (right panels).  Arrow indicates putative USP25 band. 
 
The results of this experiment are shown in Figure 5.12.  Unfortunately it 
appears that both sera recognise a number of antigens in the adipocytes lysates.  
However there are noticeable bands at approximately 140 kD in all three lanes 
for both sera, which corresponds to the molecular weight of USP25 from previous 
studies (Meulmeester et al., 2008).  These bands appear to be depleted on 
incubation with GST-USP25, which indicates that these bands may represent 
endogenous USP25.  However this result is very preliminary as the experiment 
was only carried out once and has been included here primarily for 
documentation purposes. 
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5.6 Chapter Discussion. 
In this chapter I set out to test the hypothesis that USP25 is recruited by 
tankyrase (through its interaction with IRAP) to GSVs, where it deubiquitinates 
GLUT4 and prevents the transporter from being delivered to the lysosome.  I 
followed two lines of investigation to test this hypothesis.  Firstly, I used an in 
vitro pull-down approach to indentify whether USP25 can interact directly with 
tankyrase, as predicted by yeast-2-hybrid analysis (Sbodio and Chi, 2002).  
Secondly I transiently depleted USP25 from adipocytes using siRNA, and analysed 
the effect on GLUT4 stability and insulin responsiveness in these cells. 
I purified recombinant GST-USP25 and GST, immobilized on glutathione-
Sepharose beads.  The GST-USP25 fusion protein pulled tankyrase 1 down from a 
3T3-L1 adipocyte lysates, whereas GST alone did not.  This shows that USP25 and 
tankyrase can interact, as previously demonstrated by yeast-2-hybrid analysis 
(Sbodio and Chi, 2002;Seimiya and Smith, 2002).   
To investigate whether this interaction is dependent on the putative tankyrase 
binding motif, as found for other tankyrase binding substrates (Chi and Lodish, 
2000;Sbodio and Chi, 2002;Seimiya and Smith, 2002) I mutated the conserved 
arginine residue at position 1049 within the motif, and introduced GST-USP25 
R1049A in to the pull-down assay.  This approach resulted in ablation of binding 
of tankyrase 1 to USP25. 
Of note, in these assays there is no obvious interaction with tankyrase 2, despite 
the fact that tankyrase 2 contains the same ankyrin repeat domains required for 
interaction as tankyrase 1 (Sbodio et al., 2002;Hsiao and Smith, 2008).  This 
result is not particularly surprising as tankyrase 2 is not present at high enough 
levels in 3T3-L1 adipocytes to interact with GST-IRAP at detectable levels in a 
pull-down assay (Sbodio et al., 2002), indicating that there may be no 
detectable interaction with USP25 for similar reasons. 
The findings from the pull-down studies indicate that USP25 is a bona fide 
tankyrase binding partner, with a functional tankyrase binding motif.  These 
data have been substantiated by immunoprecipitation experiments, showing an 
interaction between tankyrase and USP25 in vivo (N-W Chi, personal 
communication).  Given that tankyrase contains multiple sites that can interact 
with partner proteins in its ankyrin repeat domains (Seimiya and Smith, 2002), it 
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seems plausible that tankyrase can act as a scaffold protein at GSVs, binding the 
GSV cargo protein IRAP and recruiting USP25. 
To investigate the role of USP25 in GLUT4 trafficking I depleted USP25 using 
siRNA.  After two consecutive days of transfection with siRNA duplexes targeted 
against USP25, there was ~35 % less GLUT4 compared to cells transfected with 
an untargeted siRNA duplex.  This suggests that GLUT4 is stabilised by the 
presence of USP25, which is consistent with my hypothesis of the role of USP25 
in deubiquitinating GLUT4, preventing its lysosomal degradation and “trapping” 
it in GSVs. 
These data are interesting in the context of recent data concerning the role of 
DUBs in plasma membrane receptor recycling.  Plasma membrane receptors 
including the Drosophila Wnt receptor Frizzled and the β2-adrenegic receptor 
(Shenoy et al., 2009;Berthouze et al., 2009;Mukai et al., 2010) can, after 
ubiquitin-dependent internalization, be stabilized by deubiquitination, allowing 
them to recycle to the cell surface and preventing their lysosomal degradation.  
However my finding is novel in the context of intracellular traffic from the TGN 
to a secretory compartment – ubiquitinated proteins sorted from the TGN into 
the endosomal system are thought to only be deubiquitinated by ESCRT-
associated DUBs such as AMSH and Doa4p before entry into multivesicular bodies 
(Swaminathan et al., 1999;Agromayor and Martin-Serrano, 2006;Nikko and 
Andre, 2007).   
Further characterization of the USP25 depleted cells by lysosome inhibition 
proved problematic as the method used for inhibition of lysosomal hydrolases, 
treatment with 15 mM NH4Cl (Amenta and Brocher, 1980;Chandler and Ballard, 
1983), generally reduced the effectiveness of USP25 knockdown (Figure 5.8 and 
data not shown).  The reduced effectiveness of the knockdown was probably due 
to the inhibition of endosome acidification by NH4Cl (Gary et al., 2007); this 
would prevent release of the siRNA from nanoparticles and its uptake into the 
cytosol.   
Another possible method for investigating whether the lysosome is involved in 
GLUT4 degradation would be to use a pulse chase experiment.  For example the 
USP25 knockdown adipocytes could be treated with siRNA duplexes for two days 
(as described in 5.4).  These cells could be subsequently treated with a lysosome 
inhibitor such as 15 mM NH4Cl and the half life of newly synthesised GLUT4 
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followed using pulse-chase labelling followed by immunoprecipitating GLUT4 at 
various timepoints.  The difference between the half life of GLUT4 in cells with 
and without lysosome inhibition could then be compared – if GLUT4 is degraded 
at the lysosome the half life of GLUT4 would be expected to be longer in cells 
treated with 15 mM NH4Cl.  Measuring the rate of degradation of newly 
synthesised GLUT4 in this manner would circumvent the problem of reduced 
siRNA uptake in the presence of an inhibited endosomal system.  Another 
possibility would be to use a lysosomal inhibitor that did not alter the 
acidification of the endosomal system and instead inhibits the lysosomal 
peptidases directly, an example being leupeptin (Maeda et al., 1971).  This 
method may not interfere with the pH dependent release of siRNA from the 
endosomal system (Gary et al., 2007). 
On assaying the glucose transport activity of the USP25 knockdown cells, they 
were found to have a reduced fold change in insulin stimulated glucose transport 
compared to cells transfected with an untargeted siRNA (Figure 5.9).  This 
suggests that GLUT4 is being trafficked away from the insulin responsive pool, or 
that the GLUT4 present in the insulin responsive pool of the knockdown cells is 
less able to respond to insulin.  When taken together with the data from Figure 
5.7 it seems possible that the observed GLUT4 depletion is responsible for the 
reduced glucose transport – perhaps the population of GLUT4 normally routed to 
GSVs (and therefore ubiquitinated) is being diverted to the lysosome in USP25 
depleted cells, resulting in the observed reduction in fold change on insulin 
stimulation. 
The attempt to generate a USP25 antiserum was partially successful.  
Recombinant GST-USP25 could be detected by both sera.  However endogenous 
USP25 from 3T3-L1 adipocytes was harder to detect, with a number of other 
bands being recognised by the sera.  Use of antigen competition seemed to show 
that USP25 was amongst the bands detected by the two sera – although this 
result remains preliminary as the competition experiment was only carried out 
once.  If this result stands up to repetition, the population of USP25 specific IgG 
would need to be immunopurified from the sera – the sera could be passed over 
a column of immobilised USP25 (antigen), allowing binding of USP25 specific IgG 
to the antigen.  Nonspecific antibodies could then be washed off and USP25 
specific IgG eluted.   
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Overall, the data presented in this chapter support the model that USP25 
associates with GLUT4 containing compartments via a complex of IRAP and 
tankyrase, acting as a scaffolding protein, in a manner dependent on its C-
terminal RTPADG motif, and that USP25 is required for maintenance of GLUT4 
stability.  However, more work clearly needs to be done to elucidate the 
underlying molecular mechanisms.  As discussed in 5.1, in yeast a constitutively 
ubiquitinated version of GLUT4 (GLUT4 7K/R-Ub) is sorted into the yeast 
endosomal system and degraded (McCann R.K., 2007).  However, when this 
fusion protein is expressed in adipocytes, it remains in the TGN, neither being 
degraded at the lysosome nor translocating in response to insulin (McCann R.K., 
2007).  These data do not necessarily implicate a DUB step in GLUT4 traffic.  It 
may be that in the case of GLUT4 in 3T3-L1 adipocytes the architecture of the C-
terminal ubiquitin fusion is not adequate to induce GGA dependent sorting out of 
the TGN to the endosomal system, unlike ubiquitination on a cytosolic lysine 
residue (this study, chapter 3, (Lamb et al., 2010)). 
My findings that USP25 depletion results in depletion of GLUT4 and alterations to 
its insulin responsive traffic are also interesting in the context of studies where 
IRAP and tankyrase are depleted.  IRAP knockout mice have normal glucose 
tolerance, but exhibit depletion in total GLUT4 levels and reduced insulin 
responsive glucose uptake in certain tissues (Keller et al., 2002).  In studies of 
3T3-L1 adipocytes depleted of IRAP (Yeh et al., 2007;Jordens et al., 2010) and 
tankyrase (Yeh et al., 2007) the insulin responsive translocation of GLUT4 is 
blunted – both these lines of evidence support a role for a putative IRAP-
tankyrase-USP25 complex at GSVs.  However, studies of tankyrase deficient mice 
have yielded conflicting data.  Tankyrase-1 knockout mice apparently have an 
expanded cellular pool of GLUT4 and a corresponding increase in insulin 
stimulated fold change in glucose transport (Yeh et al., 2009).  In contrast, 
tankyrase-2 knockout mice do not exhibit any significant perturbation in insulin 
stimulated glucose transport (Chiang et al., 2008).  Further study of tankyrase 
depletion and its effects on GLUT4 would clearly be valuable. 
Overexpression of dominant interfering or dominant negative versions of DUBs is 
a technique often used to interpret their function (Mukai et al., 2010).  Given 
the data I have presented a catalytically inactive mutant such as that described 
in previous studies (Denuc et al., 2009), where the conserved catalytic cysteine 
(C178) residue is mutated could be used.  This could theoretically prevent 
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active, endogenous USP25 binding to the tankyrase scaffold and potentially 
replicate the phenotype seen for USP25 knockdown cells.  In the aforementioned 
study this mutant was used to study the stability of a specific USP25 substrate, 
MyBPC1 (Denuc et al., 2009). 
Another useful tool would be a 3T3-L1 fibroblast cell line with a stable USP25 
knockdown, or a knockdown which is under the control of an inducible system.  
This would make it possible to “add back” an siRNA resistant USP25 and observe 
whether the knockdown phenotype is rescued.  As 3T3-L1 adipocytes are 
relatively difficult to work with in terms of generating a stable cell line due to 
the limited number of times the cells can be passaged, one possibility for 
generation of a stable cell line is to use a more tractable cell line where insulin 
signalling has been reconstituted.  Chinese hamster ovary (CHO) cells expressing 
GLUT4 have been shown to recapitulate aspects of the insulin responsive GLUT4 
trafficking pathway seen in 3T3-L1 adipocytes (Dobson et al., 1996;Lampson et 
al., 2000) and may prove a useful model system for testing effects of USP25 
knockdown and overexpression before moving to work on adipocytes. 
The USP25 R1049A mutant, which I showed to be deficient in tankyrase binding, 
could also be expressed in this background.  If interaction with tankyrase is 
required for USP25 to exert its stabilising effect on GLUT4, the tankyrase binding 
deficient R1049A mutant would be expected not to have this effect.  A stable 
knockdown of USP25 would also be helpful in addressing the issue of how GLUT4 
is depleted in the absence of USP25.  It would be possible to use lysosome 
inhibitors such as NH4Cl or leupeptin on this cell line as there would be no issues 
with transfection reagents altering siRNA uptake.  Another possibility for 
interfering with lysosomal function in USP25 depleted cells would be to knock 
down expression of components of the ESCRT machinery as this would interfere 
with multivesicular body formation and thus lysosomal protein degradation.  
Depletion of ESCRTI, II and III subunits has previously been shown to stabilise 
EGFR and prevent internalisation into MVBs (Bache et al., 2006;Malerod et al., 
2007). 
In summary, the data in this chapter substantiate the yeast two hybrid (Sbodio 
and Chi, 2002) and in vivo immunoprecipitation (N-W Chi, unpublished) data that 
tankyrase and USP25 can interact, and moreover demonstrate that the 
interaction is dependant on the RTPADG motif between residues 1049 and 1054  
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of USP25.  Additionally, the data indicate that USP25 is involved in maintaining 
GLUT4 stability.  These findings support my hypothesis that a deubiquitination 
step is required for the insulin responsive traffic of GLUT4. 
  
 
 
 
 
 
Chapter 6 – Final Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6  146 
The overall aim of this study was to investigate the mechanisms underlying 
GLUT4 entry the insulin responsive compartment, which is one of the key 
questions remaining to be addressed in our understanding of GLUT4 traffic 
(Bryant et al., 2002).  More specifically I tested the hypothesis that 
ubiquitination of GLUT4 is required for the GGA-dependent sorting step from the 
trans-Golgi network (TGN) to the insulin responsive compartment, with 
subsequent deubiquitination stabilising GLUT4 and preventing its traffic to the 
lysosome. 
 
6.1 Ubiquitination of GLUT4 
Previous work in the Bryant group has shown that GLUT4 expressed in yeast 
traffics in a nitrogen-regulated manner similar to Gap1p (McCann R.K., 2007).  
Like Gap1p, GLUT4 expressed in yeast is ubiquitinated (Lamb et al., 2010), and 
functional ubiquitin acceptor sites as well as the Ggas are required for its 
trafficking into the endosomal system (Lamb et al., 2010).  Given these data I 
decided to first test whether GLUT4 is ubiquitinated in 3T3-L1 adipocytes, and if 
so, whether ubiquitination is required for entry into the insulin responsive 
compartment. 
Initial work on GLUT4 ubiquitination in 3T3-L1 cells had been carried out by a 
former member of the group (Dr. R.K. McCann), using a retroviral expression 
construct encoding GLUT4 with an HA-tag in the first exofacial loop (pHA-GLUT4) 
(Shewan et al., 2000) and a construct expressing ubiquitin resistant HA-GLUT4 
7K/R (pRM4; Table 2.3 (Lamb et al., 2010)).  However in these initial 
experiments, HA-GLUT4 was expressed at approximately twenty fold greater 
levels than HA-GLUT4 7K/R (McCann R.K., 2007), as pRM4 lacked sequences 5’ of 
the GLUT4 open reading frame which seemed to raise expression of HA-GLUT4 
(Fukumoto et al., 1989;Quon et al., 1994).  Concerns were also raised about the 
structure of HA-GLUT4 7K/R.  Five of the seven cytosolic lysines are located 
within the large intracellular loop of GLUT4, a region required for binding of 
factors involved in GLUT4 sorting – specifically, the lysine residue at position 245 
is involved in recruitment of the ARF GAP ACAP1, required for clathrin coat 
nucleation (Li et al., 2007).  Therefore, mutation of the five lysines within the 
large intracellular loop could disrupt the structure of this region, altering 
binding of ACAP1 and consequently blocking entry into GSVs. 
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I addressed these concerns in Chapter 3 by making use of constructs already 
present in the lab encoding versions of HA-GLUT4 with single cytosolic lysines 
outwith the large intracellular loop (pRM35 and 36 encoding HA-GLUT4 6K/R 109 
and 495 respectively ((Table 2.3)).  These constructs were based on pRM4 and 
should thus express at the level seen for the 7K/R mutant.  Firstly, in 
collaboration with Dr R.K. McCann, I subcloned a fragment of pHA-GLUT4 into 
simultaneously digested pRM36, generating a retroviral expression construct 
encoding the HA-GLUT4 ORF but lacking the 5’ sequence (pRM55).  When 
assayed by western blotting, levels of HA-GLUT4 (expressed from pRM55), HA-
GLUT4 7K/R and the two 6K/R mutants were similar, which dealt with the issue 
of the overexpression of HA-GLUT4 previously observed (McCann R.K., 2007). 
Also, in collaboration with Dr R.K. McCann I developed a pull-down assay, using a 
GST tagged UBA domain of the yeast protein Dsk2p (Ohno et al., 2005) (GST-
UBA), to enrich for ubiquitinated species.  This approach showed that a small 
proportion of endogenous GLUT4 is ubiquitinated (Figure 3.6) – this was 
quantified by our group, showing approximately 0.1 % of total GLUT4 is 
ubiquitinated in 3T3-L1 adipocytes (Lamb et al., 2010).  I went on to use this 
approach to analyse the ubiquitination status of HA-GLUT4, HA-GLUT4 7K/R and 
the two 6K/R mutants, and found that HA-GLUT4 and both 6K/R mutants were 
ubiquitinated to a similar extent, whereas HA-GLUT4 7K/R was not (Figure 
3.6)(Lamb et al., 2010). 
To address the issue of disruption of the structure of the large intracellular loop 
in HA-GLUT4 7K/R, I expressed HA-GLUT4, HA-GLUT4 7K/R and the two 6K/R 
mutants in 3T3-L1 adipocytes and studied their ability to translocate in response 
to insulin stimulation using labelling of the exofacial HA tag.  This approach 
showed that HA-GLUT4 7K/R does not translocate in response to insulin, whereas 
HA-GLUT4 and the two HA-GLUT4 6K/R mutants all translocated to a similar 
extent (Figure 3.8) (Lamb et al., 2010).  These findings support the hypothesis 
that GLUT4 ubiquitination is required to enter GSVs, as only those versions of 
GLUT4 with functional ubiquitination sites translocate in response to insulin.  
Also, these data suggest that mutation of the lysine residues within the large 
intracellular loop does not alter the structure of this region sufficiently to affect 
recruitment of factors involved in GLUT4 translocation, such as ACAP1 (Li et al., 
2007).  The mutations introduced into the large intracellular loop of GLUT4 by Li 
et al were alanine scanning mutations, so the bulky basic R-group of lysine was 
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being replaced by the much smaller, neutral alanine.  In this study the lysines 
were being replaced by another residue with a bulky, basic R-group, arginine, 
and this would be expected to alter the charge and structure of the large 
intracellular loop much less. 
To confirm that the defect in HA-GLUT4 7K/R sorting was at the level of entry 
into GSVs rather than translocation itself, I utilised two subcellular fractionation 
approaches.  The first was to isolate light density microsomes (which include 
GSVs) from adipocytes and separate them on a self forming iodixanol gradients 
(Hashiramoto and James, 2000).  This method proved too variable even with wild 
type HA-GLUT4 to give reliable results (Figure 3.9). 
Instead, I utilised a differential centrifugation method that produces a fraction 
enriched in GSVs (Xu and Kandror, 2002;Kupriyanova et al., 2002;Li and Kandror, 
2005).  Using this method, HA-GLUT4 7K/R was found to be depleted from the 
GSV enriched fraction, containing approximately 30 % of total GLUT4 (Figure 
3.10) (Lamb et al., 2010).  This was significantly less than the approximately 55 
% of total GLUT4 observed for HA-GLUT4 and the two 6K/R mutants (Lamb et 
al., 2010). 
The data presented in Chapter 3 support the hypothesis that GLUT4 
ubiquitination is required to sort the transporter into the insulin responsive 
compartment.  GLUT4 ubiquitination can be added to the C-terminal TELEY 
motif as a signal on GLUT4 required for its sorting into GSVs (Shewan et al., 
2000;Blot and McGraw, 2008).  
Previously, ubiquitination of membrane proteins has been thought of as a signal 
for internalisation and subsequent degradation of membrane proteins, including 
MHCII (Shin et al., 2006) and aquaporin 2 (Kamsteeg et al., 2006). Sorting of Fas 
ligand into secretory lysosomes also requires ubiquitination, but likely has more 
in common with ESCRT dependent sorting into multivesicular bodies than sorting 
into classical secretory compartments (Zuccato et al., 2007).  The finding that 
GLUT4 ubiquitination is required for sorting into its secretory compartment is 
therefore novel in terms of protein sorting from the TGN.  
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6.2 The GGA3 GAT domain and GLUT4 traffic. 
To further characterise how ubiquitin dependent sorting of GLUT4 occurs, I 
turned my attention to the GGA family of clathrin adaptors which, as mentioned 
earlier, have been implicated in sorting GLUT4 into GSVs (Watson et al., 2004;Li 
and Kandror, 2005).  The GAT domain of GGAs is responsible for ubiquitin 
binding (Scott et al., 2004;Shiba et al., 2004;Bilodeau et al., 2004), and GGA3 
GAT appears to have the highest avidity for ubiquitin (Puertollano and 
Bonifacino, 2004;Shiba et al., 2004).  With this in mind, in Chapter 4 I used a 
ubiquitin binding deficient mutant of GGA3 (E250N D284G) to study the 
interaction with GLUT4 in vitro, and effects on GLUT4 sorting in vivo.  In an in 
vitro pull-down assay using immobilised GST-GGA3 VHS-GAT (GST-VHS-GAT) and 
a ubiquitin binding deficient mutant thereof (GST-VHS-GATmut) I demonstrated 
that GLUT4 expressed in yeast can bind to GST-VHS-GAT, however this 
interaction is reduced on mutation of the ubiquitin binding region of the GAT 
domain (Figure 4.6). 
I attempted to use the pull-down approach to investigate the role of the GAT 
domain in binding endogenous GLUT4 from 3T3-L1 adipocytes.  However it 
proved difficult to detect any interaction between recombinant GST-VHS-GAT 
and GLUT4 with this approach (Figure 4.7); possibly due to the relatively low 
affinity of the GAT domain for ubiquitin (Kawasaki et al., 2005), and the small 
proportion (0.1 %) of ubiquitinated GLUT4 in 3T3-L1 cells (Lamb et al., 2010). 
What possible methods could be used to overcome these obstacles, to better 
study the interaction of endogenous GLUT4 and the GGAs?  One possibility would 
be to enrich ubiquitinated species in 3T3-L1 cells, perhaps by lysosome inhibition 
(Chandler and Ballard, 1983) or knockdown of ESCRT subunits, which has been 
shown to result in an accumulation of ubiquitinated species at endosomes 
(Bishop et al., 2002).  A second possibility would be to take a more biochemical 
approach and use immobilised GST-UBA (described in Chapter 3) to purify 
ubiquitinated proteins from a large amount of adipocyte lysate – this would 
include GLUT4-Ub.  The ubiquitinated proteins could be eluted from the GST-
UBA column and passed over a GST-VHS-GAT or GST-VHS-GATmut column, and 
interacting proteins detected by immunoblot.  However this approach would be 
no small undertaking and would require significant optimisation.   
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It would also be interesting to study the effect of introducing yeast-expressed 
GLUT4-7K/R into the GST-VHS-GAT/GST-VHS-GATmut pull-down assay.  As this 
mutant is ubiquitin resistant, it would be expected to bind GST-VHS-GAT much 
less readily than the wild type transporter. 
Further characterisation of the role of the GGA3 GAT domain in GLUT4 sorting in 
yeast in vivo would also be beneficial.  As I have previously discussed (1.2.2), a 
chimaeric protein consisting of yeast Gga2p with the GAT domain of human 
GGA3 (Gga2p-GATGGA3) rescues Gap1p trafficking defects when expressed in a 
gga1/2∆ yeast strain (Bilodeau et al., 2004).  Our group has shown that GLUT4 
expressed in yeast traffics in a nitrogen-responsive and ubiquitin-dependent 
manner similar to Gap1p (McCann R.K., 2007;Lamb et al., 2010), and that GLUT4 
sorting into the yeast endosomal system requires Ggas (Lamb et al., 2010).  
Therefore if GLUT4 and Gga2p-GATGGA3 were co-expressed in a gga1/2∆ yeast 
strain this system could be used to analyse the effect of mutations in the 
ubiquitin binding GAT of GGA3 domain on GLUT4 sorting. 
Having established that GST-VHS-GATmut is impaired in its ability to interact with 
ubiquitin, I went on to express full length myc-GGA3 (short isoform) and a 
mutant version harbouring the E250N D284G point mutations (myc-GGA3mut) from 
retroviral constructs in 3T3-L1 adipocytes, to study the effects of expressing the 
mutant on GLUT4 loading into GSVs and glucose transport.  My first observation 
on expression of these two proteins in 3T3-L1 cells was that myc-GGA3mut was 
expressed at much higher levels than the wild type protein, despite the 
expression cassettes being in identical vector backgrounds (pBABE puro; 
(Morgenstern and Land, 1990)).  As I speculated in section 4.5, it may be that 
the reduced ubiquitin binding function of myc-GGA3mut results in a reduction in 
its ubiquitination, leading to increased stability.  It already known that GAT 
mutation alters GGA3 ubiquitination (Shiba et al., 2004) although the stability of 
GGA3 in this context was not measured.  Use of pulse-chase to radiolabel newly 
synthesised myc-GGA3 and myc-GGA3mut could allow the stability of both 
proteins to be measured.  Despite the observed difference in expression there 
was no obvious effect on the subcellular localisation of myc-GGA3mut compared 
to the wild-type protein (Figure 4.9). 
With the differing expression of myc-GGA3 and myc-GGA3mut in mind, I went on 
to analyse the effects of expressing these two proteins on the loading of GLUT4 
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into the GSV enriched 16,000 xg supernatant, as had been done previously in 
cells expressing a dominant negative GGA (Li and Kandror, 2005).  Expression of 
myc-GGA3mut resulted in 10 % less total GLUT4 being loaded into the GSV 
enriched fraction (Figure 4.10).  This result was interesting in that it replicated 
the decreased loading of GLUT4 into the 16,000 xg supernatant observed by Li 
and Kandror (2005), albeit to a lesser extent, and indicated that the ubiquitin 
binding function of the GAT domain is at least partly required for sorting GLUT4 
into GSVs.  There was no significant effect of myc-GGA3 expression on GLUT4 
loading into the 16,000 xg supernatant, which might be expected due to the low 
expression of the wild type protein.  It is also important to note that the 2005 
study (Li and Kandror) did not use a wild-type GGA protein as a control, instead 
comparing empty vector transfected cells with cells expressing dominant 
negative GGA (EGFP-VHS-GAT).   
Although there is a significant effect on GLUT4 loading into the 16,000 xg 
supernatant on expression of myc-GGA3mut, this did not translate into a 
significant effect on GLUT4 translocation as measure indirectly by [3H] 2-
deoxyglucose uptake (Figure 4.11).  The variability of the measured uptake rates 
(as detailed in Appendix I) likely contributed to this. 
Although more technically challenging, the effect of myc-GGA3/myc-GGA3mut 
expression on GLUT4 translocation could be measured more directly by using the 
HA-GLUT4 translocation assay detailed in chapter 3.  3T3-L1 cells could be stably 
infected with a retroviral construct with a particular antibiotic resistance, for 
example hygromycin, encoding HA-GLUT4.  This stable cell line could then 
subsequently be infected with the pBABE puro based GGA3 constructs, and their 
effects on HA-GLUT4 translocation measured by analysing the levels of HA 
immunoreactivity in the plasma membrane of insulin stimulated adipocytes. 
In summary, my work on the role of the GGA3 GAT domain in GLUT4 traffic has 
shown that the ubiquitin binding function of this domain is at least partially 
required for the sorting of GLUT4 into the insulin responsive compartment, 
perhaps working in concert with other GSV cargoes such as sortilin to sort GLUT4 
into GSVs from the TGN.  My data, when considered with previous studies from 
our lab, indicate that GGA3 facilitates ubiquitin dependent GLUT4 sorting into 
GSVs. 
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6.3 The deubiquitinase USP25 and GLUT4 traffic. 
Although my work in chapters 3 and 4, and previous studies from our group 
(McCann R.K., 2007;Lamb et al., 2010) have implicated GLUT4 ubiquitination in 
its sorting into GSVs, there is a caveat in that ubiquitination of membrane 
proteins directs them into the ESCRT dependent MVB sorting pathway, 
eventually leading to degradation at the lysosome (Hicke and Dunn, 2003;Piper 
and Luzio, 2007).  Our group has previously shown that only 0.1 % of endogenous 
GLUT4 is ubiquitinated in 3T3-L1 adipocytes (Lamb et al., 2010), suggesting that 
the modification is transient.  A requirement for deubiquitination has previously 
been demonstrated for the recycling of several cell surface proteins, including 
Frizzled (Mukai et al., 2010) and β2-AR (Berthouze et al., 2009).  Given these 
data, I reasoned that the ubiquitin modification on GLUT4 may be a transient 
one, and that there may be a deubiquitination step involved in GLUT4 traffic.   
A link between GLUT4 traffic and a deubiquitinase has been provided by several 
studies from the laboratory of Nai-Wen Chi (UCSD).  Work from his laboratory 
identified a role for the GSV cargo IRAP and its binding partner tankyrase in the 
trafficking of GLUT4 (Chi and Lodish, 2000;Yeh et al., 2007).  Yeast two hybrid 
studies by the same group identified that the deubiquitinase USP25 can interact 
with tankyrase and contains a putative tankyrase binding motif (RTPADG) near 
the C-terminus (Sbodio and Chi, 2002). 
To extend these data, I used a GST pull-down approach to investigate the 
interaction between tankyrase and recombinant USP25. I found that GST-USP25 
could pull detectable levels of tankyrase 1 out of an adipocyte lysate (Figure 
5.4), and that mutation of the conserved arginine residue within the putative 
tankyrase binding motif prevented this interaction (Figure 5.6).  These findings 
substantiate the yeast-2-hybrid data (Sbodio and Chi, 2002) and more recently 
generated in vivo co-immunoprecipitation data (N-W Chi, unpublished) that 
USP25 and tankyrase interact, and moreover show that the interaction is direct 
and depends on the integrity of the USP25 RTPADG motif.  This supports my 
hypothesis that tankyrase and IRAP form a platform to recruit the DUB USP25 to 
GSVs. 
Although the pull-down data are conclusive, it would be interesting to extend 
the investigation of the USP25-tankyrase interaction further.  For instance, an 
epitope tagged version of USP25 R1049A and its wild type counterpart could be 
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expressed in 3T3-L1 adipocytes, immunoprecipitated and co-precipitated 
proteins blotted for tankyrase.  If tankyrase 1 was not co-immunoprecipitated 
with USP25 R1049A this would lend further weight to my hypothesis that the two 
proteins interact directly and form part of a complex in 3T3-L1 adipocytes. 
Another possibility would be to attempt to reconstitute the putative IRAP-
tankrase-USP25 complex in vitro.  It has previously been demonstrated that the 
IRAP RQSPDG tankyrase binding motif alone readily binds tankyrase 1 from a 
3T3-L1 lysate when expressed as a GST fusion protein (GST-RQSPDG) (Sbodio et 
al., 2002).  This recombinant protein could be immobilised on glutathione-
Sepharose beads and recombinant USP25 and tankyrase added to the beads 
individually and in combination with appropriate controls, for example, non-
tankyrase binding versions of GST-RQSPDG and USP25, or adding recombinant 
USP28 in place of USP25, as it is a homologue of USP25 (Valero et al., 2001).  If 
the three proteins formed a complex, I would anticipate recombinant USP25 to 
be pulled down by the GST-RQSPDG, with tankyrase 1 acting as a scaffold linking 
the two molecules.  This method would however require some optimisation, 
especially regarding expression of recombinant tankyrase 1. 
I went on to deplete USP25 in 3T3-L1 adipocytes using siRNA (Figure 5.7) and 
found that depletion of USP25 resulted in a reduction in the amount of GLUT4 in 
3T3-L1 adipocytes (Figure 5.7), suggesting that USP25 is involved in maintaining 
GLUT4 stability.  My initial attempt to ascertain whether the lysosome was 
responsible for this reduction in GLUT4 levels was hampered by the transfection 
method used and the lysosome inhibitors available; however further 
investigation of this would be valuable, as discussed in section 5.6.  I went on to 
analyse the effect of the observed GLUT4 depletion on insulin responsive glucose 
uptake, and found that the fold change in [3H] 2-deoxyglucose uptake was 
reduced on USP25 knockdown.  These data suggest that the proportion of GLUT4 
lost on USP25 knockdown may represent an insulin responsive pool of the 
protein.  Further analysis of USP25 depleted cells is important, for example the 
subcellular fractionation approach applied in chapters 3 and 4 (Li and Kandror, 
2005;Lamb et al., 2010) could shed light on whether the observed GLUT4 
depletion is actually from GSVs. 
Overall, my investigation of knockdown of USP25 in 3T3-L1 adipocytes supports 
my hypothesis that USP25 is recruited to GSVs by IRAP and tankyrase, and acts to 
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deubiquitinate GLUT4, “trapping” it in GSVs and preventing its traffic to the 
lysosome.  These findings are interesting in the context of studies highlighting 
the importance of deubiquitinases in stabilising cell surface proteins (McCullough 
et al., 2004;Berthouze et al., 2009;Mukai et al., 2010). 
 
6.4 Future directions 
The work I have presented in this thesis implicates ubiquitination of GLUT4 in 
the sorting of the transporter into GSVs.  I have also begun to characterise the 
roles of GGA3 and USP25 in the ubiquitin dependent sorting of GLUT4.  What 
other directions could the study of GLUT4 ubiquitination take? 
One issue to address is which E3 ligase ubiquitinates GLUT4 in 3T3-L1 cells.  Of 
the three enzyme families in the ubiquitination cascade, the E3 ligases are the 
most numerous (with approximately 600 ligases encoded by the human genome 
(Li et al., 2008)) and give the reaction its substrate specificity (Hicke and Dunn, 
2003;Ciechanover, 2005).  Two possible approaches could be taken to identify 
which of the many ligases ubiquitinated GLUT4.  A screen approach using a 
fluorescent GLUT4 reporter (HA-GLUT4-GFP for example (Blot and McGraw, 
2008)) expressed in a readily transfected cell line, such as HEK-293, would be 
one option.  If USP25 was stably depleted in these cells, for example using a 
retroviral shRNA construct, this would deplete GLUT4 and reduce GFP 
fluorescence in these cells to a minimal level.  An siRNA library of E3 ligases 
(Stagg et al., 2009) could be used in this background and the cells assayed for 
fluorescence.  The prediction would be that depletion of the ligase that 
ubiquitinates GLUT4 would result in an increase in GFP fluorescence in these 
cells, as the transporter would be diverted from lysosomal degradation. 
A second possibility would be to look for ligases which can interact with GLUT4, 
or indeed other GSV components, and characterise whether their depletion or 
overexpression affects GLUT4 sorting.  One candidate is βTrCP (β transducing 
repeat containing protein), which is the substrate recognition component of the 
SCF (Skip-Cullin-F box) ligase complex, shown to be required for growth hormone 
receptor degradation (Govers et al., 1999;van Kerkhof et al., 2007).   βTrCP 
recognises motifs related to the sequence DDSWVEFIELD on substrates (Govers et 
al., 1999).  GLUT4 contains a variant of this motif (G. Gould, I. Adamson and N. 
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Bryant, unpublished) and has previously been proposed as a candidate for βTrCP 
directed ubiquitination (Govers et al., 1999).  Mutagenesis of this motif in the 
context of HA-GLUT4, and subsequent analysis of the ubiquitination status, 
insulin responsiveness and subcellular localisation of the mutant would test 
whether this ligase is responsible for ubiquitin dependent GLUT4 traffic. 
GLUT4 has been shown to be SUMOlated (Lalioti et al., 2002).  Levels of GLUT4 
are raised in 3T3-L1 cells by overexpression of the SUMO conjugating enzyme 
Ubc9 and decreased by depletion of the enzyme (Giorgino et al., 2000;Liu et al., 
2007).  However it seems that the scaffolding role of Ubc9 is more important 
than its enzymatic activity in maintaining GLUT4 stability, as overexpression of a 
catalytically inactive version of Ubc9 has the same effect on GLUT4 stability as 
overexpressing the wild type enzyme (Liu et al., 2007).  Further study of the 
interplay between GLUT4 SUMOlation and ubiquitination would be of interest, 
especially in light of data implicating SUMOlation as a tag for protein 
ubiquitination (Mullen and Brill, 2008). 
Finally, as the overall aim of this thesis is to better understand the biology of 
insulin responsive tissues and consequently type 2 diabetes, it would be 
interesting to extend these studies into tissue samples from type 2 diabetic 
patients.  One study has demonstrated that adipose tissue from a cohort of type 
2 diabetic patients, while displaying normal expression of IRAP, exhibits 
markedly altered localisation of the peptidase, with the protein redistributed 
from the GSV enriched LDM (low density microsome) compartment to the HDM 
(high density microsome) and plasma membrane (Maianu et al., 2001).  This IRAP 
redistribution was associated with a depletion of GLUT4 from all membrane 
subfractions (Maianu et al., 2001).  When taken together with the data I have 
generated in this thesis, these findings suggest that the IRAP-tankyrase-USP25 
complex may be being trafficked away from the GSV compartment in this cohort 
of type 2 diabetes patients, resulting in increased ubiquitination and thus 
lysosomal degradation of GLUT4. 
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7.1 Appendix I – Glucose transport assay data for Figure 
4.11 
Basal 
 pBABE myc-GGA3 myc-GGA3mut 
 0.00114 0.00466 0.00234 
 0.00444 0.00307 0.00356 
 0.00119 0.00305 0.003112 
 0.00431 0.00646 0.00571 
Mean 0.00273 0.00431 0.00368 
Standard Deviation 0.00181 0.00162 0.00145 
 
Insulin 
 pBABE myc-GGA3 myc-GGA3mut 
 0.0162 0.0118 0.0117 
 0.0565 0.0334 0.0322 
 0.0271 0.0324 0.0220 
 0.0546 0.0713 0.0398 
Mean 0.0386 0.0372 0.0264 
Standard Deviation 0.0200 0.0248 0.0122 
 
Table 7.1 [3H] 2-deoxyglucose uptake data for Figure 4.11. 
Data are expressed as nmoles [3H] 2-deoxyglucose per minute per well. 
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7.2 Appendix II – Glucose transport assay data for Figure 
5.9 
Basal 
Scrambled siRNA25 siRNA27 
376.6667 562.5567 482.78 
205.2233 508.7833 437.8933 
131.3333 325.3367 346.56 
 
Insulin 
Scrambled siRNA25 siRNA27 
1773.34 761.5567 722.7867 
1207.333 1704.123 1013.94 
609.78 1168.45 1278.237 
 
Table 7.2 Glucose transport assay data for Figure 5.9 
Data are expressed as total counts in 5 minutes. 
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